id	sid	tid	token	lemma	pos
cvj-35	1	1	microsoft	microsoft	PROPN
cvj-35	1	2	word	word	PROPN
cvj-35	1	3	munteanu_dec_2021.docx	munteanu_dec_2021.docx	VERB
cvj-35	1	4	cluj	cluj	NOUN
cvj-35	1	5	vet	vet	NOUN
cvj-35	1	6	j	j	PROPN
cvj-35	1	7	2021	2021	NUM
cvj-35	1	8	,	,	PUNCT
cvj-35	1	9	26	26	NUM
cvj-35	1	10	,	,	PUNCT
cvj-35	1	11	3	3	NUM
cvj-35	1	12	http://clujveterinaryjournal.ro	http://clujveterinaryjournal.ro	PROPN
cvj-35	1	13	review	review	VERB
cvj-35	1	14	the	the	DET
cvj-35	1	15	link	link	NOUN
cvj-35	1	16	between	between	ADP
cvj-35	1	17	mammary	mammary	ADJ
cvj-35	1	18	cancer	cancer	NOUN
cvj-35	1	19	,	,	PUNCT
cvj-35	1	20	excessive	excessive	ADJ
cvj-35	1	21	adipose	adipose	ADJ
cvj-35	1	22	tissue	tissue	NOUN
cvj-35	1	23	and	and	CCONJ
cvj-35	1	24	cholesterol	cholesterol	NOUN
cvj-35	1	25	camelia	camelia	NOUN
cvj-35	1	26	munteanu1	munteanu1	PROPN
cvj-35	1	27	and	and	CCONJ
cvj-35	1	28	bianca	bianca	PROPN
cvj-35	1	29	pop	pop	PROPN
cvj-35	1	30	2	2	NUM
cvj-35	1	31	,	,	PUNCT
cvj-35	1	32	*	*	PROPN
cvj-35	1	33	1university	1university	NUM
cvj-35	1	34	of	of	ADP
cvj-35	1	35	agricultural	agricultural	ADJ
cvj-35	1	36	sciences	science	NOUN
cvj-35	1	37	and	and	CCONJ
cvj-35	1	38	veterinary	veterinary	ADJ
cvj-35	1	39	medicine	medicine	NOUN
cvj-35	1	40	,	,	PUNCT
cvj-35	1	41	department	department	NOUN
cvj-35	1	42	of	of	ADP
cvj-35	1	43	plant	plant	NOUN
cvj-35	1	44	culture	culture	NOUN
cvj-35	1	45	clujnapoca	clujnapoca	NOUN
cvj-35	1	46	,	,	PUNCT
cvj-35	1	47	romania	romania	PROPN
cvj-35	1	48	;	;	PUNCT
cvj-35	1	49	camelia.munteanu@usamvcluj.ro	camelia.munteanu@usamvcluj.ro	VERB
cvj-35	1	50	2university	2university	NUM
cvj-35	1	51	of	of	ADP
cvj-35	1	52	agricultural	agricultural	ADJ
cvj-35	1	53	sciences	science	NOUN
cvj-35	1	54	and	and	CCONJ
cvj-35	1	55	veterinary	veterinary	ADJ
cvj-35	1	56	medicine	medicine	NOUN
cvj-35	1	57	,	,	PUNCT
cvj-35	1	58	department	department	NOUN
cvj-35	1	59	of	of	ADP
cvj-35	1	60	plant	plant	NOUN
cvj-35	1	61	culture	culture	NOUN
cvj-35	1	62	clujnapoca	clujnapoca	NOUN
cvj-35	1	63	,	,	PUNCT
cvj-35	1	64	romania	romania	PROPN
cvj-35	1	65	;	;	PUNCT
cvj-35	1	66	bianca-alexandra.pop@student.usamvcluj.ro	bianca-alexandra.pop@student.usamvcluj.ro	NOUN
cvj-35	1	67	*	*	PUNCT
cvj-35	1	68	correspondence	correspondence	NOUN
cvj-35	1	69	:	:	PUNCT
cvj-35	1	70	bianca	bianca	PROPN
cvj-35	1	71	pop	pop	PROPN
cvj-35	1	72	,	,	PUNCT
cvj-35	1	73	camelia.munteanu@usamvcluj.ro	camelia.munteanu@usamvcluj.ro	NOUN
cvj-35	1	74	;	;	PUNCT
cvj-35	1	75	tel	tel	PROPN
cvj-35	1	76	.	.	PUNCT
cvj-35	1	77	:	:	PUNCT
cvj-35	1	78	0728513284	0728513284	NUM
cvj-35	1	79	abstract	abstract	ADJ
cvj-35	1	80	:	:	PUNCT
cvj-35	1	81	mammary	mammary	ADJ
cvj-35	1	82	cancer	cancer	NOUN
cvj-35	1	83	remains	remain	VERB
cvj-35	1	84	the	the	DET
cvj-35	1	85	most	most	ADV
cvj-35	1	86	frequent	frequent	ADJ
cvj-35	1	87	worldwide	worldwide	ADJ
cvj-35	1	88	type	type	NOUN
cvj-35	1	89	of	of	ADP
cvj-35	1	90	cancer	cancer	NOUN
cvj-35	1	91	in	in	ADP
cvj-35	1	92	females	female	NOUN
cvj-35	1	93	.	.	PUNCT
cvj-35	2	1	from	from	ADP
cvj-35	2	2	a	a	DET
cvj-35	2	3	health	health	NOUN
cvj-35	2	4	point	point	NOUN
cvj-35	2	5	of	of	ADP
cvj-35	2	6	view	view	NOUN
cvj-35	2	7	,	,	PUNCT
cvj-35	2	8	it	it	PRON
cvj-35	2	9	is	be	AUX
cvj-35	2	10	a	a	DET
cvj-35	2	11	huge	huge	ADJ
cvj-35	2	12	challenge	challenge	NOUN
cvj-35	2	13	.	.	PUNCT
cvj-35	3	1	as	as	ADP
cvj-35	3	2	a	a	DET
cvj-35	3	3	definition	definition	NOUN
cvj-35	3	4	,	,	PUNCT
cvj-35	3	5	we	we	PRON
cvj-35	3	6	can	can	AUX
cvj-35	3	7	say	say	VERB
cvj-35	3	8	that	that	SCONJ
cvj-35	3	9	a	a	DET
cvj-35	3	10	group	group	NOUN
cvj-35	3	11	of	of	ADP
cvj-35	3	12	biologically	biologically	ADV
cvj-35	3	13	and	and	CCONJ
cvj-35	3	14	molecularly	molecularly	ADV
cvj-35	3	15	heterogeneous	heterogeneous	ADJ
cvj-35	3	16	diseases	disease	NOUN
cvj-35	3	17	is	be	AUX
cvj-35	3	18	represented	represent	VERB
cvj-35	3	19	by	by	ADP
cvj-35	3	20	mammary	mammary	ADJ
cvj-35	3	21	cancer	cancer	NOUN
cvj-35	3	22	.	.	PUNCT
cvj-35	4	1	an	an	DET
cvj-35	4	2	important	important	ADJ
cvj-35	4	3	causal	causal	ADJ
cvj-35	4	4	factor	factor	NOUN
cvj-35	4	5	for	for	ADP
cvj-35	4	6	this	this	DET
cvj-35	4	7	disease	disease	NOUN
cvj-35	4	8	is	be	AUX
cvj-35	4	9	genetic	genetic	ADJ
cvj-35	4	10	predisposition	predisposition	NOUN
cvj-35	4	11	,	,	PUNCT
cvj-35	4	12	especially	especially	ADV
cvj-35	4	13	mutations	mutation	NOUN
cvj-35	4	14	in	in	ADP
cvj-35	4	15	the	the	DET
cvj-35	4	16	brca1	brca1	PROPN
cvj-35	4	17	or	or	CCONJ
cvj-35	4	18	brca2	brca2	NOUN
cvj-35	4	19	gene	gene	NOUN
cvj-35	4	20	.	.	PUNCT
cvj-35	5	1	the	the	DET
cvj-35	5	2	mammary	mammary	ADJ
cvj-35	5	3	gland	gland	NOUN
cvj-35	5	4	is	be	AUX
cvj-35	5	5	stimulated	stimulate	VERB
cvj-35	5	6	by	by	ADP
cvj-35	5	7	hormones	hormone	NOUN
cvj-35	5	8	both	both	PRON
cvj-35	5	9	morphologically	morphologically	ADV
cvj-35	5	10	and	and	CCONJ
cvj-35	5	11	physiologically	physiologically	ADV
cvj-35	5	12	.	.	PUNCT
cvj-35	6	1	the	the	DET
cvj-35	6	2	most	most	ADV
cvj-35	6	3	significant	significant	ADJ
cvj-35	6	4	of	of	ADP
cvj-35	6	5	these	these	PRON
cvj-35	6	6	are	be	AUX
cvj-35	6	7	estrogens	estrogen	NOUN
cvj-35	6	8	.	.	PUNCT
cvj-35	7	1	estrogen	estrogen	NOUN
cvj-35	7	2	is	be	AUX
cvj-35	7	3	the	the	DET
cvj-35	7	4	main	main	ADJ
cvj-35	7	5	female	female	ADJ
cvj-35	7	6	hormone	hormone	NOUN
cvj-35	7	7	,	,	PUNCT
cvj-35	7	8	but	but	CCONJ
cvj-35	7	9	it	it	PRON
cvj-35	7	10	is	be	AUX
cvj-35	7	11	present	present	ADJ
cvj-35	7	12	in	in	ADP
cvj-35	7	13	both	both	DET
cvj-35	7	14	females	female	NOUN
cvj-35	7	15	and	and	CCONJ
cvj-35	7	16	males	male	NOUN
cvj-35	7	17	.	.	PUNCT
cvj-35	8	1	elevated	elevated	ADJ
cvj-35	8	2	levels	level	NOUN
cvj-35	8	3	of	of	ADP
cvj-35	8	4	this	this	DET
cvj-35	8	5	hormone	hormone	NOUN
cvj-35	8	6	may	may	AUX
cvj-35	8	7	increase	increase	VERB
cvj-35	8	8	the	the	DET
cvj-35	8	9	risk	risk	NOUN
cvj-35	8	10	of	of	ADP
cvj-35	8	11	developing	develop	VERB
cvj-35	8	12	mammary	mammary	ADJ
cvj-35	8	13	cancer	cancer	NOUN
cvj-35	8	14	.	.	PUNCT
cvj-35	9	1	in	in	ADP
cvj-35	9	2	post	post	ADJ
cvj-35	9	3	-	-	ADJ
cvj-35	9	4	climacteric	climacteric	ADJ
cvj-35	9	5	excessive	excessive	ADJ
cvj-35	9	6	adipose	adipose	ADJ
cvj-35	9	7	tissue	tissue	NOUN
cvj-35	9	8	,	,	PUNCT
cvj-35	9	9	estrogens	estrogen	NOUN
cvj-35	9	10	biosynthesis	biosynthesis	NOUN
cvj-35	9	11	is	be	AUX
cvj-35	9	12	catalyzed	catalyze	VERB
cvj-35	9	13	by	by	ADP
cvj-35	9	14	aromatase	aromatase	NOUN
cvj-35	9	15	,	,	PUNCT
cvj-35	9	16	converting	convert	VERB
cvj-35	9	17	adrenal	adrenal	ADJ
cvj-35	9	18	androgens	androgen	NOUN
cvj-35	9	19	into	into	ADP
cvj-35	9	20	estrogen	estrogen	NOUN
cvj-35	9	21	.	.	PUNCT
cvj-35	10	1	risk	risk	NOUN
cvj-35	10	2	factors	factor	NOUN
cvj-35	10	3	for	for	ADP
cvj-35	10	4	developing	develop	VERB
cvj-35	10	5	mammary	mammary	ADJ
cvj-35	10	6	cancer	cancer	NOUN
cvj-35	10	7	,	,	PUNCT
cvj-35	10	8	such	such	ADJ
cvj-35	10	9	as	as	ADP
cvj-35	10	10	excessive	excessive	ADJ
cvj-35	10	11	adipose	adipose	ADJ
cvj-35	10	12	tissue	tissue	NOUN
cvj-35	10	13	,	,	PUNCT
cvj-35	10	14	age	age	NOUN
cvj-35	10	15	at	at	ADP
cvj-35	10	16	menarche	menarche	NOUN
cvj-35	10	17	and	and	CCONJ
cvj-35	10	18	the	the	DET
cvj-35	10	19	use	use	NOUN
cvj-35	10	20	of	of	ADP
cvj-35	10	21	exogenous	exogenous	ADJ
cvj-35	10	22	hormones	hormone	NOUN
cvj-35	10	23	may	may	AUX
cvj-35	10	24	increase	increase	VERB
cvj-35	10	25	the	the	DET
cvj-35	10	26	risk	risk	NOUN
cvj-35	10	27	of	of	ADP
cvj-35	10	28	developing	develop	VERB
cvj-35	10	29	it	it	PRON
cvj-35	10	30	.	.	PUNCT
cvj-35	11	1	the	the	DET
cvj-35	11	2	aim	aim	NOUN
cvj-35	11	3	of	of	ADP
cvj-35	11	4	this	this	DET
cvj-35	11	5	paper	paper	NOUN
cvj-35	11	6	is	be	AUX
cvj-35	11	7	to	to	PART
cvj-35	11	8	show	show	VERB
cvj-35	11	9	the	the	DET
cvj-35	11	10	link	link	NOUN
cvj-35	11	11	between	between	ADP
cvj-35	11	12	cholesterol	cholesterol	NOUN
cvj-35	11	13	,	,	PUNCT
cvj-35	11	14	excessive	excessive	ADJ
cvj-35	11	15	adipose	adipose	ADJ
cvj-35	11	16	tissue	tissue	NOUN
cvj-35	11	17	and	and	CCONJ
cvj-35	11	18	the	the	DET
cvj-35	11	19	increased	increase	VERB
cvj-35	11	20	risk	risk	NOUN
cvj-35	11	21	of	of	ADP
cvj-35	11	22	developing	develop	VERB
cvj-35	11	23	mammary	mammary	ADJ
cvj-35	11	24	cancer	cancer	NOUN
cvj-35	11	25	.	.	PUNCT
cvj-35	12	1	keywords	keyword	NOUN
cvj-35	12	2	:	:	PUNCT
cvj-35	12	3	cancer	cancer	NOUN
cvj-35	12	4	,	,	PUNCT
cvj-35	12	5	estrogen	estrogen	NOUN
cvj-35	12	6	,	,	PUNCT
cvj-35	12	7	hormones	hormone	NOUN
cvj-35	12	8	,	,	PUNCT
cvj-35	12	9	cholesterol	cholesterol	NOUN
cvj-35	12	10	,	,	PUNCT
cvj-35	12	11	obesity	obesity	NOUN
cvj-35	12	12	introduction	introduction	NOUN
cvj-35	12	13	obesity	obesity	NOUN
cvj-35	12	14	is	be	AUX
cvj-35	12	15	a	a	DET
cvj-35	12	16	risk	risk	NOUN
cvj-35	12	17	factor	factor	NOUN
cvj-35	12	18	for	for	ADP
cvj-35	12	19	both	both	DET
cvj-35	12	20	mammary	mammary	ADJ
cvj-35	12	21	cancer	cancer	NOUN
cvj-35	12	22	as	as	ADV
cvj-35	12	23	well	well	ADV
cvj-35	12	24	as	as	ADP
cvj-35	12	25	a	a	DET
cvj-35	12	26	strong	strong	ADJ
cvj-35	12	27	prognosis	prognosis	NOUN
cvj-35	12	28	,	,	PUNCT
cvj-35	12	29	which	which	PRON
cvj-35	12	30	predicts	predict	VERB
cvj-35	12	31	side	side	ADJ
cvj-35	12	32	effects	effect	NOUN
cvj-35	12	33	of	of	ADP
cvj-35	12	34	the	the	DET
cvj-35	12	35	disease	disease	NOUN
cvj-35	12	36	.	.	PUNCT
cvj-35	13	1	clinical	clinical	ADJ
cvj-35	13	2	evidence	evidence	NOUN
cvj-35	13	3	shows	show	VERB
cvj-35	13	4	that	that	SCONJ
cvj-35	13	5	obese	obese	ADJ
cvj-35	13	6	patients	patient	NOUN
cvj-35	13	7	with	with	ADP
cvj-35	13	8	mammary	mammary	ADJ
cvj-35	13	9	cancer	cancer	NOUN
cvj-35	13	10	who	who	PRON
cvj-35	13	11	are	be	AUX
cvj-35	13	12	being	be	AUX
cvj-35	13	13	treated	treat	VERB
cvj-35	13	14	with	with	ADP
cvj-35	13	15	chemotherapy	chemotherapy	NOUN
cvj-35	13	16	or	or	CCONJ
cvj-35	13	17	aromatase	aromatase	ADJ
cvj-35	13	18	inhibitors	inhibitor	NOUN
cvj-35	13	19	are	be	AUX
cvj-35	13	20	more	more	ADV
cvj-35	13	21	likely	likely	ADJ
cvj-35	13	22	to	to	PART
cvj-35	13	23	have	have	VERB
cvj-35	13	24	a	a	DET
cvj-35	13	25	recurrence	recurrence	NOUN
cvj-35	13	26	of	of	ADP
cvj-35	13	27	the	the	DET
cvj-35	13	28	disease	disease	NOUN
cvj-35	13	29	compare	compare	VERB
cvj-35	13	30	to	to	ADP
cvj-35	13	31	females	female	NOUN
cvj-35	13	32	with	with	ADP
cvj-35	13	33	normal	normal	ADJ
cvj-35	13	34	body	body	NOUN
cvj-35	13	35	mass	mass	NOUN
cvj-35	13	36	index	index	NOUN
cvj-35	13	37	[	[	X
cvj-35	13	38	1	1	NUM
cvj-35	13	39	]	]	PUNCT
cvj-35	13	40	.	.	PUNCT
cvj-35	14	1	information	information	NOUN
cvj-35	14	2	about	about	ADP
cvj-35	14	3	adipose	adipose	NOUN
cvj-35	14	4	tissue	tissue	NOUN
cvj-35	14	5	has	have	AUX
cvj-35	14	6	increased	increase	VERB
cvj-35	14	7	significantly	significantly	ADV
cvj-35	14	8	in	in	ADP
cvj-35	14	9	recent	recent	ADJ
cvj-35	14	10	years	year	NOUN
cvj-35	14	11	.	.	PUNCT
cvj-35	15	1	although	although	SCONJ
cvj-35	15	2	adipose	adipose	ADJ
cvj-35	15	3	tissue	tissue	NOUN
cvj-35	15	4	has	have	AUX
cvj-35	15	5	always	always	ADV
cvj-35	15	6	been	be	AUX
cvj-35	15	7	described	describe	VERB
cvj-35	15	8	for	for	ADP
cvj-35	15	9	lipid	lipid	NOUN
cvj-35	15	10	storage	storage	NOUN
cvj-35	15	11	,	,	PUNCT
cvj-35	15	12	it	it	PRON
cvj-35	15	13	is	be	AUX
cvj-35	15	14	now	now	ADV
cvj-35	15	15	identified	identify	VERB
cvj-35	15	16	as	as	ADP
cvj-35	15	17	a	a	DET
cvj-35	15	18	true	true	ADJ
cvj-35	15	19	organ	organ	NOUN
cvj-35	15	20	that	that	PRON
cvj-35	15	21	possesses	possess	VERB
cvj-35	15	22	both	both	CCONJ
cvj-35	15	23	metabolic	metabolic	NOUN
cvj-35	15	24	and	and	CCONJ
cvj-35	15	25	endocrine	endocrine	NOUN
cvj-35	15	26	functions	function	NOUN
cvj-35	15	27	.	.	PUNCT
cvj-35	16	1	it	it	PRON
cvj-35	16	2	releases	release	VERB
cvj-35	16	3	a	a	DET
cvj-35	16	4	variety	variety	NOUN
cvj-35	16	5	of	of	ADP
cvj-35	16	6	substances	substance	NOUN
cvj-35	16	7	into	into	ADP
cvj-35	16	8	the	the	DET
cvj-35	16	9	bloodstream	bloodstream	NOUN
cvj-35	16	10	to	to	PART
cvj-35	16	11	communicate	communicate	VERB
cvj-35	16	12	with	with	ADP
cvj-35	16	13	other	other	ADJ
cvj-35	16	14	organs	organ	NOUN
cvj-35	16	15	and	and	CCONJ
cvj-35	16	16	tissues	tissue	NOUN
cvj-35	16	17	[	[	X
cvj-35	16	18	2	2	NUM
cvj-35	16	19	]	]	PUNCT
cvj-35	16	20	.	.	PUNCT
cvj-35	17	1	adipokines	adipokine	NOUN
cvj-35	17	2	,	,	PUNCT
cvj-35	17	3	adipose	adipose	ADP
cvj-35	17	4	tissue	tissue	NOUN
cvj-35	17	5	-	-	PUNCT
cvj-35	17	6	specific	specific	ADJ
cvj-35	17	7	substances	substance	NOUN
cvj-35	17	8	,	,	PUNCT
cvj-35	17	9	are	be	AUX
cvj-35	17	10	essential	essential	ADJ
cvj-35	17	11	in	in	ADP
cvj-35	17	12	determining	determine	VERB
cvj-35	17	13	a	a	DET
cvj-35	17	14	group	group	NOUN
cvj-35	17	15	of	of	ADP
cvj-35	17	16	physiological	physiological	ADJ
cvj-35	17	17	responses	response	NOUN
cvj-35	17	18	,	,	PUNCT
cvj-35	17	19	namely	namely	ADV
cvj-35	17	20	glucose	glucose	NOUN
cvj-35	17	21	and	and	CCONJ
cvj-35	17	22	lipid	lipid	NOUN
cvj-35	17	23	metabolism	metabolism	NOUN
cvj-35	17	24	,	,	PUNCT
cvj-35	17	25	homeostasis	homeostasis	NOUN
cvj-35	17	26	,	,	PUNCT
cvj-35	17	27	angiogenesis	angiogenesis	NOUN
cvj-35	17	28	,	,	PUNCT
cvj-35	17	29	inflammation	inflammation	NOUN
cvj-35	17	30	and	and	CCONJ
cvj-35	17	31	satiety	satiety	NOUN
cvj-35	17	32	[	[	X
cvj-35	17	33	3	3	NUM
cvj-35	17	34	]	]	PUNCT
cvj-35	17	35	.	.	PUNCT
cvj-35	18	1	on	on	ADP
cvj-35	18	2	one	one	NUM
cvj-35	18	3	hand	hand	NOUN
cvj-35	18	4	,	,	PUNCT
cvj-35	18	5	disorder	disorder	NOUN
cvj-35	18	6	of	of	ADP
cvj-35	18	7	the	the	DET
cvj-35	18	8	hormonal	hormonal	ADJ
cvj-35	18	9	role	role	NOUN
cvj-35	18	10	and	and	CCONJ
cvj-35	18	11	uncontrolled	uncontrolled	ADJ
cvj-35	18	12	expression	expression	NOUN
cvj-35	18	13	of	of	ADP
cvj-35	18	14	adipokines	adipokine	NOUN
cvj-35	18	15	in	in	ADP
cvj-35	18	16	adipose	adipose	ADJ
cvj-35	18	17	tissue	tissue	NOUN
cvj-35	18	18	,	,	PUNCT
cvj-35	18	19	causes	cause	VERB
cvj-35	18	20	overweight	overweight	ADJ
cvj-35	18	21	or	or	CCONJ
cvj-35	18	22	obese	obese	ADJ
cvj-35	18	23	,	,	PUNCT
cvj-35	18	24	eventually	eventually	ADV
cvj-35	18	25	connecting	connect	VERB
cvj-35	18	26	obesity	obesity	NOUN
cvj-35	18	27	with	with	ADP
cvj-35	18	28	mammary	mammary	ADJ
cvj-35	18	29	cancer	cancer	NOUN
cvj-35	18	30	risk	risk	NOUN
cvj-35	18	31	[	[	X
cvj-35	18	32	4	4	NUM
cvj-35	18	33	]	]	PUNCT
cvj-35	18	34	.	.	PUNCT
cvj-35	19	1	on	on	ADP
cvj-35	19	2	the	the	DET
cvj-35	19	3	other	other	ADJ
cvj-35	19	4	hand	hand	NOUN
cvj-35	19	5	,	,	PUNCT
cvj-35	19	6	there	there	PRON
cvj-35	19	7	are	be	VERB
cvj-35	19	8	studies	study	NOUN
cvj-35	19	9	that	that	PRON
cvj-35	19	10	show	show	VERB
cvj-35	19	11	that	that	SCONJ
cvj-35	19	12	increased	increase	VERB
cvj-35	19	13	adiposity	adiposity	NOUN
cvj-35	19	14	induces	induce	VERB
cvj-35	19	15	the	the	DET
cvj-35	19	16	growth	growth	NOUN
cvj-35	19	17	and	and	CCONJ
cvj-35	19	18	advancement	advancement	NOUN
cvj-35	19	19	of	of	ADP
cvj-35	19	20	mammary	mammary	ADJ
cvj-35	19	21	cancer	cancer	NOUN
cvj-35	19	22	in	in	ADP
cvj-35	19	23	post	post	ADJ
cvj-35	19	24	-	-	ADJ
cvj-35	19	25	climacteric	climacteric	ADJ
cvj-35	19	26	females	female	NOUN
cvj-35	19	27	through	through	ADP
cvj-35	19	28	the	the	DET
cvj-35	19	29	secretion	secretion	NOUN
cvj-35	19	30	of	of	ADP
cvj-35	19	31	estrogen	estrogen	NOUN
cvj-35	20	1	[	[	X
cvj-35	20	2	4	4	NUM
cvj-35	20	3	]	]	PUNCT
cvj-35	20	4	.	.	PUNCT
cvj-35	21	1	received	receive	VERB
cvj-35	21	2	:	:	PUNCT
cvj-35	21	3	20.12.2021	20.12.2021	NUM
cvj-35	21	4	accepted	accept	VERB
cvj-35	21	5	:	:	PUNCT
cvj-35	21	6	30.12.2021	30.12.2021	NOUN
cvj-35	21	7	published	publish	VERB
cvj-35	21	8	:	:	PUNCT
cvj-35	21	9	31.12.2021	31.12.2021	NUM
cvj-35	21	10	doi	doi	NOUN
cvj-35	21	11	:	:	PUNCT
cvj-35	21	12	10.52331	10.52331	NUM
cvj-35	21	13	/	/	SYM
cvj-35	21	14	cvj.v26i3.35	cvj.v26i3.35	NOUN
cvj-35	21	15	copyright	copyright	NOUN
cvj-35	21	16	:	:	PUNCT
cvj-35	21	17	©	©	PROPN
cvj-35	21	18	2021by	2021by	PROPN
cvj-35	21	19	the	the	DET
cvj-35	21	20	authors	author	NOUN
cvj-35	21	21	.	.	PUNCT
cvj-35	22	1	submitted	submit	VERB
cvj-35	22	2	for	for	ADP
cvj-35	22	3	possible	possible	ADJ
cvj-35	22	4	open	open	ADJ
cvj-35	22	5	access	access	NOUN
cvj-35	22	6	publication	publication	NOUN
cvj-35	22	7	under	under	ADP
cvj-35	22	8	the	the	DET
cvj-35	22	9	terms	term	NOUN
cvj-35	22	10	and	and	CCONJ
cvj-35	22	11	conditions	condition	NOUN
cvj-35	22	12	of	of	ADP
cvj-35	22	13	the	the	DET
cvj-35	22	14	creative	creative	ADJ
cvj-35	22	15	commons	common	NOUN
cvj-35	22	16	attribution	attribution	NOUN
cvj-35	22	17	(	(	PUNCT
cvj-35	22	18	cc	cc	NOUN
cvj-35	22	19	by	by	ADP
cvj-35	22	20	)	)	PUNCT
cvj-35	22	21	license	license	NOUN
cvj-35	22	22	(	(	PUNCT
cvj-35	22	23	http://creativecommons.org/licenses	http://creativecommons.org/licenses	X
cvj-35	22	24	/by/4.0/	/by/4.0/	PROPN
cvj-35	22	25	)	)	PUNCT
cvj-35	22	26	.	.	PUNCT
cvj-35	23	1	cluj	cluj	PROPN
cvj-35	23	2	vet	vet	PROPN
cvj-35	23	3	j	j	PROPN
cvj-35	23	4	2021	2021	NUM
cvj-35	23	5	,	,	PUNCT
cvj-35	23	6	26	26	NUM
cvj-35	23	7	,	,	PUNCT
cvj-35	23	8	3	3	NUM
cvj-35	23	9	22	22	NUM
cvj-35	23	10	2	2	NUM
cvj-35	23	11	.	.	PUNCT
cvj-35	24	1	the	the	DET
cvj-35	24	2	role	role	NOUN
cvj-35	24	3	and	and	CCONJ
cvj-35	24	4	effects	effect	NOUN
cvj-35	24	5	of	of	ADP
cvj-35	24	6	estrogens	estrogen	NOUN
cvj-35	24	7	the	the	DET
cvj-35	24	8	main	main	ADJ
cvj-35	24	9	roles	role	NOUN
cvj-35	24	10	of	of	ADP
cvj-35	24	11	estrogen	estrogen	NOUN
cvj-35	24	12	are	be	AUX
cvj-35	24	13	to	to	PART
cvj-35	24	14	induce	induce	VERB
cvj-35	24	15	cell	cell	NOUN
cvj-35	24	16	proliferation	proliferation	NOUN
cvj-35	24	17	and	and	CCONJ
cvj-35	24	18	the	the	DET
cvj-35	24	19	development	development	NOUN
cvj-35	24	20	of	of	ADP
cvj-35	24	21	genitals	genital	NOUN
cvj-35	24	22	and	and	CCONJ
cvj-35	24	23	other	other	ADJ
cvj-35	24	24	tissues	tissue	NOUN
cvj-35	24	25	involved	involve	VERB
cvj-35	24	26	in	in	ADP
cvj-35	24	27	reproduction	reproduction	NOUN
cvj-35	24	28	[	[	X
cvj-35	24	29	5	5	NUM
cvj-35	24	30	]	]	PUNCT
cvj-35	24	31	.	.	PUNCT
cvj-35	25	1	estrogens	estrogen	NOUN
cvj-35	25	2	help	help	VERB
cvj-35	25	3	with	with	ADP
cvj-35	25	4	:	:	PUNCT
cvj-35	25	5	1	1	X
cvj-35	25	6	.	.	X
cvj-35	26	1	development	development	NOUN
cvj-35	26	2	of	of	ADP
cvj-35	26	3	the	the	DET
cvj-35	26	4	stromal	stromal	ADJ
cvj-35	26	5	tissue	tissue	NOUN
cvj-35	26	6	of	of	ADP
cvj-35	26	7	the	the	DET
cvj-35	26	8	breasts	breast	NOUN
cvj-35	26	9	;	;	PUNCT
cvj-35	26	10	2	2	X
cvj-35	26	11	.	.	X
cvj-35	26	12	formation	formation	NOUN
cvj-35	26	13	of	of	ADP
cvj-35	26	14	a	a	DET
cvj-35	26	15	well	well	ADV
cvj-35	26	16	-	-	PUNCT
cvj-35	26	17	represented	represent	VERB
cvj-35	26	18	pipeline	pipeline	NOUN
cvj-35	26	19	system	system	NOUN
cvj-35	26	20	;	;	PUNCT
cvj-35	26	21	3	3	X
cvj-35	26	22	.	.	X
cvj-35	26	23	deposition	deposition	NOUN
cvj-35	26	24	of	of	ADP
cvj-35	26	25	adipose	adipose	ADJ
cvj-35	26	26	tissue	tissue	NOUN
cvj-35	26	27	in	in	ADP
cvj-35	26	28	the	the	DET
cvj-35	26	29	breasts	breast	NOUN
cvj-35	26	30	.	.	PUNCT
cvj-35	27	1	the	the	DET
cvj-35	27	2	mammary	mammary	ADJ
cvj-35	27	3	lobes	lobe	NOUN
cvj-35	27	4	and	and	CCONJ
cvj-35	27	5	alveoli	alveolus	NOUN
cvj-35	27	6	develop	develop	VERB
cvj-35	27	7	only	only	ADV
cvj-35	27	8	to	to	ADP
cvj-35	27	9	a	a	DET
cvj-35	27	10	small	small	ADJ
cvj-35	27	11	extent	extent	NOUN
cvj-35	27	12	under	under	ADP
cvj-35	27	13	the	the	DET
cvj-35	27	14	influence	influence	NOUN
cvj-35	27	15	of	of	ADP
cvj-35	27	16	estrogen	estrogen	NOUN
cvj-35	27	17	.	.	PUNCT
cvj-35	28	1	progesterone	progesterone	NOUN
cvj-35	28	2	and	and	CCONJ
cvj-35	28	3	prolactin	prolactin	NOUN
cvj-35	28	4	are	be	AUX
cvj-35	28	5	the	the	DET
cvj-35	28	6	hormones	hormone	NOUN
cvj-35	28	7	that	that	PRON
cvj-35	28	8	have	have	VERB
cvj-35	28	9	a	a	DET
cvj-35	28	10	decisive	decisive	ADJ
cvj-35	28	11	effect	effect	NOUN
cvj-35	28	12	on	on	ADP
cvj-35	28	13	the	the	DET
cvj-35	28	14	growth	growth	NOUN
cvj-35	28	15	and	and	CCONJ
cvj-35	28	16	functioning	functioning	NOUN
cvj-35	28	17	of	of	ADP
cvj-35	28	18	these	these	DET
cvj-35	28	19	structures	structure	NOUN
cvj-35	28	20	[	[	X
cvj-35	28	21	6	6	NUM
cvj-35	28	22	]	]	PUNCT
cvj-35	28	23	.	.	PUNCT
cvj-35	29	1	2.1	2.1	NUM
cvj-35	29	2	effects	effect	NOUN
cvj-35	29	3	of	of	ADP
cvj-35	29	4	estrogen	estrogen	NOUN
cvj-35	29	5	on	on	ADP
cvj-35	29	6	metabolism	metabolism	NOUN
cvj-35	29	7	and	and	CCONJ
cvj-35	29	8	adipose	adipose	PRON
cvj-35	29	9	tissue	tissue	NOUN
cvj-35	29	10	deposition	deposition	NOUN
cvj-35	29	11	estrogen	estrogen	NOUN
cvj-35	29	12	synthesis	synthesis	NOUN
cvj-35	29	13	in	in	ADP
cvj-35	29	14	obese	obese	NOUN
cvj-35	29	15	adipose	adipose	ADJ
cvj-35	29	16	tissue	tissue	NOUN
cvj-35	29	17	.	.	PUNCT
cvj-35	30	1	estrogen	estrogen	NOUN
cvj-35	30	2	biosynthesis	biosynthesis	NOUN
cvj-35	30	3	occurs	occur	VERB
cvj-35	30	4	primarily	primarily	ADV
cvj-35	30	5	in	in	ADP
cvj-35	30	6	the	the	DET
cvj-35	30	7	adipose	adipose	ADJ
cvj-35	30	8	tissue	tissue	NOUN
cvj-35	30	9	in	in	ADP
cvj-35	30	10	post	post	ADJ
cvj-35	30	11	-	-	ADJ
cvj-35	30	12	climacteric	climacteric	ADJ
cvj-35	30	13	females	female	NOUN
cvj-35	30	14	,	,	PUNCT
cvj-35	30	15	through	through	ADP
cvj-35	30	16	the	the	DET
cvj-35	30	17	conversion	conversion	NOUN
cvj-35	30	18	of	of	ADP
cvj-35	30	19	adrenal	adrenal	ADJ
cvj-35	30	20	androgens	androgen	NOUN
cvj-35	30	21	to	to	ADP
cvj-35	30	22	estrogen	estrogen	NOUN
cvj-35	30	23	by	by	ADP
cvj-35	30	24	aromatase	aromatase	NOUN
cvj-35	30	25	[	[	X
cvj-35	30	26	7	7	NUM
cvj-35	30	27	]	]	PUNCT
cvj-35	30	28	.	.	PUNCT
cvj-35	31	1	several	several	ADJ
cvj-35	31	2	cellular	cellular	ADJ
cvj-35	31	3	and	and	CCONJ
cvj-35	31	4	molecular	molecular	ADJ
cvj-35	31	5	changes	change	NOUN
cvj-35	31	6	in	in	ADP
cvj-35	31	7	obese	obese	NOUN
cvj-35	31	8	adipose	adipose	ADJ
cvj-35	31	9	tissue	tissue	NOUN
cvj-35	31	10	alter	alter	VERB
cvj-35	31	11	the	the	DET
cvj-35	31	12	biosynthesis	biosynthesis	NOUN
cvj-35	31	13	and	and	CCONJ
cvj-35	31	14	metabolism	metabolism	NOUN
cvj-35	31	15	of	of	ADP
cvj-35	31	16	estrogen	estrogen	NOUN
cvj-35	31	17	.	.	PUNCT
cvj-35	32	1	activation	activation	NOUN
cvj-35	32	2	of	of	ADP
cvj-35	32	3	the	the	DET
cvj-35	32	4	nf	nf	ADJ
cvj-35	32	5	-	-	PUNCT
cvj-35	32	6	κb	κb	NOUN
cvj-35	32	7	pathway	pathway	NOUN
cvj-35	32	8	leads	lead	VERB
cvj-35	32	9	to	to	ADP
cvj-35	32	10	an	an	DET
cvj-35	32	11	increase	increase	NOUN
cvj-35	32	12	in	in	ADP
cvj-35	32	13	aromatase	aromatase	ADJ
cvj-35	32	14	expression	expression	NOUN
cvj-35	32	15	in	in	ADP
cvj-35	32	16	breast	breast	NOUN
cvj-35	32	17	adipocytes	adipocyte	NOUN
cvj-35	32	18	and	and	CCONJ
cvj-35	32	19	,	,	PUNCT
cvj-35	32	20	therefore	therefore	ADV
cvj-35	32	21	,	,	PUNCT
cvj-35	32	22	to	to	ADP
cvj-35	32	23	a	a	DET
cvj-35	32	24	higher	high	ADJ
cvj-35	32	25	estrogen	estrogen	NOUN
cvj-35	32	26	synthesis	synthesis	NOUN
cvj-35	32	27	(	(	PUNCT
cvj-35	32	28	figure	figure	NOUN
cvj-35	32	29	1	1	NUM
cvj-35	32	30	)	)	PUNCT
cvj-35	32	31	(	(	PUNCT
cvj-35	32	32	simpson	simpson	PROPN
cvj-35	32	33	et	et	PROPN
cvj-35	32	34	al	al	PROPN
cvj-35	32	35	.	.	PROPN
cvj-35	32	36	,	,	PUNCT
cvj-35	32	37	2013	2013	NUM
cvj-35	32	38	)	)	PUNCT
cvj-35	32	39	.	.	PUNCT
cvj-35	33	1	similarly	similarly	ADV
cvj-35	33	2	,	,	PUNCT
cvj-35	33	3	several	several	ADJ
cvj-35	33	4	cytokines	cytokine	NOUN
cvj-35	33	5	that	that	PRON
cvj-35	33	6	are	be	AUX
cvj-35	33	7	regulated	regulate	VERB
cvj-35	33	8	in	in	ADP
cvj-35	33	9	obese	obese	NOUN
cvj-35	33	10	adipose	adipose	ADJ
cvj-35	33	11	tissue	tissue	NOUN
cvj-35	33	12	,	,	PUNCT
cvj-35	33	13	such	such	ADJ
cvj-35	33	14	as	as	ADP
cvj-35	33	15	tnf	tnf	PROPN
cvj-35	33	16	-	-	PUNCT
cvj-35	33	17	α	α	PROPN
cvj-35	33	18	and	and	CCONJ
cvj-35	33	19	il-6	il-6	NOUN
cvj-35	33	20	,	,	PUNCT
cvj-35	33	21	stimulate	stimulate	VERB
cvj-35	33	22	aromatase	aromatase	ADJ
cvj-35	33	23	activity	activity	NOUN
cvj-35	33	24	[	[	X
cvj-35	33	25	8	8	NUM
cvj-35	33	26	]	]	PUNCT
cvj-35	33	27	.	.	PUNCT
cvj-35	34	1	excess	excess	ADJ
cvj-35	34	2	breast	breast	NOUN
cvj-35	34	3	fat	fat	NOUN
cvj-35	34	4	,	,	PUNCT
cvj-35	34	5	microscopic	microscopic	ADJ
cvj-35	34	6	outbreaks	outbreak	NOUN
cvj-35	34	7	of	of	ADP
cvj-35	34	8	adipocytes	adipocyte	NOUN
cvj-35	34	9	surrounded	surround	VERB
cvj-35	34	10	by	by	ADP
cvj-35	34	11	macrophages	macrophage	NOUN
cvj-35	34	12	,	,	PUNCT
cvj-35	34	13	present	present	ADJ
cvj-35	34	14	increased	increase	VERB
cvj-35	34	15	aromatase	aromatase	NOUN
cvj-35	34	16	activity	activity	NOUN
cvj-35	34	17	[	[	X
cvj-35	34	18	9	9	NUM
cvj-35	34	19	]	]	PUNCT
cvj-35	34	20	.	.	PUNCT
cvj-35	35	1	moreover	moreover	ADV
cvj-35	35	2	,	,	PUNCT
cvj-35	35	3	in	in	ADP
cvj-35	35	4	post	post	ADJ
cvj-35	35	5	-	-	ADJ
cvj-35	35	6	climacteric	climacteric	ADJ
cvj-35	35	7	females	female	NOUN
cvj-35	35	8	,	,	PUNCT
cvj-35	35	9	bmi	bmi	PROPN
cvj-35	35	10	is	be	AUX
cvj-35	35	11	directly	directly	ADV
cvj-35	35	12	proportional	proportional	ADJ
cvj-35	35	13	to	to	ADP
cvj-35	35	14	serial	serial	ADJ
cvj-35	35	15	concentrations	concentration	NOUN
cvj-35	35	16	of	of	ADP
cvj-35	35	17	estrone	estrone	NOUN
cvj-35	35	18	and	and	CCONJ
cvj-35	35	19	estradiol	estradiol	PROPN
cvj-35	35	20	and	and	CCONJ
cvj-35	35	21	inversely	inversely	ADV
cvj-35	35	22	proportional	proportional	ADJ
cvj-35	35	23	to	to	ADP
cvj-35	35	24	hormone	hormone	NOUN
cvj-35	35	25	-	-	PUNCT
cvj-35	35	26	binding	bind	VERB
cvj-35	35	27	globulin	globulin	NOUN
cvj-35	35	28	levels	level	NOUN
cvj-35	35	29	,	,	PUNCT
cvj-35	35	30	leading	lead	VERB
cvj-35	35	31	to	to	ADP
cvj-35	35	32	an	an	DET
cvj-35	35	33	increase	increase	NOUN
cvj-35	35	34	in	in	ADP
cvj-35	35	35	total	total	ADJ
cvj-35	35	36	bioavailable	bioavailable	ADJ
cvj-35	35	37	estrogen	estrogen	NOUN
cvj-35	36	1	[	[	X
cvj-35	36	2	7	7	NUM
cvj-35	36	3	]	]	PUNCT
cvj-35	36	4	.	.	PUNCT
cvj-35	37	1	compared	compare	VERB
cvj-35	37	2	to	to	ADP
cvj-35	37	3	females	female	NOUN
cvj-35	37	4	with	with	ADP
cvj-35	37	5	a	a	DET
cvj-35	37	6	bmi	bmi	NOUN
cvj-35	37	7	<	<	X
cvj-35	37	8	22.5	22.5	NUM
cvj-35	37	9	kg	kg	NOUN
cvj-35	37	10	/	/	SYM
cvj-35	37	11	m2	m2	PROPN
cvj-35	37	12	,	,	PUNCT
cvj-35	37	13	obese	obese	ADJ
cvj-35	37	14	females	female	NOUN
cvj-35	37	15	have	have	VERB
cvj-35	37	16	an	an	DET
cvj-35	37	17	86	86	NUM
cvj-35	37	18	%	%	NOUN
cvj-35	37	19	increase	increase	NOUN
cvj-35	37	20	in	in	ADP
cvj-35	37	21	circulating	circulate	VERB
cvj-35	37	22	estradiol	estradiol	PROPN
cvj-35	37	23	,	,	PUNCT
cvj-35	37	24	a	a	DET
cvj-35	37	25	60	60	NUM
cvj-35	37	26	%	%	NOUN
cvj-35	37	27	increase	increase	NOUN
cvj-35	37	28	in	in	ADP
cvj-35	37	29	estrone	estrone	NOUN
cvj-35	37	30	,	,	PUNCT
cvj-35	37	31	and	and	CCONJ
cvj-35	37	32	a	a	DET
cvj-35	37	33	20	20	NUM
cvj-35	37	34	%	%	NOUN
cvj-35	37	35	increase	increase	NOUN
cvj-35	37	36	in	in	ADP
cvj-35	37	37	testosterone	testosterone	NOUN
cvj-35	38	1	[	[	X
cvj-35	38	2	10	10	NUM
cvj-35	38	3	]	]	PUNCT
cvj-35	38	4	.	.	PUNCT
cvj-35	39	1	3	3	X
cvj-35	39	2	.	.	NOUN
cvj-35	39	3	mammary	mammary	ADJ
cvj-35	39	4	cancer	cancer	NOUN
cvj-35	39	5	and	and	CCONJ
cvj-35	39	6	excessive	excessive	ADJ
cvj-35	39	7	adipose	adipose	ADJ
cvj-35	39	8	tissue	tissue	NOUN
cvj-35	39	9	-	-	PUNCT
cvj-35	39	10	mechanism	mechanism	NOUN
cvj-35	39	11	chronic	chronic	ADJ
cvj-35	39	12	activation	activation	NOUN
cvj-35	39	13	of	of	ADP
cvj-35	39	14	nf	nf	NOUN
cvj-35	39	15	-	-	PUNCT
cvj-35	39	16	κb	κb	NOUN
cvj-35	39	17	in	in	ADP
cvj-35	39	18	adipose	adipose	PRON
cvj-35	39	19	tissue	tissue	NOUN
cvj-35	39	20	not	not	PART
cvj-35	39	21	only	only	ADV
cvj-35	39	22	causes	cause	VERB
cvj-35	39	23	obesity	obesity	NOUN
cvj-35	39	24	-	-	PUNCT
cvj-35	39	25	mediated	mediate	VERB
cvj-35	39	26	inflammation	inflammation	NOUN
cvj-35	39	27	,	,	PUNCT
cvj-35	39	28	but	but	CCONJ
cvj-35	39	29	also	also	ADV
cvj-35	39	30	stimulates	stimulate	VERB
cvj-35	39	31	anti	anti	ADJ
cvj-35	39	32	-	-	ADJ
cvj-35	39	33	apoptotic	apoptotic	ADJ
cvj-35	39	34	genes	gene	NOUN
cvj-35	39	35	and	and	CCONJ
cvj-35	39	36	the	the	DET
cvj-35	39	37	proliferation	proliferation	NOUN
cvj-35	39	38	of	of	ADP
cvj-35	39	39	mammary	mammary	ADJ
cvj-35	39	40	cancer	cancer	NOUN
cvj-35	39	41	,	,	PUNCT
cvj-35	39	42	invasion	invasion	NOUN
cvj-35	39	43	,	,	PUNCT
cvj-35	39	44	angiogenesis	angiogenesis	NOUN
cvj-35	39	45	and	and	CCONJ
cvj-35	39	46	metastasis	metastasis	PRON
cvj-35	39	47	[	[	X
cvj-35	39	48	11	11	NUM
cvj-35	39	49	]	]	PUNCT
cvj-35	39	50	.	.	PUNCT
cvj-35	40	1	concentrations	concentration	NOUN
cvj-35	40	2	of	of	ADP
cvj-35	40	3	il-6	il-6	NOUN
cvj-35	40	4	in	in	ADP
cvj-35	40	5	peritumoral	peritumoral	ADJ
cvj-35	40	6	fat	fat	NOUN
cvj-35	40	7	are	be	AUX
cvj-35	40	8	higher	high	ADJ
cvj-35	40	9	than	than	ADP
cvj-35	40	10	in	in	ADP
cvj-35	40	11	all	all	DET
cvj-35	40	12	other	other	ADJ
cvj-35	40	13	regions	region	NOUN
cvj-35	40	14	and	and	CCONJ
cvj-35	40	15	grow	grow	VERB
cvj-35	40	16	with	with	ADP
cvj-35	40	17	increasing	increase	VERB
cvj-35	40	18	tumor	tumor	NOUN
cvj-35	40	19	size	size	NOUN
cvj-35	40	20	and	and	CCONJ
cvj-35	40	21	lymph	lymph	NOUN
cvj-35	40	22	node	node	ADJ
cvj-35	40	23	involvement	involvement	NOUN
cvj-35	40	24	.	.	PUNCT
cvj-35	41	1	some	some	DET
cvj-35	41	2	studies	study	NOUN
cvj-35	41	3	have	have	AUX
cvj-35	41	4	shown	show	VERB
cvj-35	41	5	that	that	SCONJ
cvj-35	41	6	the	the	DET
cvj-35	41	7	interaction	interaction	NOUN
cvj-35	41	8	between	between	ADP
cvj-35	41	9	cancer	cancer	NOUN
cvj-35	41	10	cells	cell	NOUN
cvj-35	41	11	and	and	CCONJ
cvj-35	41	12	adipocytes	adipocyte	NOUN
cvj-35	41	13	induces	induce	VERB
cvj-35	41	14	both	both	DET
cvj-35	41	15	cell	cell	NOUN
cvj-35	41	16	types	type	NOUN
cvj-35	41	17	to	to	PART
cvj-35	41	18	increase	increase	VERB
cvj-35	41	19	the	the	DET
cvj-35	41	20	secretion	secretion	NOUN
cvj-35	41	21	of	of	ADP
cvj-35	41	22	cytokines	cytokine	NOUN
cvj-35	41	23	il-6	il-6	NOUN
cvj-35	41	24	,	,	PUNCT
cvj-35	41	25	il-8	il-8	NOUN
cvj-35	41	26	,	,	PUNCT
cvj-35	41	27	ccl2	ccl2	NOUN
cvj-35	41	28	and	and	CCONJ
cvj-35	41	29	ccl5	ccl5	PROPN
cvj-35	41	30	.	.	PUNCT
cvj-35	42	1	in	in	ADP
cvj-35	42	2	addition	addition	NOUN
cvj-35	42	3	,	,	PUNCT
cvj-35	42	4	this	this	DET
cvj-35	42	5	phenomenon	phenomenon	NOUN
cvj-35	42	6	promotes	promote	VERB
cvj-35	42	7	tumor	tumor	NOUN
cvj-35	42	8	invasion	invasion	NOUN
cvj-35	42	9	and	and	CCONJ
cvj-35	42	10	metastasis	metastasis	PRON
cvj-35	42	11	[	[	X
cvj-35	42	12	11	11	NUM
cvj-35	42	13	,	,	PUNCT
cvj-35	42	14	12	12	NUM
cvj-35	42	15	]	]	PUNCT
cvj-35	42	16	.	.	PUNCT
cvj-35	43	1	adipose	adipose	ADP
cvj-35	43	2	tissue	tissue	NOUN
cvj-35	43	3	normally	normally	ADV
cvj-35	43	4	helps	help	VERB
cvj-35	43	5	stimulate	stimulate	VERB
cvj-35	43	6	up	up	ADP
cvj-35	43	7	to	to	PART
cvj-35	43	8	35	35	NUM
cvj-35	43	9	%	%	NOUN
cvj-35	43	10	of	of	ADP
cvj-35	43	11	circulating	circulate	VERB
cvj-35	43	12	il-6	il-6	NOUN
cvj-35	43	13	.	.	PUNCT
cvj-35	44	1	it	it	PRON
cvj-35	44	2	is	be	AUX
cvj-35	44	3	also	also	ADV
cvj-35	44	4	responsible	responsible	ADJ
cvj-35	44	5	for	for	ADP
cvj-35	44	6	the	the	DET
cvj-35	44	7	increase	increase	NOUN
cvj-35	44	8	in	in	ADP
cvj-35	44	9	serum	serum	NOUN
cvj-35	44	10	il-6	il-6	NOUN
cvj-35	44	11	after	after	ADP
cvj-35	44	12	climacterium	climacterium	NOUN
cvj-35	44	13	.	.	PUNCT
cvj-35	45	1	in	in	ADP
cvj-35	45	2	this	this	DET
cvj-35	45	3	way	way	NOUN
cvj-35	45	4	it	it	PRON
cvj-35	45	5	can	can	AUX
cvj-35	45	6	help	help	VERB
cvj-35	45	7	increase	increase	VERB
cvj-35	45	8	the	the	DET
cvj-35	45	9	risk	risk	NOUN
cvj-35	45	10	of	of	ADP
cvj-35	45	11	mammary	mammary	ADJ
cvj-35	45	12	cancer	cancer	NOUN
cvj-35	45	13	and	and	CCONJ
cvj-35	45	14	the	the	DET
cvj-35	45	15	progression	progression	NOUN
cvj-35	45	16	of	of	ADP
cvj-35	45	17	the	the	DET
cvj-35	45	18	tumor	tumor	NOUN
cvj-35	45	19	.	.	PUNCT
cvj-35	46	1	il-8	il-8	PUNCT
cvj-35	46	2	resulting	result	VERB
cvj-35	46	3	from	from	ADP
cvj-35	46	4	cancer	cancer	NOUN
cvj-35	46	5	cells	cell	NOUN
cvj-35	46	6	,	,	PUNCT
cvj-35	46	7	surrounding	surround	VERB
cvj-35	46	8	adipocytes	adipocyte	NOUN
cvj-35	46	9	,	,	PUNCT
cvj-35	46	10	endothelial	endothelial	ADJ
cvj-35	46	11	cells	cell	NOUN
cvj-35	46	12	,	,	PUNCT
cvj-35	46	13	infiltrating	infiltrating	ADJ
cvj-35	46	14	neutrophils	neutrophil	NOUN
cvj-35	46	15	,	,	PUNCT
cvj-35	46	16	and	and	CCONJ
cvj-35	46	17	tumor	tumor	NOUN
cvj-35	46	18	-	-	PUNCT
cvj-35	46	19	associated	associate	VERB
cvj-35	46	20	macrophages	macrophage	NOUN
cvj-35	46	21	(	(	PUNCT
cvj-35	46	22	tam	tam	NOUN
cvj-35	46	23	)	)	PUNCT
cvj-35	46	24	develops	develop	VERB
cvj-35	46	25	angiogenesis	angiogenesis	NOUN
cvj-35	46	26	,	,	PUNCT
cvj-35	46	27	tumor	tumor	NOUN
cvj-35	46	28	growth	growth	NOUN
cvj-35	46	29	,	,	PUNCT
cvj-35	46	30	metastasis	metastasis	NOUN
cvj-35	46	31	,	,	PUNCT
cvj-35	46	32	and	and	CCONJ
cvj-35	46	33	resistance	resistance	NOUN
cvj-35	46	34	to	to	ADP
cvj-35	46	35	chemotherapy	chemotherapy	NOUN
cvj-35	46	36	[	[	X
cvj-35	46	37	13	13	NUM
cvj-35	46	38	]	]	PUNCT
cvj-35	46	39	.	.	PUNCT
cvj-35	47	1	4	4	X
cvj-35	47	2	.	.	X
cvj-35	47	3	the	the	DET
cvj-35	47	4	link	link	NOUN
cvj-35	47	5	between	between	ADP
cvj-35	47	6	overweight	overweight	NOUN
cvj-35	47	7	and	and	CCONJ
cvj-35	47	8	tumorigenesis	tumorigenesis	NOUN
cvj-35	47	9	along	along	ADP
cvj-35	47	10	with	with	ADP
cvj-35	47	11	obesity	obesity	NOUN
cvj-35	47	12	,	,	PUNCT
cvj-35	47	13	the	the	DET
cvj-35	47	14	secreted	secrete	VERB
cvj-35	47	15	cytokines	cytokine	NOUN
cvj-35	47	16	go	go	VERB
cvj-35	47	17	from	from	ADP
cvj-35	47	18	an	an	DET
cvj-35	47	19	anti	anti	ADJ
cvj-35	47	20	-	-	ADJ
cvj-35	47	21	inflammatory	inflammatory	ADJ
cvj-35	47	22	profile	profile	NOUN
cvj-35	47	23	to	to	ADP
cvj-35	47	24	a	a	DET
cvj-35	47	25	pro	pro	ADJ
cvj-35	47	26	-	-	ADJ
cvj-35	47	27	inflammatory	inflammatory	ADJ
cvj-35	47	28	and	and	CCONJ
cvj-35	47	29	proangiogenic	proangiogenic	ADJ
cvj-35	47	30	profile	profile	NOUN
cvj-35	47	31	.	.	PUNCT
cvj-35	48	1	the	the	DET
cvj-35	48	2	secretion	secretion	NOUN
cvj-35	48	3	of	of	ADP
cvj-35	48	4	pro	pro	ADJ
cvj-35	48	5	-	-	ADJ
cvj-35	48	6	inflammatory	inflammatory	ADJ
cvj-35	48	7	and	and	CCONJ
cvj-35	48	8	proangiogenic	proangiogenic	ADJ
cvj-35	48	9	cytokines	cytokine	NOUN
cvj-35	48	10	also	also	ADV
cvj-35	48	11	increases	increase	VERB
cvj-35	48	12	in	in	ADP
cvj-35	48	13	adipocytes	adipocyte	NOUN
cvj-35	48	14	,	,	PUNCT
cvj-35	48	15	and	and	CCONJ
cvj-35	48	16	ultimately	ultimately	ADV
cvj-35	48	17	results	result	VERB
cvj-35	48	18	in	in	ADP
cvj-35	48	19	the	the	DET
cvj-35	48	20	multiplication	multiplication	NOUN
cvj-35	48	21	of	of	ADP
cvj-35	48	22	cancer	cancer	NOUN
cvj-35	48	23	cells	cell	NOUN
cvj-35	48	24	.	.	PUNCT
cvj-35	49	1	in	in	ADP
cvj-35	49	2	this	this	DET
cvj-35	49	3	way	way	NOUN
cvj-35	49	4	,	,	PUNCT
cvj-35	49	5	the	the	DET
cvj-35	49	6	stimulation	stimulation	NOUN
cvj-35	49	7	of	of	ADP
cvj-35	49	8	angiogenesis	angiogenesis	NOUN
cvj-35	49	9	,	,	PUNCT
cvj-35	49	10	the	the	DET
cvj-35	49	11	expansion	expansion	NOUN
cvj-35	49	12	of	of	ADP
cvj-35	49	13	cancer	cancer	NOUN
cvj-35	49	14	stem	stem	NOUN
cvj-35	49	15	cells	cell	NOUN
cvj-35	49	16	,	,	PUNCT
cvj-35	49	17	invasion	invasion	NOUN
cvj-35	49	18	and	and	CCONJ
cvj-35	49	19	metastasis	metastasis	NOUN
cvj-35	49	20	takes	take	VERB
cvj-35	49	21	place	place	NOUN
cvj-35	49	22	[	[	X
cvj-35	49	23	14	14	NUM
cvj-35	49	24	]	]	SYM
cvj-35	49	25	.	.	PUNCT
cvj-35	50	1	cluj	cluj	PROPN
cvj-35	50	2	vet	vet	PROPN
cvj-35	50	3	j	j	PROPN
cvj-35	50	4	2021	2021	NUM
cvj-35	50	5	,	,	PUNCT
cvj-35	50	6	26	26	NUM
cvj-35	50	7	,	,	PUNCT
cvj-35	50	8	3	3	NUM
cvj-35	50	9	23	23	NUM
cvj-35	50	10	excessive	excessive	ADJ
cvj-35	50	11	adipose	adipose	PRON
cvj-35	50	12	tissue	tissue	NOUN
cvj-35	50	13	accumulates	accumulate	VERB
cvj-35	50	14	mediators	mediator	NOUN
cvj-35	50	15	of	of	ADP
cvj-35	50	16	antitumor	antitumor	PROPN
cvj-35	50	17	immunity	immunity	NOUN
cvj-35	50	18	,	,	PUNCT
cvj-35	50	19	such	such	ADJ
cvj-35	50	20	as	as	ADP
cvj-35	50	21	cd8	cd8	PROPN
cvj-35	50	22	-	-	ADJ
cvj-35	50	23	positive	positive	ADJ
cvj-35	50	24	(	(	PUNCT
cvj-35	50	25	cd8	cd8	PROPN
cvj-35	50	26	+	+	PROPN
cvj-35	50	27	)	)	PUNCT
cvj-35	50	28	t	t	NOUN
cvj-35	50	29	cells	cell	NOUN
cvj-35	50	30	,	,	PUNCT
cvj-35	50	31	natural	natural	ADJ
cvj-35	50	32	killer	killer	NOUN
cvj-35	50	33	(	(	PUNCT
cvj-35	50	34	nk	nk	PROPN
cvj-35	50	35	)	)	PUNCT
cvj-35	50	36	cells	cell	NOUN
cvj-35	50	37	,	,	PUNCT
cvj-35	50	38	and	and	CCONJ
cvj-35	50	39	dendritic	dendritic	ADJ
cvj-35	50	40	cells	cell	NOUN
cvj-35	50	41	,	,	PUNCT
cvj-35	50	42	myeloid	myeloid	NOUN
cvj-35	50	43	-	-	PUNCT
cvj-35	50	44	derived	derive	VERB
cvj-35	50	45	suppressor	suppressor	NOUN
cvj-35	50	46	cells	cell	NOUN
cvj-35	50	47	(	(	PUNCT
cvj-35	50	48	mdsc	mdsc	NOUN
cvj-35	50	49	)	)	PUNCT
cvj-35	50	50	,	,	PUNCT
cvj-35	50	51	and	and	CCONJ
cvj-35	50	52	tumorassociated	tumorassociate	VERB
cvj-35	50	53	macrophages	macrophage	NOUN
cvj-35	50	54	(	(	PUNCT
cvj-35	50	55	tam	tam	NOUN
cvj-35	50	56	)	)	PUNCT
cvj-35	50	57	which	which	PRON
cvj-35	50	58	suppresses	suppress	VERB
cvj-35	50	59	antitumor	antitumor	PROPN
cvj-35	50	60	immunity	immunity	NOUN
cvj-35	50	61	(	(	PUNCT
cvj-35	50	62	fig.1	fig.1	PROPN
cvj-35	50	63	)	)	PUNCT
cvj-35	50	64	.	.	PUNCT
cvj-35	51	1	in	in	ADP
cvj-35	51	2	addition	addition	NOUN
cvj-35	51	3	,	,	PUNCT
cvj-35	51	4	stimulation	stimulation	NOUN
cvj-35	51	5	of	of	ADP
cvj-35	51	6	adipocyte	adipocyte	ADJ
cvj-35	51	7	aromatase	aromatase	NOUN
cvj-35	51	8	results	result	NOUN
cvj-35	51	9	in	in	ADP
cvj-35	51	10	higher	high	ADJ
cvj-35	51	11	estrogen	estrogen	NOUN
cvj-35	51	12	synthesis	synthesis	NOUN
cvj-35	51	13	and	and	CCONJ
cvj-35	51	14	thus	thus	ADV
cvj-35	51	15	potentiates	potentiate	VERB
cvj-35	51	16	the	the	DET
cvj-35	51	17	development	development	NOUN
cvj-35	51	18	of	of	ADP
cvj-35	51	19	estrogen	estrogen	NOUN
cvj-35	51	20	receptor	receptor	NOUN
cvj-35	51	21	-	-	PUNCT
cvj-35	51	22	positive	positive	ADJ
cvj-35	51	23	(	(	PUNCT
cvj-35	51	24	er	er	INTJ
cvj-35	51	25	+	+	ADJ
cvj-35	51	26	)	)	PUNCT
cvj-35	51	27	mammary	mammary	ADJ
cvj-35	51	28	cancer	cancer	NOUN
cvj-35	51	29	[	[	X
cvj-35	51	30	13	13	NUM
cvj-35	51	31	]	]	PUNCT
cvj-35	51	32	.	.	PUNCT
cvj-35	52	1	adipocyte	adipocyte	ADJ
cvj-35	52	2	hypertrophy	hypertrophy	NOUN
cvj-35	52	3	induces	induce	VERB
cvj-35	52	4	the	the	DET
cvj-35	52	5	secretion	secretion	NOUN
cvj-35	52	6	of	of	ADP
cvj-35	52	7	inflammatory	inflammatory	ADJ
cvj-35	52	8	cytokines	cytokine	NOUN
cvj-35	52	9	,	,	PUNCT
cvj-35	52	10	chemokines	chemokine	NOUN
cvj-35	52	11	,	,	PUNCT
cvj-35	52	12	and	and	CCONJ
cvj-35	52	13	leptin	leptin	VERB
cvj-35	52	14	as	as	ADP
cvj-35	52	15	a	a	DET
cvj-35	52	16	result	result	NOUN
cvj-35	52	17	of	of	ADP
cvj-35	52	18	an	an	DET
cvj-35	52	19	increase	increase	NOUN
cvj-35	52	20	in	in	ADP
cvj-35	52	21	the	the	DET
cvj-35	52	22	number	number	NOUN
cvj-35	52	23	and	and	CCONJ
cvj-35	52	24	size	size	NOUN
cvj-35	52	25	of	of	ADP
cvj-35	52	26	adipocytes	adipocytes	PROPN
cvj-35	52	27	.	.	PUNCT
cvj-35	53	1	these	these	DET
cvj-35	53	2	adipokines	adipokine	NOUN
cvj-35	53	3	then	then	ADV
cvj-35	53	4	induce	induce	VERB
cvj-35	53	5	macrophage	macrophage	ADJ
cvj-35	53	6	recruitment	recruitment	NOUN
cvj-35	53	7	and	and	CCONJ
cvj-35	53	8	polarization	polarization	NOUN
cvj-35	53	9	.	.	PUNCT
cvj-35	54	1	macrophages	macrophage	NOUN
cvj-35	54	2	secrete	secrete	VERB
cvj-35	54	3	inflammatory	inflammatory	ADJ
cvj-35	54	4	cytokines	cytokine	NOUN
cvj-35	54	5	,	,	PUNCT
cvj-35	54	6	which	which	PRON
cvj-35	54	7	can	can	AUX
cvj-35	54	8	act	act	VERB
cvj-35	54	9	directly	directly	ADV
cvj-35	54	10	to	to	PART
cvj-35	54	11	stimulate	stimulate	VERB
cvj-35	54	12	mammary	mammary	ADJ
cvj-35	54	13	cancer	cancer	NOUN
cvj-35	54	14	.	.	PUNCT
cvj-35	55	1	in	in	ADP
cvj-35	55	2	the	the	DET
cvj-35	55	3	end	end	NOUN
cvj-35	55	4	,	,	PUNCT
cvj-35	55	5	all	all	DET
cvj-35	55	6	this	this	PRON
cvj-35	55	7	leads	lead	VERB
cvj-35	55	8	to	to	ADP
cvj-35	55	9	an	an	DET
cvj-35	55	10	increase	increase	NOUN
cvj-35	55	11	in	in	ADP
cvj-35	55	12	the	the	DET
cvj-35	55	13	production	production	NOUN
cvj-35	55	14	of	of	ADP
cvj-35	55	15	aromatase	aromatase	NOUN
cvj-35	55	16	and	and	CCONJ
cvj-35	55	17	estrogen	estrogen	NOUN
cvj-35	55	18	.	.	PUNCT
cvj-35	56	1	in	in	ADP
cvj-35	56	2	addition	addition	NOUN
cvj-35	56	3	,	,	PUNCT
cvj-35	56	4	they	they	PRON
cvj-35	56	5	induce	induce	VERB
cvj-35	56	6	the	the	DET
cvj-35	56	7	expression	expression	NOUN
cvj-35	56	8	of	of	ADP
cvj-35	56	9	pro	pro	ADJ
cvj-35	56	10	-	-	ADJ
cvj-35	56	11	angiogenic	angiogenic	ADJ
cvj-35	56	12	factors	factor	NOUN
cvj-35	56	13	[	[	X
cvj-35	56	14	13	13	NUM
cvj-35	56	15	]	]	PUNCT
cvj-35	56	16	.	.	PUNCT
cvj-35	57	1	inflammation	inflammation	NOUN
cvj-35	57	2	of	of	ADP
cvj-35	57	3	adipose	adipose	ADJ
cvj-35	57	4	tissue	tissue	NOUN
cvj-35	57	5	also	also	ADV
cvj-35	57	6	promotes	promote	VERB
cvj-35	57	7	the	the	DET
cvj-35	57	8	development	development	NOUN
cvj-35	57	9	of	of	ADP
cvj-35	57	10	insulin	insulin	NOUN
cvj-35	57	11	resistance	resistance	NOUN
cvj-35	57	12	,	,	PUNCT
cvj-35	57	13	leading	lead	VERB
cvj-35	57	14	to	to	ADP
cvj-35	57	15	the	the	DET
cvj-35	57	16	release	release	NOUN
cvj-35	57	17	of	of	ADP
cvj-35	57	18	insulin	insulin	NOUN
cvj-35	57	19	and	and	CCONJ
cvj-35	57	20	insulin	insulin	NOUN
cvj-35	57	21	-	-	PUNCT
cvj-35	57	22	like	like	ADJ
cvj-35	57	23	growth	growth	NOUN
cvj-35	57	24	factor	factor	NOUN
cvj-35	57	25	(	(	PUNCT
cvj-35	57	26	igf	igf	PROPN
cvj-35	57	27	)	)	PUNCT
cvj-35	57	28	.	.	PUNCT
cvj-35	58	1	insulin	insulin	NOUN
cvj-35	58	2	resistance	resistance	NOUN
cvj-35	58	3	and	and	CCONJ
cvj-35	58	4	igf	igf	PROPN
cvj-35	58	5	can	can	AUX
cvj-35	58	6	directly	directly	ADV
cvj-35	58	7	promote	promote	VERB
cvj-35	58	8	mammary	mammary	ADJ
cvj-35	58	9	cancer	cancer	NOUN
cvj-35	58	10	.	.	PUNCT
cvj-35	59	1	similarly	similarly	ADV
cvj-35	59	2	,	,	PUNCT
cvj-35	59	3	adipocyte	adipocyte	NOUN
cvj-35	59	4	leptin	leptin	NOUN
cvj-35	59	5	acts	act	VERB
cvj-35	59	6	directly	directly	ADV
cvj-35	59	7	on	on	ADP
cvj-35	59	8	cancer	cancer	NOUN
cvj-35	59	9	cells	cell	NOUN
cvj-35	59	10	.	.	PUNCT
cvj-35	60	1	moreover	moreover	ADV
cvj-35	60	2	,	,	PUNCT
cvj-35	60	3	the	the	DET
cvj-35	60	4	decrease	decrease	NOUN
cvj-35	60	5	in	in	ADP
cvj-35	60	6	adiponectin	adiponectin	NOUN
cvj-35	60	7	caused	cause	VERB
cvj-35	60	8	by	by	ADP
cvj-35	60	9	excess	excess	ADJ
cvj-35	60	10	adipose	adipose	ADJ
cvj-35	60	11	tissue	tissue	NOUN
cvj-35	60	12	has	have	VERB
cvj-35	60	13	the	the	DET
cvj-35	60	14	same	same	ADJ
cvj-35	60	15	effect	effect	NOUN
cvj-35	60	16	[	[	X
cvj-35	60	17	13	13	NUM
cvj-35	60	18	]	]	SYM
cvj-35	60	19	.	.	PUNCT
cvj-35	61	1	5	5	X
cvj-35	61	2	.	.	X
cvj-35	61	3	cholesterol	cholesterol	NOUN
cvj-35	61	4	and	and	CCONJ
cvj-35	61	5	the	the	DET
cvj-35	61	6	risk	risk	NOUN
cvj-35	61	7	of	of	ADP
cvj-35	61	8	mammary	mammary	ADJ
cvj-35	61	9	cancer	cancer	NOUN
cvj-35	61	10	a	a	DET
cvj-35	61	11	number	number	NOUN
cvj-35	61	12	of	of	ADP
cvj-35	61	13	measures	measure	NOUN
cvj-35	61	14	have	have	AUX
cvj-35	61	15	been	be	AUX
cvj-35	61	16	implemented	implement	VERB
cvj-35	61	17	to	to	PART
cvj-35	61	18	detect	detect	VERB
cvj-35	61	19	and	and	CCONJ
cvj-35	61	20	treat	treat	VERB
cvj-35	61	21	elevated	elevated	ADJ
cvj-35	61	22	cholesterol	cholesterol	NOUN
cvj-35	61	23	,	,	PUNCT
cvj-35	61	24	largely	largely	ADV
cvj-35	61	25	through	through	ADP
cvj-35	61	26	the	the	DET
cvj-35	61	27	use	use	NOUN
cvj-35	61	28	of	of	ADP
cvj-35	61	29	statins	statin	NOUN
cvj-35	61	30	(	(	PUNCT
cvj-35	61	31	figure	figure	NOUN
cvj-35	61	32	2	2	NUM
cvj-35	61	33	)	)	PUNCT
cvj-35	61	34	and	and	CCONJ
cvj-35	61	35	more	more	ADV
cvj-35	61	36	recently	recently	ADV
cvj-35	61	37	by	by	ADP
cvj-35	61	38	pcsk-9	pcsk-9	NOUN
cvj-35	61	39	inhibitors	inhibitor	NOUN
cvj-35	61	40	[	[	X
cvj-35	61	41	15	15	NUM
cvj-35	61	42	]	]	PUNCT
cvj-35	61	43	.	.	PUNCT
cvj-35	62	1	pcsk9	pcsk9	NOUN
cvj-35	62	2	inhibitors	inhibitor	NOUN
cvj-35	62	3	are	be	AUX
cvj-35	62	4	monoclonal	monoclonal	NOUN
cvj-35	62	5	antibodies	antibody	NOUN
cvj-35	62	6	that	that	PRON
cvj-35	62	7	inhibit	inhibit	VERB
cvj-35	62	8	proprotein	proprotein	PROPN
cvj-35	62	9	convertase	convertase	PROPN
cvj-35	62	10	subtilisin	subtilisin	PROPN
cvj-35	62	11	/	/	SYM
cvj-35	62	12	kexin	kexin	NOUN
cvj-35	62	13	type	type	NOUN
cvj-35	62	14	9	9	NUM
cvj-35	62	15	(	(	PUNCT
cvj-35	62	16	pcsk9	pcsk9	NOUN
cvj-35	62	17	)	)	PUNCT
cvj-35	62	18	.	.	PUNCT
cvj-35	63	1	pcsk9	pcsk9	PROPN
cvj-35	63	2	is	be	AUX
cvj-35	63	3	a	a	DET
cvj-35	63	4	protein	protein	NOUN
cvj-35	63	5	that	that	PRON
cvj-35	63	6	binds	bind	VERB
cvj-35	63	7	to	to	PART
cvj-35	63	8	ldl	ldl	VERB
cvj-35	63	9	receptors	receptor	NOUN
cvj-35	63	10	for	for	ADP
cvj-35	63	11	degradation	degradation	NOUN
cvj-35	63	12	and	and	CCONJ
cvj-35	63	13	thus	thus	ADV
cvj-35	63	14	reduces	reduce	VERB
cvj-35	63	15	the	the	DET
cvj-35	63	16	liver	liver	NOUN
cvj-35	63	17	's	's	PART
cvj-35	63	18	ability	ability	NOUN
cvj-35	63	19	to	to	PART
cvj-35	63	20	remove	remove	VERB
cvj-35	63	21	ldl	ldl	NOUN
cvj-35	63	22	-	-	PUNCT
cvj-35	63	23	cholesterol	cholesterol	NOUN
cvj-35	63	24	from	from	ADP
cvj-35	63	25	the	the	DET
cvj-35	63	26	blood	blood	NOUN
cvj-35	63	27	,	,	PUNCT
cvj-35	63	28	also	also	ADV
cvj-35	63	29	called	call	VERB
cvj-35	63	30	"	"	PUNCT
cvj-35	63	31	bad	bad	ADJ
cvj-35	63	32	"	"	PUNCT
cvj-35	63	33	cholesterol	cholesterol	NOUN
cvj-35	63	34	[	[	X
cvj-35	63	35	16	16	NUM
cvj-35	63	36	]	]	PUNCT
cvj-35	63	37	.	.	PUNCT
cvj-35	64	1	the	the	DET
cvj-35	64	2	pcsk9	pcsk9	PROPN
cvj-35	64	3	inhibitor	inhibitor	NOUN
cvj-35	64	4	is	be	AUX
cvj-35	64	5	synthesized	synthesize	VERB
cvj-35	64	6	to	to	PART
cvj-35	64	7	bind	bind	VERB
cvj-35	64	8	to	to	ADP
cvj-35	64	9	pcsk9	pcsk9	NOUN
cvj-35	64	10	and	and	CCONJ
cvj-35	64	11	prevent	prevent	VERB
cvj-35	64	12	pcsk9	pcsk9	NOUN
cvj-35	64	13	from	from	ADP
cvj-35	64	14	binding	bind	VERB
cvj-35	64	15	to	to	ADP
cvj-35	64	16	ldl	ldl	VERB
cvj-35	64	17	(	(	PUNCT
cvj-35	64	18	low	low	ADJ
cvj-35	64	19	density	density	NOUN
cvj-35	64	20	lipoprotein	lipoprotein	ADJ
cvj-35	64	21	)	)	PUNCT
cvj-35	64	22	receptors	receptor	NOUN
cvj-35	64	23	on	on	ADP
cvj-35	64	24	the	the	DET
cvj-35	64	25	surface	surface	NOUN
cvj-35	64	26	of	of	ADP
cvj-35	64	27	liver	liver	NOUN
cvj-35	64	28	cells	cell	NOUN
cvj-35	64	29	.	.	PUNCT
cvj-35	65	1	in	in	ADP
cvj-35	65	2	the	the	DET
cvj-35	65	3	absence	absence	NOUN
cvj-35	65	4	of	of	ADP
cvj-35	65	5	pcsk9	pcsk9	NOUN
cvj-35	65	6	,	,	PUNCT
cvj-35	65	7	there	there	PRON
cvj-35	65	8	will	will	AUX
cvj-35	65	9	be	be	AUX
cvj-35	65	10	more	more	ADJ
cvj-35	65	11	ldl	ldl	NOUN
cvj-35	65	12	receptors	receptor	NOUN
cvj-35	65	13	on	on	ADP
cvj-35	65	14	the	the	DET
cvj-35	65	15	surface	surface	NOUN
cvj-35	65	16	of	of	ADP
cvj-35	65	17	liver	liver	NOUN
cvj-35	65	18	cells	cell	NOUN
cvj-35	65	19	to	to	PART
cvj-35	65	20	remove	remove	VERB
cvj-35	65	21	ldl	ldl	NOUN
cvj-35	65	22	-	-	PUNCT
cvj-35	65	23	cholesterol	cholesterol	NOUN
cvj-35	65	24	from	from	ADP
cvj-35	65	25	the	the	DET
cvj-35	65	26	blood	blood	NOUN
cvj-35	65	27	,	,	PUNCT
cvj-35	65	28	resulting	result	VERB
cvj-35	65	29	in	in	ADP
cvj-35	65	30	a	a	DET
cvj-35	65	31	lower	low	ADJ
cvj-35	65	32	concentration	concentration	NOUN
cvj-35	65	33	of	of	ADP
cvj-35	65	34	ldl	ldl	NOUN
cvj-35	65	35	cholesterol	cholesterol	NOUN
cvj-35	65	36	in	in	ADP
cvj-35	65	37	the	the	DET
cvj-35	65	38	blood	blood	NOUN
cvj-35	65	39	.	.	PUNCT
cvj-35	66	1	in	in	ADP
cvj-35	66	2	the	the	DET
cvj-35	66	3	last	last	ADJ
cvj-35	66	4	decade	decade	NOUN
cvj-35	66	5	,	,	PUNCT
cvj-35	66	6	there	there	PRON
cvj-35	66	7	have	have	AUX
cvj-35	66	8	been	be	AUX
cvj-35	66	9	more	more	ADV
cvj-35	66	10	and	and	CCONJ
cvj-35	66	11	more	more	ADJ
cvj-35	66	12	results	result	NOUN
cvj-35	66	13	associating	associate	VERB
cvj-35	66	14	cholesterol	cholesterol	NOUN
cvj-35	66	15	with	with	ADP
cvj-35	66	16	other	other	ADJ
cvj-35	66	17	modifiable	modifiable	ADJ
cvj-35	66	18	risk	risk	NOUN
cvj-35	66	19	factors	factor	NOUN
cvj-35	66	20	,	,	PUNCT
cvj-35	66	21	such	such	ADJ
cvj-35	66	22	as	as	ADP
cvj-35	66	23	obesity	obesity	NOUN
cvj-35	66	24	and	and	CCONJ
cvj-35	66	25	diabetes	diabetes	NOUN
cvj-35	66	26	[	[	X
cvj-35	66	27	17	17	NUM
cvj-35	66	28	,	,	PUNCT
cvj-35	66	29	18	18	NUM
cvj-35	66	30	]	]	PUNCT
cvj-35	66	31	.	.	PUNCT
cvj-35	67	1	unfortunately	unfortunately	ADV
cvj-35	67	2	,	,	PUNCT
cvj-35	67	3	the	the	DET
cvj-35	67	4	combined	combined	ADJ
cvj-35	67	5	action	action	NOUN
cvj-35	67	6	of	of	ADP
cvj-35	67	7	these	these	DET
cvj-35	67	8	factors	factor	NOUN
cvj-35	67	9	is	be	AUX
cvj-35	67	10	reflected	reflect	VERB
cvj-35	67	11	in	in	ADP
cvj-35	67	12	a	a	DET
cvj-35	67	13	number	number	NOUN
cvj-35	67	14	of	of	ADP
cvj-35	67	15	cancers	cancer	NOUN
cvj-35	67	16	,	,	PUNCT
cvj-35	67	17	including	include	VERB
cvj-35	67	18	mammary	mammary	ADJ
cvj-35	67	19	cancer	cancer	NOUN
cvj-35	67	20	[	[	X
cvj-35	67	21	19	19	NUM
cvj-35	67	22	]	]	PUNCT
cvj-35	67	23	.	.	PUNCT
cvj-35	68	1	high	high	ADJ
cvj-35	68	2	blood	blood	NOUN
cvj-35	68	3	cholesterol	cholesterol	NOUN
cvj-35	68	4	is	be	AUX
cvj-35	68	5	often	often	ADV
cvj-35	68	6	associated	associate	VERB
cvj-35	68	7	with	with	ADP
cvj-35	68	8	obesity	obesity	NOUN
cvj-35	68	9	[	[	X
cvj-35	68	10	20	20	NUM
cvj-35	68	11	]	]	PUNCT
cvj-35	68	12	.	.	PUNCT
cvj-35	69	1	its	its	PRON
cvj-35	69	2	impact	impact	NOUN
cvj-35	69	3	as	as	ADP
cvj-35	69	4	a	a	DET
cvj-35	69	5	risk	risk	NOUN
cvj-35	69	6	factor	factor	NOUN
cvj-35	69	7	in	in	ADP
cvj-35	69	8	the	the	DET
cvj-35	69	9	occurrence	occurrence	NOUN
cvj-35	69	10	of	of	ADP
cvj-35	69	11	mammary	mammary	ADJ
cvj-35	69	12	cancer	cancer	NOUN
cvj-35	69	13	is	be	AUX
cvj-35	69	14	not	not	PART
cvj-35	69	15	very	very	ADV
cvj-35	69	16	clear	clear	ADJ
cvj-35	69	17	and	and	CCONJ
cvj-35	69	18	it	it	PRON
cvj-35	69	19	has	have	AUX
cvj-35	69	20	not	not	PART
cvj-35	69	21	been	be	AUX
cvj-35	69	22	established	establish	VERB
cvj-35	69	23	which	which	PRON
cvj-35	69	24	of	of	ADP
cvj-35	69	25	the	the	DET
cvj-35	69	26	3	3	NUM
cvj-35	69	27	parameters	parameter	NOUN
cvj-35	69	28	:	:	PUNCT
cvj-35	69	29	total	total	ADJ
cvj-35	69	30	cholesterol	cholesterol	NOUN
cvj-35	69	31	,	,	PUNCT
cvj-35	69	32	ldl	ldl	NOUN
cvj-35	69	33	or	or	CCONJ
cvj-35	69	34	hdl	hdl	NOUN
cvj-35	69	35	contributes	contribute	VERB
cvj-35	69	36	to	to	ADP
cvj-35	69	37	the	the	DET
cvj-35	69	38	appearance	appearance	NOUN
cvj-35	69	39	of	of	ADP
cvj-35	69	40	the	the	DET
cvj-35	69	41	disease	disease	NOUN
cvj-35	69	42	[	[	X
cvj-35	69	43	21	21	NUM
cvj-35	69	44	]	]	PUNCT
cvj-35	69	45	.	.	PUNCT
cvj-35	70	1	the	the	DET
cvj-35	70	2	systematic	systematic	ADJ
cvj-35	70	3	analysis	analysis	NOUN
cvj-35	70	4	and	and	CCONJ
cvj-35	70	5	meta	meta	NOUN
cvj-35	70	6	-	-	PUNCT
cvj-35	70	7	analysis	analysis	NOUN
cvj-35	70	8	of	of	ADP
cvj-35	70	9	prospective	prospective	ADJ
cvj-35	70	10	studies	study	NOUN
cvj-35	70	11	that	that	PRON
cvj-35	70	12	investigated	investigate	VERB
cvj-35	70	13	the	the	DET
cvj-35	70	14	association	association	NOUN
cvj-35	70	15	between	between	ADP
cvj-35	70	16	total	total	ADJ
cvj-35	70	17	cholesterol	cholesterol	NOUN
cvj-35	70	18	(	(	PUNCT
cvj-35	70	19	ct	ct	PROPN
cvj-35	70	20	)	)	PUNCT
cvj-35	70	21	,	,	PUNCT
cvj-35	70	22	hdl	hdl	PROPN
cvj-35	70	23	-	-	PUNCT
cvj-35	70	24	c	c	PROPN
cvj-35	70	25	,	,	PUNCT
cvj-35	70	26	ldl	ldl	NOUN
cvj-35	70	27	-	-	PUNCT
cvj-35	70	28	c	c	PROPN
cvj-35	70	29	,	,	PUNCT
cvj-35	70	30	apoa1	apoa1	PROPN
cvj-35	70	31	and	and	CCONJ
cvj-35	70	32	apob	apob	PROPN
cvj-35	70	33	and	and	CCONJ
cvj-35	70	34	the	the	DET
cvj-35	70	35	risk	risk	NOUN
cvj-35	70	36	of	of	ADP
cvj-35	70	37	mammary	mammary	ADJ
cvj-35	70	38	cancer	cancer	NOUN
cvj-35	70	39	suggested	suggest	VERB
cvj-35	70	40	an	an	DET
cvj-35	70	41	inversely	inversely	ADV
cvj-35	70	42	proportional	proportional	ADJ
cvj-35	70	43	,	,	PUNCT
cvj-35	70	44	statistically	statistically	ADV
cvj-35	70	45	significant	significant	ADJ
cvj-35	70	46	link	link	NOUN
cvj-35	70	47	[	[	X
cvj-35	70	48	22	22	NUM
cvj-35	70	49	]	]	PUNCT
cvj-35	70	50	.	.	PUNCT
cvj-35	71	1	at	at	ADP
cvj-35	71	2	the	the	DET
cvj-35	71	3	end	end	NOUN
cvj-35	71	4	of	of	ADP
cvj-35	71	5	the	the	DET
cvj-35	71	6	twentieth	twentieth	ADJ
cvj-35	71	7	century	century	NOUN
cvj-35	71	8	,	,	PUNCT
cvj-35	71	9	some	some	DET
cvj-35	71	10	epidemiological	epidemiological	ADJ
cvj-35	71	11	research	research	NOUN
cvj-35	71	12	(	(	PUNCT
cvj-35	71	13	small	small	ADJ
cvj-35	71	14	sample	sample	NOUN
cvj-35	71	15	size	size	NOUN
cvj-35	71	16	)	)	PUNCT
cvj-35	71	17	studied	study	VERB
cvj-35	71	18	the	the	DET
cvj-35	71	19	impact	impact	NOUN
cvj-35	71	20	of	of	ADP
cvj-35	71	21	serum	serum	NOUN
cvj-35	71	22	cholesterol	cholesterol	NOUN
cvj-35	71	23	on	on	ADP
cvj-35	71	24	the	the	DET
cvj-35	71	25	incidence	incidence	NOUN
cvj-35	71	26	of	of	ADP
cvj-35	71	27	malignancy	malignancy	NOUN
cvj-35	71	28	,	,	PUNCT
cvj-35	71	29	but	but	CCONJ
cvj-35	71	30	the	the	DET
cvj-35	71	31	results	result	NOUN
cvj-35	71	32	were	be	AUX
cvj-35	71	33	inconclusive	inconclusive	ADJ
cvj-35	71	34	[	[	X
cvj-35	71	35	23	23	NUM
cvj-35	71	36	]	]	PUNCT
cvj-35	71	37	.	.	PUNCT
cvj-35	72	1	others	other	NOUN
cvj-35	72	2	have	have	AUX
cvj-35	72	3	suggested	suggest	VERB
cvj-35	72	4	that	that	SCONJ
cvj-35	72	5	red	red	ADJ
cvj-35	72	6	and	and	CCONJ
cvj-35	72	7	processed	process	VERB
cvj-35	72	8	meat	meat	NOUN
cvj-35	72	9	,	,	PUNCT
cvj-35	72	10	which	which	PRON
cvj-35	72	11	contain	contain	VERB
cvj-35	72	12	a	a	DET
cvj-35	72	13	higher	high	ADJ
cvj-35	72	14	amount	amount	NOUN
cvj-35	72	15	of	of	ADP
cvj-35	72	16	ldl	ldl	NOUN
cvj-35	72	17	cholesterol	cholesterol	NOUN
cvj-35	72	18	,	,	PUNCT
cvj-35	72	19	are	be	AUX
cvj-35	72	20	risk	risk	NOUN
cvj-35	72	21	factors	factor	NOUN
cvj-35	72	22	for	for	ADP
cvj-35	72	23	colorectal	colorectal	ADJ
cvj-35	72	24	,	,	PUNCT
cvj-35	72	25	mammary	mammary	ADJ
cvj-35	72	26	and	and	CCONJ
cvj-35	72	27	endometrial	endometrial	ADJ
cvj-35	72	28	cancer	cancer	NOUN
cvj-35	72	29	[	[	X
cvj-35	72	30	24	24	NUM
cvj-35	72	31	]	]	PUNCT
cvj-35	72	32	.	.	PUNCT
cvj-35	73	1	a	a	DET
cvj-35	73	2	larger	large	ADJ
cvj-35	73	3	study	study	NOUN
cvj-35	73	4	published	publish	VERB
cvj-35	73	5	in	in	ADP
cvj-35	73	6	science	science	NOUN
cvj-35	73	7	shows	show	VERB
cvj-35	73	8	the	the	DET
cvj-35	73	9	role	role	NOUN
cvj-35	73	10	of	of	ADP
cvj-35	73	11	cholesterol	cholesterol	NOUN
cvj-35	73	12	in	in	ADP
cvj-35	73	13	the	the	DET
cvj-35	73	14	development	development	NOUN
cvj-35	73	15	of	of	ADP
cvj-35	73	16	mammary	mammary	ADJ
cvj-35	73	17	cancer	cancer	NOUN
cvj-35	73	18	in	in	ADP
cvj-35	73	19	mice	mouse	NOUN
cvj-35	73	20	.	.	PUNCT
cvj-35	74	1	moreover	moreover	ADV
cvj-35	74	2	,	,	PUNCT
cvj-35	74	3	the	the	DET
cvj-35	74	4	authors	author	NOUN
cvj-35	74	5	also	also	ADV
cvj-35	74	6	showed	show	VERB
cvj-35	74	7	that	that	SCONJ
cvj-35	74	8	knockout	knockout	NOUN
cvj-35	74	9	mice	mouse	NOUN
cvj-35	74	10	in	in	ADP
cvj-35	74	11	which	which	PRON
cvj-35	74	12	cholesterol	cholesterol	NOUN
cvj-35	74	13	levels	level	NOUN
cvj-35	74	14	increased	increase	VERB
cvj-35	74	15	and	and	CCONJ
cvj-35	74	16	were	be	AUX
cvj-35	74	17	treated	treat	VERB
cvj-35	74	18	with	with	ADP
cvj-35	74	19	statins	statin	NOUN
cvj-35	74	20	had	have	VERB
cvj-35	74	21	a	a	DET
cvj-35	74	22	lower	low	ADJ
cvj-35	74	23	predisposition	predisposition	NOUN
cvj-35	74	24	to	to	ADP
cvj-35	74	25	developing	develop	VERB
cvj-35	74	26	mammary	mammary	ADJ
cvj-35	74	27	cancer	cancer	NOUN
cvj-35	74	28	[	[	X
cvj-35	74	29	25	25	NUM
cvj-35	74	30	]	]	PUNCT
cvj-35	74	31	.	.	PUNCT
cvj-35	75	1	at	at	ADP
cvj-35	75	2	the	the	DET
cvj-35	75	3	cellular	cellular	ADJ
cvj-35	75	4	level	level	NOUN
cvj-35	75	5	,	,	PUNCT
cvj-35	75	6	it	it	PRON
cvj-35	75	7	has	have	AUX
cvj-35	75	8	been	be	AUX
cvj-35	75	9	shown	show	VERB
cvj-35	75	10	that	that	SCONJ
cvj-35	75	11	there	there	PRON
cvj-35	75	12	are	be	VERB
cvj-35	75	13	many	many	ADJ
cvj-35	75	14	physiological	physiological	ADJ
cvj-35	75	15	mechanisms	mechanism	NOUN
cvj-35	75	16	.	.	PUNCT
cvj-35	76	1	low	low	ADJ
cvj-35	76	2	serum	serum	NOUN
cvj-35	76	3	cholesterol	cholesterol	NOUN
cvj-35	76	4	can	can	AUX
cvj-35	76	5	increase	increase	VERB
cvj-35	76	6	the	the	DET
cvj-35	76	7	fluidity	fluidity	NOUN
cvj-35	76	8	of	of	ADP
cvj-35	76	9	the	the	DET
cvj-35	76	10	cell	cell	NOUN
cvj-35	76	11	membrane	membrane	NOUN
cvj-35	76	12	which	which	PRON
cvj-35	76	13	may	may	AUX
cvj-35	76	14	result	result	VERB
cvj-35	76	15	in	in	ADP
cvj-35	76	16	the	the	DET
cvj-35	76	17	spread	spread	NOUN
cvj-35	76	18	of	of	ADP
cvj-35	76	19	cancer	cancer	NOUN
cvj-35	76	20	cells	cell	NOUN
cvj-35	76	21	[	[	X
cvj-35	76	22	26	26	NUM
cvj-35	76	23	]	]	PUNCT
cvj-35	76	24	.	.	PUNCT
cvj-35	77	1	conversely	conversely	ADV
cvj-35	77	2	,	,	PUNCT
cvj-35	77	3	the	the	DET
cvj-35	77	4	loss	loss	NOUN
cvj-35	77	5	of	of	ADP
cvj-35	77	6	membrane	membrane	NOUN
cvj-35	77	7	cholesterol	cholesterol	NOUN
cvj-35	77	8	can	can	AUX
cvj-35	77	9	decrease	decrease	VERB
cvj-35	77	10	the	the	DET
cvj-35	77	11	antigenicity	antigenicity	NOUN
cvj-35	77	12	of	of	ADP
cvj-35	77	13	tumor	tumor	NOUN
cvj-35	77	14	cells	cell	NOUN
cvj-35	77	15	,	,	PUNCT
cvj-35	77	16	which	which	PRON
cvj-35	77	17	results	result	VERB
cvj-35	77	18	in	in	ADP
cvj-35	77	19	the	the	DET
cvj-35	77	20	avoidance	avoidance	NOUN
cvj-35	77	21	of	of	ADP
cvj-35	77	22	the	the	DET
cvj-35	77	23	action	action	NOUN
cvj-35	77	24	of	of	ADP
cvj-35	77	25	the	the	DET
cvj-35	77	26	immune	immune	ADJ
cvj-35	77	27	system	system	NOUN
cvj-35	77	28	[	[	X
cvj-35	77	29	27	27	NUM
cvj-35	77	30	]	]	PUNCT
cvj-35	77	31	.	.	PUNCT
cvj-35	78	1	cluj	cluj	PROPN
cvj-35	78	2	vet	vet	PROPN
cvj-35	78	3	j	j	PROPN
cvj-35	78	4	2021	2021	NUM
cvj-35	78	5	,	,	PUNCT
cvj-35	78	6	26	26	NUM
cvj-35	78	7	,	,	PUNCT
cvj-35	78	8	3	3	NUM
cvj-35	78	9	24	24	NUM
cvj-35	78	10	5.1	5.1	NUM
cvj-35	78	11	cholesterol	cholesterol	NOUN
cvj-35	78	12	,	,	PUNCT
cvj-35	78	13	hfd	hfd	PROPN
cvj-35	78	14	(	(	PUNCT
cvj-35	78	15	high	high	ADJ
cvj-35	78	16	-	-	PUNCT
cvj-35	78	17	fat	fat	NOUN
cvj-35	78	18	diet	diet	NOUN
cvj-35	78	19	)	)	PUNCT
cvj-35	78	20	,	,	PUNCT
cvj-35	78	21	27hc	27hc	NOUN
cvj-35	78	22	and	and	CCONJ
cvj-35	78	23	cancer	cancer	NOUN
cvj-35	78	24	biology	biology	NOUN
cvj-35	79	1	cholesterol	cholesterol	NOUN
cvj-35	79	2	represents	represent	VERB
cvj-35	79	3	a	a	DET
cvj-35	79	4	major	major	ADJ
cvj-35	79	5	factor	factor	NOUN
cvj-35	79	6	mammary	mammary	ADJ
cvj-35	79	7	cancer	cancer	NOUN
cvj-35	79	8	risk	risk	NOUN
cvj-35	79	9	.	.	PUNCT
cvj-35	80	1	unfortunately	unfortunately	ADV
cvj-35	80	2	,	,	PUNCT
cvj-35	80	3	the	the	DET
cvj-35	80	4	mechanism	mechanism	NOUN
cvj-35	80	5	by	by	ADP
cvj-35	80	6	which	which	PRON
cvj-35	80	7	it	it	PRON
cvj-35	80	8	takes	take	VERB
cvj-35	80	9	place	place	NOUN
cvj-35	80	10	is	be	AUX
cvj-35	80	11	not	not	PART
cvj-35	80	12	fully	fully	ADV
cvj-35	80	13	known	know	VERB
cvj-35	80	14	.	.	PUNCT
cvj-35	81	1	most	most	ADV
cvj-35	81	2	likely	likely	ADJ
cvj-35	81	3	the	the	DET
cvj-35	81	4	increase	increase	NOUN
cvj-35	81	5	in	in	ADP
cvj-35	81	6	cholesterol	cholesterol	NOUN
cvj-35	81	7	content	content	NOUN
cvj-35	81	8	in	in	ADP
cvj-35	81	9	cell	cell	NOUN
cvj-35	81	10	membranes	membrane	NOUN
cvj-35	81	11	and	and	CCONJ
cvj-35	81	12	after	after	ADP
cvj-35	81	13	the	the	DET
cvj-35	81	14	affecting	affecting	NOUN
cvj-35	81	15	of	of	ADP
cvj-35	81	16	the	the	DET
cvj-35	81	17	membrane	membrane	NOUN
cvj-35	81	18	fluidity	fluidity	NOUN
cvj-35	81	19	caused	cause	VERB
cvj-35	81	20	by	by	ADP
cvj-35	81	21	dyslipidemia	dyslipidemia	NOUN
cvj-35	81	22	may	may	AUX
cvj-35	81	23	represent	represent	VERB
cvj-35	81	24	a	a	DET
cvj-35	81	25	possible	possible	ADJ
cvj-35	81	26	explanation	explanation	NOUN
cvj-35	81	27	.	.	PUNCT
cvj-35	82	1	also	also	ADV
cvj-35	82	2	,	,	PUNCT
cvj-35	82	3	there	there	PRON
cvj-35	82	4	are	be	VERB
cvj-35	82	5	researches	research	NOUN
cvj-35	82	6	that	that	PRON
cvj-35	82	7	show	show	VERB
cvj-35	82	8	the	the	DET
cvj-35	82	9	functionality	functionality	NOUN
cvj-35	82	10	of	of	ADP
cvj-35	82	11	the	the	DET
cvj-35	82	12	metabolite	metabolite	NOUN
cvj-35	82	13	,	,	PUNCT
cvj-35	82	14	27	27	NUM
cvj-35	82	15	-	-	PUNCT
cvj-35	82	16	hydroxycholesterol	hydroxycholesterol	NOUN
cvj-35	82	17	(	(	PUNCT
cvj-35	82	18	27hc	27hc	NOUN
cvj-35	82	19	)	)	PUNCT
cvj-35	82	20	as	as	ADP
cvj-35	82	21	an	an	DET
cvj-35	82	22	estrogen	estrogen	NOUN
cvj-35	83	1	[	[	X
cvj-35	83	2	21	21	NUM
cvj-35	83	3	,	,	PUNCT
cvj-35	83	4	28	28	NUM
cvj-35	83	5	]	]	PUNCT
cvj-35	83	6	.	.	PUNCT
cvj-35	84	1	the	the	DET
cvj-35	84	2	intensive	intensive	ADJ
cvj-35	84	3	proliferation	proliferation	NOUN
cvj-35	84	4	of	of	ADP
cvj-35	84	5	estrogen	estrogen	NOUN
cvj-35	84	6	receptor	receptor	NOUN
cvj-35	84	7	(	(	PUNCT
cvj-35	84	8	er)-positive	er)-positive	ADJ
cvj-35	84	9	mammary	mammary	ADJ
cvj-35	84	10	cancer	cancer	NOUN
cvj-35	84	11	cells	cell	NOUN
cvj-35	84	12	is	be	AUX
cvj-35	84	13	a	a	DET
cvj-35	84	14	result	result	NOUN
cvj-35	84	15	of	of	ADP
cvj-35	84	16	its	its	PRON
cvj-35	84	17	action	action	NOUN
cvj-35	84	18	.	.	PUNCT
cvj-35	85	1	in	in	ADP
cvj-35	85	2	this	this	DET
cvj-35	85	3	way	way	NOUN
cvj-35	85	4	,	,	PUNCT
cvj-35	85	5	the	the	DET
cvj-35	85	6	treatments	treatment	NOUN
cvj-35	85	7	used	use	VERB
cvj-35	85	8	in	in	ADP
cvj-35	85	9	mammary	mammary	ADJ
cvj-35	85	10	cancer	cancer	NOUN
cvj-35	85	11	in	in	ADP
cvj-35	85	12	order	order	NOUN
cvj-35	85	13	to	to	PART
cvj-35	85	14	lower	lower	VERB
cvj-35	85	15	the	the	DET
cvj-35	85	16	concentration	concentration	NOUN
cvj-35	85	17	of	of	ADP
cvj-35	85	18	cholesterol	cholesterol	NOUN
cvj-35	85	19	are	be	AUX
cvj-35	85	20	justified	justify	VERB
cvj-35	85	21	[	[	X
cvj-35	85	22	21	21	NUM
cvj-35	85	23	]	]	PUNCT
cvj-35	85	24	.	.	PUNCT
cvj-35	86	1	in	in	ADP
cvj-35	86	2	animals	animal	NOUN
cvj-35	86	3	,	,	PUNCT
cvj-35	86	4	the	the	DET
cvj-35	86	5	specific	specific	ADJ
cvj-35	86	6	contribution	contribution	NOUN
cvj-35	86	7	of	of	ADP
cvj-35	86	8	cholesterol	cholesterol	NOUN
cvj-35	86	9	,	,	PUNCT
cvj-35	86	10	a	a	DET
cvj-35	86	11	comorbidity	comorbidity	NOUN
cvj-35	86	12	of	of	ADP
cvj-35	86	13	obesity	obesity	NOUN
cvj-35	86	14	,	,	PUNCT
cvj-35	86	15	in	in	ADP
cvj-35	86	16	the	the	DET
cvj-35	86	17	pathogenesis	pathogenesis	NOUN
cvj-35	86	18	of	of	ADP
cvj-35	86	19	cancer	cancer	NOUN
cvj-35	86	20	was	be	AUX
cvj-35	86	21	underestimated	underestimate	VERB
cvj-35	86	22	.	.	PUNCT
cvj-35	87	1	this	this	PRON
cvj-35	87	2	may	may	AUX
cvj-35	87	3	be	be	AUX
cvj-35	87	4	due	due	ADJ
cvj-35	87	5	to	to	ADP
cvj-35	87	6	the	the	DET
cvj-35	87	7	fact	fact	NOUN
cvj-35	87	8	that	that	SCONJ
cvj-35	87	9	no	no	DET
cvj-35	87	10	increase	increase	NOUN
cvj-35	87	11	in	in	ADP
cvj-35	87	12	cholesterol	cholesterol	NOUN
cvj-35	87	13	was	be	AUX
cvj-35	87	14	observed	observe	VERB
cvj-35	87	15	after	after	ADP
cvj-35	87	16	a	a	DET
cvj-35	87	17	hyperlipidemic	hyperlipidemic	ADJ
cvj-35	87	18	diet	diet	NOUN
cvj-35	87	19	(	(	PUNCT
cvj-35	87	20	hfd	hfd	PROPN
cvj-35	87	21	high	high	ADJ
cvj-35	87	22	-	-	PUNCT
cvj-35	87	23	fat	fat	NOUN
cvj-35	87	24	diet	diet	NOUN
cvj-35	87	25	)	)	PUNCT
cvj-35	87	26	.	.	PUNCT
cvj-35	88	1	to	to	PART
cvj-35	88	2	address	address	VERB
cvj-35	88	3	this	this	PRON
cvj-35	88	4	,	,	PUNCT
cvj-35	88	5	a	a	DET
cvj-35	88	6	high	high	ADJ
cvj-35	88	7	-	-	PUNCT
cvj-35	88	8	fat	fat	NOUN
cvj-35	88	9	diet	diet	NOUN
cvj-35	88	10	was	be	AUX
cvj-35	88	11	used	use	VERB
cvj-35	88	12	in	in	ADP
cvj-35	88	13	humanized	humanize	VERB
cvj-35	88	14	apoe3	apoe3	NOUN
cvj-35	88	15	mice	mouse	NOUN
cvj-35	88	16	.	.	PUNCT
cvj-35	89	1	circulating	circulate	VERB
cvj-35	89	2	cholesterol	cholesterol	NOUN
cvj-35	89	3	levels	level	NOUN
cvj-35	89	4	were	be	AUX
cvj-35	89	5	subsequently	subsequently	ADV
cvj-35	89	6	determined	determine	VERB
cvj-35	89	7	[	[	X
cvj-35	89	8	25	25	NUM
cvj-35	89	9	]	]	PUNCT
cvj-35	89	10	.	.	PUNCT
cvj-35	90	1	the	the	DET
cvj-35	90	2	observed	observed	ADJ
cvj-35	90	3	increase	increase	NOUN
cvj-35	90	4	in	in	ADP
cvj-35	90	5	circulating	circulate	VERB
cvj-35	90	6	cholesterol	cholesterol	NOUN
cvj-35	90	7	in	in	ADP
cvj-35	90	8	hfd	hfd	PROPN
cvj-35	90	9	-	-	PUNCT
cvj-35	90	10	fed	fed	PROPN
cvj-35	90	11	mice	mice	NOUN
cvj-35	90	12	is	be	AUX
cvj-35	90	13	the	the	DET
cvj-35	90	14	result	result	NOUN
cvj-35	90	15	of	of	ADP
cvj-35	90	16	intensified	intensify	VERB
cvj-35	90	17	of	of	ADP
cvj-35	90	18	novo	novo	NOUN
cvj-35	90	19	synthesis	synthesis	NOUN
cvj-35	90	20	.	.	PUNCT
cvj-35	91	1	however	however	ADV
cvj-35	91	2	,	,	PUNCT
cvj-35	91	3	the	the	DET
cvj-35	91	4	effect	effect	NOUN
cvj-35	91	5	of	of	ADP
cvj-35	91	6	hfd	hfd	PROPN
cvj-35	91	7	on	on	ADP
cvj-35	91	8	tumor	tumor	NOUN
cvj-35	91	9	growth	growth	NOUN
cvj-35	91	10	was	be	AUX
cvj-35	91	11	attenuated	attenuate	VERB
cvj-35	91	12	by	by	ADP
cvj-35	91	13	statin	statin	ADJ
cvj-35	91	14	treatment	treatment	NOUN
cvj-35	91	15	or	or	CCONJ
cvj-35	91	16	inhibition	inhibition	NOUN
cvj-35	91	17	of	of	ADP
cvj-35	91	18	cyp27a1	cyp27a1	NOUN
cvj-35	91	19	[	[	X
cvj-35	91	20	25	25	NUM
cvj-35	91	21	]	]	PUNCT
cvj-35	91	22	.	.	PUNCT
cvj-35	92	1	these	these	DET
cvj-35	92	2	findings	finding	NOUN
cvj-35	92	3	confirm	confirm	VERB
cvj-35	92	4	the	the	DET
cvj-35	92	5	importance	importance	NOUN
cvj-35	92	6	of	of	ADP
cvj-35	92	7	cholesterol	cholesterol	NOUN
cvj-35	92	8	and	and	CCONJ
cvj-35	92	9	dyslipidemia	dyslipidemia	NOUN
cvj-35	92	10	in	in	ADP
cvj-35	92	11	mammary	mammary	ADJ
cvj-35	92	12	cancer	cancer	NOUN
cvj-35	92	13	and	and	CCONJ
cvj-35	92	14	highlight	highlight	VERB
cvj-35	92	15	the	the	DET
cvj-35	92	16	importance	importance	NOUN
cvj-35	92	17	of	of	ADP
cvj-35	92	18	27hc	27hc	NOUN
cvj-35	92	19	and	and	CCONJ
cvj-35	92	20	er	er	INTJ
cvj-35	92	21	as	as	ADP
cvj-35	92	22	mediators	mediator	NOUN
cvj-35	92	23	of	of	ADP
cvj-35	92	24	these	these	DET
cvj-35	92	25	effects	effect	NOUN
cvj-35	92	26	.	.	PUNCT
cvj-35	93	1	on	on	ADP
cvj-35	93	2	the	the	DET
cvj-35	93	3	other	other	ADJ
cvj-35	93	4	hand	hand	NOUN
cvj-35	93	5	,	,	PUNCT
cvj-35	93	6	there	there	PRON
cvj-35	93	7	are	be	VERB
cvj-35	93	8	studies	study	NOUN
cvj-35	93	9	showing	show	VERB
cvj-35	93	10	that	that	SCONJ
cvj-35	93	11	the	the	DET
cvj-35	93	12	effect	effect	NOUN
cvj-35	93	13	of	of	ADP
cvj-35	93	14	statins	statin	NOUN
cvj-35	93	15	in	in	ADP
cvj-35	93	16	mammary	mammary	ADJ
cvj-35	93	17	cancer	cancer	NOUN
cvj-35	93	18	is	be	AUX
cvj-35	93	19	not	not	PART
cvj-35	93	20	beneficial	beneficial	ADJ
cvj-35	93	21	[	[	X
cvj-35	93	22	29	29	NUM
cvj-35	93	23	]	]	PUNCT
cvj-35	93	24	.	.	PUNCT
cvj-35	94	1	6	6	X
cvj-35	94	2	.	.	PUNCT
cvj-35	94	3	conclusions	conclusion	NOUN
cvj-35	94	4	the	the	DET
cvj-35	94	5	effects	effect	NOUN
cvj-35	94	6	of	of	ADP
cvj-35	94	7	excessive	excessive	ADJ
cvj-35	94	8	adipose	adipose	ADJ
cvj-35	94	9	tissue	tissue	NOUN
cvj-35	94	10	on	on	ADP
cvj-35	94	11	the	the	DET
cvj-35	94	12	risk	risk	NOUN
cvj-35	94	13	of	of	ADP
cvj-35	94	14	mammary	mammary	ADJ
cvj-35	94	15	cancer	cancer	NOUN
cvj-35	94	16	differ	differ	VERB
cvj-35	94	17	depending	depend	VERB
cvj-35	94	18	on	on	ADP
cvj-35	94	19	the	the	DET
cvj-35	94	20	status	status	NOUN
cvj-35	94	21	of	of	ADP
cvj-35	94	22	the	the	DET
cvj-35	94	23	er	er	INTJ
cvj-35	94	24	.	.	PUNCT
cvj-35	94	25	obesity	obesity	NOUN
cvj-35	94	26	is	be	AUX
cvj-35	94	27	associated	associate	VERB
cvj-35	94	28	with	with	ADP
cvj-35	94	29	a	a	DET
cvj-35	94	30	significantly	significantly	ADV
cvj-35	94	31	higher	high	ADJ
cvj-35	94	32	risk	risk	NOUN
cvj-35	94	33	of	of	ADP
cvj-35	94	34	er	er	ADJ
cvj-35	94	35	-	-	PUNCT
cvj-35	94	36	positive	positive	ADJ
cvj-35	94	37	mammary	mammary	ADJ
cvj-35	94	38	cancer	cancer	NOUN
cvj-35	94	39	.	.	PUNCT
cvj-35	95	1	the	the	DET
cvj-35	95	2	effect	effect	NOUN
cvj-35	95	3	is	be	AUX
cvj-35	95	4	insignificant	insignificant	ADJ
cvj-35	95	5	for	for	ADP
cvj-35	95	6	er	er	ADJ
cvj-35	95	7	-	-	PUNCT
cvj-35	95	8	negative	negative	ADJ
cvj-35	95	9	mammary	mammary	ADJ
cvj-35	95	10	cancer	cancer	NOUN
cvj-35	95	11	after	after	ADP
cvj-35	95	12	climacterium	climacterium	NOUN
cvj-35	95	13	[	[	X
cvj-35	95	14	30	30	NUM
cvj-35	95	15	]	]	PUNCT
cvj-35	95	16	.	.	PUNCT
cvj-35	96	1	high	high	ADJ
cvj-35	96	2	concentrations	concentration	NOUN
cvj-35	96	3	of	of	ADP
cvj-35	96	4	cytokines	cytokine	NOUN
cvj-35	96	5	and	and	CCONJ
cvj-35	96	6	leptins	leptin	NOUN
cvj-35	96	7	secreted	secrete	VERB
cvj-35	96	8	by	by	ADP
cvj-35	96	9	adipose	adipose	ADJ
cvj-35	96	10	tissue	tissue	NOUN
cvj-35	96	11	increase	increase	VERB
cvj-35	96	12	the	the	DET
cvj-35	96	13	number	number	NOUN
cvj-35	96	14	of	of	ADP
cvj-35	96	15	preadipocytes	preadipocyte	NOUN
cvj-35	96	16	,	,	PUNCT
cvj-35	96	17	that	that	PRON
cvj-35	96	18	release	release	VERB
cvj-35	96	19	free	free	ADJ
cvj-35	96	20	fatty	fatty	NOUN
cvj-35	96	21	acids	acid	NOUN
cvj-35	96	22	(	(	PUNCT
cvj-35	96	23	ffa	ffa	NOUN
cvj-35	96	24	)	)	PUNCT
cvj-35	96	25	and	and	CCONJ
cvj-35	96	26	activate	activate	VERB
cvj-35	96	27	the	the	DET
cvj-35	96	28	nf	nf	ADJ
cvj-35	96	29	-	-	PUNCT
cvj-35	96	30	κb	κb	NOUN
cvj-35	96	31	pathway	pathway	NOUN
cvj-35	96	32	.	.	PUNCT
cvj-35	97	1	this	this	DET
cvj-35	97	2	pathway	pathway	NOUN
cvj-35	97	3	controls	control	VERB
cvj-35	97	4	dna	dna	PROPN
cvj-35	97	5	transcription	transcription	NOUN
cvj-35	97	6	,	,	PUNCT
cvj-35	97	7	cytokine	cytokine	ADJ
cvj-35	97	8	production	production	NOUN
cvj-35	97	9	,	,	PUNCT
cvj-35	97	10	and	and	CCONJ
cvj-35	97	11	apoptosis	apoptosis	NOUN
cvj-35	97	12	in	in	ADP
cvj-35	97	13	both	both	PRON
cvj-35	97	14	adipocytes	adipocytes	ADJ
cvj-35	97	15	and	and	CCONJ
cvj-35	97	16	immune	immune	ADJ
cvj-35	97	17	cells	cell	NOUN
cvj-35	97	18	in	in	ADP
cvj-35	97	19	order	order	NOUN
cvj-35	97	20	to	to	PART
cvj-35	97	21	produce	produce	VERB
cvj-35	97	22	chronic	chronic	ADJ
cvj-35	97	23	inflammation	inflammation	NOUN
cvj-35	97	24	[	[	X
cvj-35	97	25	31	31	NUM
cvj-35	97	26	]	]	PUNCT
cvj-35	97	27	.	.	PUNCT
cvj-35	98	1	the	the	DET
cvj-35	98	2	high	high	ADJ
cvj-35	98	3	number	number	NOUN
cvj-35	98	4	of	of	ADP
cvj-35	98	5	preadipocytes	preadipocyte	NOUN
cvj-35	98	6	causes	cause	VERB
cvj-35	98	7	high	high	ADJ
cvj-35	98	8	concentrations	concentration	NOUN
cvj-35	98	9	of	of	ADP
cvj-35	98	10	il-6	il-6	NOUN
cvj-35	98	11	,	,	PUNCT
cvj-35	98	12	il-8	il-8	NOUN
cvj-35	98	13	,	,	PUNCT
cvj-35	98	14	ccl2	ccl2	PROPN
cvj-35	98	15	,	,	PUNCT
cvj-35	98	16	ccl5	ccl5	PROPN
cvj-35	98	17	and	and	CCONJ
cvj-35	98	18	vegf	vegf	PROPN
cvj-35	98	19	with	with	ADP
cvj-35	98	20	a	a	DET
cvj-35	98	21	positive	positive	ADJ
cvj-35	98	22	effect	effect	NOUN
cvj-35	98	23	on	on	ADP
cvj-35	98	24	the	the	DET
cvj-35	98	25	production	production	NOUN
cvj-35	98	26	of	of	ADP
cvj-35	98	27	nf	nf	NOUN
cvj-35	98	28	-	-	PUNCT
cvj-35	98	29	κb	κb	NOUN
cvj-35	98	30	and	and	CCONJ
cvj-35	98	31	cytokines	cytokine	VERB
cvj-35	98	32	[	[	X
cvj-35	98	33	32	32	NUM
cvj-35	98	34	]	]	PUNCT
cvj-35	98	35	.	.	PUNCT
cvj-35	99	1	in	in	ADP
cvj-35	99	2	addition	addition	NOUN
cvj-35	99	3	,	,	PUNCT
cvj-35	99	4	contact	contact	NOUN
cvj-35	99	5	between	between	ADP
cvj-35	99	6	adipocytes	adipocyte	NOUN
cvj-35	99	7	and	and	CCONJ
cvj-35	99	8	invasive	invasive	ADJ
cvj-35	99	9	cancer	cancer	NOUN
cvj-35	99	10	cells	cell	NOUN
cvj-35	99	11	synergistically	synergistically	ADV
cvj-35	99	12	regulates	regulate	VERB
cvj-35	99	13	cytokine	cytokine	ADJ
cvj-35	99	14	secretion	secretion	NOUN
cvj-35	99	15	.	.	PUNCT
cvj-35	100	1	9	9	NUM
cvj-35	100	2	tnf	tnf	PROPN
cvj-35	100	3	-	-	PUNCT
cvj-35	100	4	α	α	PROPN
cvj-35	100	5	also	also	ADV
cvj-35	100	6	called	call	VERB
cvj-35	100	7	tumor	tumor	NOUN
cvj-35	100	8	necrosis	necrosis	NOUN
cvj-35	100	9	factor	factor	NOUN
cvj-35	100	10	alpha	alpha	NOUN
cvj-35	100	11	and	and	CCONJ
cvj-35	100	12	il-6	il-6	NOUN
cvj-35	100	13	affects	affect	VERB
cvj-35	100	14	insulin	insulin	NOUN
cvj-35	100	15	receptor	receptor	NOUN
cvj-35	100	16	activation	activation	NOUN
cvj-35	100	17	[	[	X
cvj-35	100	18	33	33	NUM
cvj-35	100	19	]	]	PUNCT
cvj-35	100	20	.	.	PUNCT
cvj-35	101	1	finally	finally	ADV
cvj-35	101	2	,	,	PUNCT
cvj-35	101	3	there	there	PRON
cvj-35	101	4	is	be	VERB
cvj-35	101	5	insulin	insulin	NOUN
cvj-35	101	6	resistance	resistance	NOUN
cvj-35	101	7	that	that	PRON
cvj-35	101	8	has	have	VERB
cvj-35	101	9	a	a	DET
cvj-35	101	10	positive	positive	ADJ
cvj-35	101	11	impact	impact	NOUN
cvj-35	101	12	on	on	ADP
cvj-35	101	13	the	the	DET
cvj-35	101	14	development	development	NOUN
cvj-35	101	15	and	and	CCONJ
cvj-35	101	16	growth	growth	NOUN
cvj-35	101	17	of	of	ADP
cvj-35	101	18	mammary	mammary	ADJ
cvj-35	101	19	cancer	cancer	NOUN
cvj-35	101	20	.	.	PUNCT
cvj-35	102	1	the	the	DET
cvj-35	102	2	nf	nf	PROPN
cvj-35	102	3	-	-	PUNCT
cvj-35	102	4	κb	κb	PROPN
cvj-35	102	5	,	,	PUNCT
cvj-35	102	6	tnf	tnf	PROPN
cvj-35	102	7	-	-	PUNCT
cvj-35	102	8	α	α	PROPN
cvj-35	102	9	and	and	CCONJ
cvj-35	102	10	il-6	il-6	NOUN
cvj-35	102	11	pathway	pathway	NOUN
cvj-35	102	12	also	also	ADV
cvj-35	102	13	stimulates	stimulate	VERB
cvj-35	102	14	the	the	DET
cvj-35	102	15	expression	expression	NOUN
cvj-35	102	16	of	of	ADP
cvj-35	102	17	aromatase	aromatase	NOUN
cvj-35	102	18	in	in	ADP
cvj-35	102	19	stromal	stromal	ADJ
cvj-35	102	20	and	and	CCONJ
cvj-35	102	21	adipocyte	adipocyte	ADJ
cvj-35	102	22	fibroblasts	fibroblast	NOUN
cvj-35	102	23	[	[	X
cvj-35	102	24	8	8	NUM
cvj-35	102	25	]	]	PUNCT
cvj-35	102	26	breast	breast	NOUN
cvj-35	102	27	.	.	PUNCT
cvj-35	103	1	the	the	DET
cvj-35	103	2	effect	effect	NOUN
cvj-35	103	3	is	be	AUX
cvj-35	103	4	an	an	DET
cvj-35	103	5	increased	increase	VERB
cvj-35	103	6	estrogen	estrogen	NOUN
cvj-35	103	7	production	production	NOUN
cvj-35	103	8	in	in	ADP
cvj-35	103	9	both	both	PRON
cvj-35	103	10	cancer	cancer	NOUN
cvj-35	103	11	and	and	CCONJ
cvj-35	103	12	stromal	stromal	ADJ
cvj-35	103	13	cells	cell	NOUN
cvj-35	103	14	.	.	PUNCT
cvj-35	104	1	in	in	ADP
cvj-35	104	2	addition	addition	NOUN
cvj-35	104	3	to	to	ADP
cvj-35	104	4	increasing	increase	VERB
cvj-35	104	5	insulin	insulin	NOUN
cvj-35	104	6	resistance	resistance	NOUN
cvj-35	104	7	,	,	PUNCT
cvj-35	104	8	igfs	igfs	NOUN
cvj-35	104	9	,	,	PUNCT
cvj-35	104	10	adipokines	adipokine	NOUN
cvj-35	104	11	,	,	PUNCT
cvj-35	104	12	and	and	CCONJ
cvj-35	104	13	local	local	ADJ
cvj-35	104	14	estrogen	estrogen	NOUN
cvj-35	104	15	production	production	NOUN
cvj-35	104	16	,	,	PUNCT
cvj-35	104	17	there	there	PRON
cvj-35	104	18	is	be	VERB
cvj-35	104	19	clear	clear	ADJ
cvj-35	104	20	evidence	evidence	NOUN
cvj-35	104	21	to	to	PART
cvj-35	104	22	support	support	VERB
cvj-35	104	23	the	the	DET
cvj-35	104	24	independent	independent	ADJ
cvj-35	104	25	role	role	NOUN
cvj-35	104	26	of	of	ADP
cvj-35	104	27	cholesterol	cholesterol	NOUN
cvj-35	104	28	as	as	ADP
cvj-35	104	29	a	a	DET
cvj-35	104	30	mediator	mediator	NOUN
cvj-35	104	31	of	of	ADP
cvj-35	104	32	the	the	DET
cvj-35	104	33	effects	effect	NOUN
cvj-35	104	34	of	of	ADP
cvj-35	104	35	dyslipidemia	dyslipidemia	NOUN
cvj-35	104	36	and/or	and/or	CCONJ
cvj-35	104	37	obesity	obesity	NOUN
cvj-35	104	38	on	on	ADP
cvj-35	104	39	the	the	DET
cvj-35	104	40	pathogenesis	pathogenesis	NOUN
cvj-35	104	41	of	of	ADP
cvj-35	104	42	mammary	mammary	ADJ
cvj-35	104	43	cancer	cancer	NOUN
cvj-35	104	44	[	[	X
cvj-35	104	45	21	21	NUM
cvj-35	104	46	]	]	PUNCT
cvj-35	104	47	.	.	PUNCT
cvj-35	105	1	a	a	DET
cvj-35	105	2	major	major	ADJ
cvj-35	105	3	mechanism	mechanism	NOUN
cvj-35	105	4	by	by	ADP
cvj-35	105	5	which	which	PRON
cvj-35	105	6	cholesterol	cholesterol	NOUN
cvj-35	105	7	triggers	trigger	VERB
cvj-35	105	8	mammary	mammary	ADJ
cvj-35	105	9	cancer	cancer	NOUN
cvj-35	105	10	includes	include	VERB
cvj-35	105	11	its	its	PRON
cvj-35	105	12	metabolite	metabolite	NOUN
cvj-35	105	13	,	,	PUNCT
cvj-35	105	14	27hc	27hc	NOUN
cvj-35	105	15	,	,	PUNCT
cvj-35	105	16	a	a	DET
cvj-35	105	17	molecule	molecule	NOUN
cvj-35	105	18	with	with	ADP
cvj-35	105	19	serm	serm	ADJ
cvj-35	105	20	activity	activity	NOUN
cvj-35	105	21	(	(	PUNCT
cvj-35	105	22	which	which	PRON
cvj-35	105	23	is	be	AUX
cvj-35	105	24	a	a	DET
cvj-35	105	25	selective	selective	ADJ
cvj-35	105	26	modulator	modulator	NOUN
cvj-35	105	27	of	of	ADP
cvj-35	105	28	estrogen	estrogen	NOUN
cvj-35	105	29	receptors	receptor	NOUN
cvj-35	105	30	)	)	PUNCT
cvj-35	105	31	.	.	PUNCT
cvj-35	106	1	studies	study	NOUN
cvj-35	106	2	highlight	highlight	VERB
cvj-35	106	3	the	the	DET
cvj-35	106	4	immediate	immediate	ADJ
cvj-35	106	5	therapeutic	therapeutic	ADJ
cvj-35	106	6	potential	potential	NOUN
cvj-35	106	7	for	for	ADP
cvj-35	106	8	modulating	modulate	VERB
cvj-35	106	9	cholesterol	cholesterol	NOUN
cvj-35	106	10	levels	level	NOUN
cvj-35	106	11	,	,	PUNCT
cvj-35	106	12	either	either	CCONJ
cvj-35	106	13	through	through	ADP
cvj-35	106	14	diet	diet	NOUN
cvj-35	106	15	or	or	CCONJ
cvj-35	106	16	medication	medication	NOUN
cvj-35	106	17	,	,	PUNCT
cvj-35	106	18	such	such	ADJ
cvj-35	106	19	as	as	ADP
cvj-35	106	20	statins	statin	NOUN
cvj-35	106	21	,	,	PUNCT
cvj-35	106	22	pcsk9	pcsk9	NOUN
cvj-35	106	23	inhibitors	inhibitor	NOUN
cvj-35	106	24	,	,	PUNCT
cvj-35	106	25	or	or	CCONJ
cvj-35	106	26	niacin	niacin	NOUN
cvj-35	106	27	[	[	X
cvj-35	106	28	34	34	NUM
cvj-35	106	29	]	]	PUNCT
cvj-35	106	30	.	.	PUNCT
cvj-35	107	1	author	author	NOUN
cvj-35	107	2	contributions	contribution	NOUN
cvj-35	107	3	:	:	PUNCT
cvj-35	107	4	for	for	ADP
cvj-35	107	5	research	research	NOUN
cvj-35	107	6	articles	article	NOUN
cvj-35	107	7	with	with	ADP
cvj-35	107	8	several	several	ADJ
cvj-35	107	9	authors	author	NOUN
cvj-35	107	10	,	,	PUNCT
cvj-35	107	11	a	a	DET
cvj-35	107	12	short	short	ADJ
cvj-35	107	13	paragraph	paragraph	NOUN
cvj-35	107	14	specifying	specify	VERB
cvj-35	107	15	their	their	PRON
cvj-35	107	16	individual	individual	ADJ
cvj-35	107	17	contributions	contribution	NOUN
cvj-35	107	18	must	must	AUX
cvj-35	107	19	be	be	AUX
cvj-35	107	20	provided	provide	VERB
cvj-35	107	21	.	.	PUNCT
cvj-35	108	1	the	the	DET
cvj-35	108	2	following	follow	VERB
cvj-35	108	3	statements	statement	NOUN
cvj-35	108	4	should	should	AUX
cvj-35	108	5	be	be	AUX
cvj-35	108	6	used	use	VERB
cvj-35	108	7	“	"	PUNCT
cvj-35	108	8	conceptualization	conceptualization	NOUN
cvj-35	108	9	,	,	PUNCT
cvj-35	108	10	m.c	m.c	PROPN
cvj-35	108	11	.	.	PROPN
cvj-35	108	12	and	and	CCONJ
cvj-35	108	13	p.b	p.b	PROPN
cvj-35	108	14	.	.	PROPN
cvj-35	108	15	;	;	PUNCT
cvj-35	108	16	methodology	methodology	NOUN
cvj-35	108	17	,	,	PUNCT
cvj-35	108	18	cluj	cluj	PROPN
cvj-35	108	19	vet	vet	NOUN
cvj-35	108	20	j	j	PROPN
cvj-35	108	21	2021	2021	NUM
cvj-35	108	22	,	,	PUNCT
cvj-35	108	23	26	26	NUM
cvj-35	108	24	,	,	PUNCT
cvj-35	108	25	3	3	NUM
cvj-35	108	26	25	25	NUM
cvj-35	108	27	p.b	p.b	PROPN
cvj-35	108	28	.	.	PROPN
cvj-35	108	29	;	;	PUNCT
cvj-35	108	30	software	software	PROPN
cvj-35	108	31	,	,	PUNCT
cvj-35	108	32	m.c	m.c	PROPN
cvj-35	108	33	.	.	PROPN
cvj-35	108	34	;	;	PUNCT
cvj-35	108	35	validation	validation	NOUN
cvj-35	108	36	,	,	PUNCT
cvj-35	108	37	m.c	m.c	PROPN
cvj-35	108	38	.	.	PROPN
cvj-35	108	39	,	,	PUNCT
cvj-35	108	40	and	and	CCONJ
cvj-35	108	41	p.b	p.b	PROPN
cvj-35	108	42	.	.	PROPN
cvj-35	108	43	;	;	PUNCT
cvj-35	108	44	formal	formal	ADJ
cvj-35	108	45	analysis	analysis	NOUN
cvj-35	108	46	,	,	PUNCT
cvj-35	108	47	p.b	p.b	PROPN
cvj-35	108	48	.	.	PROPN
cvj-35	108	49	;	;	PUNCT
cvj-35	108	50	investigation	investigation	NOUN
cvj-35	108	51	,	,	PUNCT
cvj-35	108	52	p.b	p.b	PROPN
cvj-35	108	53	.	.	PROPN
cvj-35	108	54	;	;	PUNCT
cvj-35	108	55	resources	resource	NOUN
cvj-35	108	56	,	,	PUNCT
cvj-35	108	57	p.b	p.b	PROPN
cvj-35	108	58	.	.	PROPN
cvj-35	108	59	;	;	PUNCT
cvj-35	108	60	data	datum	NOUN
cvj-35	108	61	curation	curation	NOUN
cvj-35	108	62	,	,	PUNCT
cvj-35	108	63	p.b	p.b	PROPN
cvj-35	108	64	.	.	PROPN
cvj-35	108	65	;	;	PUNCT
cvj-35	109	1	writing	writing	NOUN
cvj-35	109	2	—	—	PUNCT
cvj-35	109	3	original	original	ADJ
cvj-35	109	4	draft	draft	NOUN
cvj-35	109	5	preparation	preparation	NOUN
cvj-35	109	6	,	,	PUNCT
cvj-35	109	7	p.b	p.b	PROPN
cvj-35	109	8	.	.	PROPN
cvj-35	109	9	;	;	PUNCT
cvj-35	109	10	writing	writing	NOUN
cvj-35	109	11	—	—	PUNCT
cvj-35	109	12	review	review	NOUN
cvj-35	109	13	and	and	CCONJ
cvj-35	109	14	editing	editing	NOUN
cvj-35	109	15	,	,	PUNCT
cvj-35	109	16	c.m	c.m	PROPN
cvj-35	109	17	.	.	PROPN
cvj-35	109	18	;	;	PUNCT
cvj-35	109	19	visualization	visualization	NOUN
cvj-35	109	20	,	,	PUNCT
cvj-35	109	21	c.m	c.m	PROPN
cvj-35	109	22	.	.	PROPN
cvj-35	109	23	;	;	PUNCT
cvj-35	109	24	supervision	supervision	NOUN
cvj-35	109	25	,	,	PUNCT
cvj-35	109	26	c.m	c.m	PROPN
cvj-35	109	27	.	.	PUNCT
cvj-35	110	1	all	all	DET
cvj-35	110	2	authors	author	NOUN
cvj-35	110	3	have	have	AUX
cvj-35	110	4	read	read	VERB
cvj-35	110	5	and	and	CCONJ
cvj-35	110	6	agreed	agree	VERB
cvj-35	110	7	to	to	ADP
cvj-35	110	8	the	the	DET
cvj-35	110	9	published	publish	VERB
cvj-35	110	10	version	version	NOUN
cvj-35	110	11	of	of	ADP
cvj-35	110	12	the	the	DET
cvj-35	110	13	manuscript	manuscript	NOUN
cvj-35	110	14	”	"	PUNCT
cvj-35	110	15	.	.	PUNCT
cvj-35	111	1	funding	funding	NOUN
cvj-35	111	2	:	:	PUNCT
cvj-35	111	3	“	"	PUNCT
cvj-35	111	4	this	this	DET
cvj-35	111	5	research	research	NOUN
cvj-35	111	6	received	receive	VERB
cvj-35	111	7	no	no	DET
cvj-35	111	8	external	external	ADJ
cvj-35	111	9	funding	funding	NOUN
cvj-35	111	10	”	"	PUNCT
cvj-35	111	11	.	.	PUNCT
cvj-35	112	1	conflicts	conflict	NOUN
cvj-35	112	2	of	of	ADP
cvj-35	112	3	interest	interest	NOUN
cvj-35	112	4	:	:	PUNCT
cvj-35	112	5	“	"	PUNCT
cvj-35	112	6	the	the	DET
cvj-35	112	7	authors	author	NOUN
cvj-35	112	8	declare	declare	VERB
cvj-35	112	9	no	no	DET
cvj-35	112	10	conflict	conflict	NOUN
cvj-35	112	11	of	of	ADP
cvj-35	112	12	interest	interest	NOUN
cvj-35	112	13	.	.	PUNCT
cvj-35	112	14	”	"	PUNCT
cvj-35	113	1	references	reference	NOUN
cvj-35	113	2	1	1	NUM
cvj-35	113	3	.	.	PUNCT
cvj-35	113	4	lee	lee	PROPN
cvj-35	113	5	,	,	PUNCT
cvj-35	113	6	k.	k.	PROPN
cvj-35	113	7	,	,	PUNCT
cvj-35	113	8	kruper	kruper	PROPN
cvj-35	113	9	,	,	PUNCT
cvj-35	113	10	l.	l.	PROPN
cvj-35	113	11	,	,	PUNCT
cvj-35	113	12	dieli	dieli	PROPN
cvj-35	113	13	-	-	PUNCT
cvj-35	113	14	conwright	conwright	NOUN
cvj-35	113	15	,	,	PUNCT
cvj-35	113	16	c.	c.	PROPN
cvj-35	113	17	m.	m.	PROPN
cvj-35	113	18	,	,	PUNCT
cvj-35	113	19	mortimer	mortimer	PROPN
cvj-35	113	20	,	,	PUNCT
cvj-35	113	21	j.	j.	PROPN
cvj-35	113	22	e.	e.	PROPN
cvj-35	113	23	the	the	DET
cvj-35	113	24	impact	impact	NOUN
cvj-35	113	25	of	of	ADP
cvj-35	113	26	obesity	obesity	NOUN
cvj-35	113	27	on	on	ADP
cvj-35	113	28	breast	breast	NOUN
cvj-35	113	29	cancer	cancer	NOUN
cvj-35	113	30	diagnosis	diagnosis	NOUN
cvj-35	113	31	and	and	CCONJ
cvj-35	113	32	treatment	treatment	NOUN
cvj-35	113	33	.	.	PUNCT
cvj-35	114	1	current	current	ADJ
cvj-35	114	2	oncology	oncology	NOUN
cvj-35	114	3	report	report	NOUN
cvj-35	114	4	2019	2019	NUM
cvj-35	114	5	,	,	PUNCT
cvj-35	114	6	21(5	21(5	NUM
cvj-35	114	7	)	)	PUNCT
cvj-35	114	8	,	,	PUNCT
cvj-35	114	9	41	41	NUM
cvj-35	114	10	.	.	PUNCT
cvj-35	115	1	https://doi.org/10.1007/s11912-019-0787-1	https://doi.org/10.1007/s11912-019-0787-1	VERB
cvj-35	115	2	2	2	NUM
cvj-35	115	3	.	.	PUNCT
cvj-35	115	4	coelho	coelho	PROPN
cvj-35	115	5	m	m	PROPN
cvj-35	115	6	,	,	PUNCT
cvj-35	115	7	oliveira	oliveira	PROPN
cvj-35	115	8	t	t	PROPN
cvj-35	115	9	,	,	PUNCT
cvj-35	115	10	fernandes	fernandes	PROPN
cvj-35	115	11	r.	r.	PROPN
cvj-35	115	12	biochemistry	biochemistry	PROPN
cvj-35	115	13	of	of	ADP
cvj-35	115	14	adipose	adipose	ADJ
cvj-35	115	15	tissue	tissue	NOUN
cvj-35	115	16	:	:	PUNCT
cvj-35	115	17	an	an	DET
cvj-35	115	18	endocrine	endocrine	ADJ
cvj-35	115	19	organ	organ	NOUN
cvj-35	115	20	.	.	PUNCT
cvj-35	116	1	arch	arch	PROPN
cvj-35	116	2	med	med	PROPN
cvj-35	116	3	sci	sci	PROPN
cvj-35	116	4	.	.	PUNCT
cvj-35	117	1	2013;9(2):191	2013;9(2):191	NUM
cvj-35	117	2	-	-	SYM
cvj-35	117	3	200	200	NUM
cvj-35	117	4	.	.	PUNCT
cvj-35	118	1	doi:10.5114	doi:10.5114	PROPN
cvj-35	118	2	/	/	SYM
cvj-35	118	3	aoms.2013.33181	aoms.2013.33181	PROPN
cvj-35	118	4	3	3	NUM
cvj-35	118	5	.	.	PUNCT
cvj-35	118	6	balistreri	balistreri	PROPN
cvj-35	118	7	,	,	PUNCT
cvj-35	118	8	c.	c.	PROPN
cvj-35	118	9	r.	r.	PROPN
cvj-35	118	10	,	,	PUNCT
cvj-35	118	11	caruso	caruso	PROPN
cvj-35	118	12	,	,	PUNCT
cvj-35	118	13	c.	c.	PROPN
cvj-35	118	14	,	,	PUNCT
cvj-35	118	15	candore	candore	PROPN
cvj-35	118	16	,	,	PUNCT
cvj-35	118	17	g.	g.	PROPN
cvj-35	118	18	the	the	DET
cvj-35	118	19	role	role	NOUN
cvj-35	118	20	of	of	ADP
cvj-35	118	21	adipose	adipose	ADJ
cvj-35	118	22	tissue	tissue	NOUN
cvj-35	118	23	and	and	CCONJ
cvj-35	118	24	adipokines	adipokine	NOUN
cvj-35	118	25	in	in	ADP
cvj-35	118	26	obesity	obesity	NOUN
cvj-35	118	27	-	-	PUNCT
cvj-35	118	28	related	relate	VERB
cvj-35	118	29	inflammatory	inflammatory	ADJ
cvj-35	118	30	diseases	disease	NOUN
cvj-35	118	31	.	.	PUNCT
cvj-35	119	1	mediators	mediator	NOUN
cvj-35	119	2	of	of	ADP
cvj-35	119	3	inflammation	inflammation	NOUN
cvj-35	119	4	2010	2010	NUM
cvj-35	119	5	,	,	PUNCT
cvj-35	119	6	802078	802078	NUM
cvj-35	119	7	.	.	PUNCT
cvj-35	120	1	https://doi.org/10.1155/2010/802078	https://doi.org/10.1155/2010/802078	PROPN
cvj-35	120	2	4	4	NUM
cvj-35	120	3	.	.	PUNCT
cvj-35	120	4	mohanty	mohanty	PROPN
cvj-35	120	5	,	,	PUNCT
cvj-35	120	6	s.	s.	PROPN
cvj-35	120	7	s.	s.	PROPN
cvj-35	120	8	,	,	PUNCT
cvj-35	120	9	mohanty	mohanty	PROPN
cvj-35	120	10	,	,	PUNCT
cvj-35	120	11	p.	p.	NOUN
cvj-35	120	12	k.	k.	PROPN
cvj-35	120	13	obesity	obesity	NOUN
cvj-35	120	14	as	as	ADP
cvj-35	120	15	potential	potential	ADJ
cvj-35	120	16	breast	breast	NOUN
cvj-35	120	17	cancer	cancer	NOUN
cvj-35	120	18	risk	risk	NOUN
cvj-35	120	19	factor	factor	NOUN
cvj-35	120	20	for	for	ADP
cvj-35	120	21	postmenopausal	postmenopausal	ADJ
cvj-35	120	22	women	woman	NOUN
cvj-35	120	23	.	.	PUNCT
cvj-35	121	1	genes	gene	NOUN
cvj-35	121	2	&	&	CCONJ
cvj-35	121	3	disease	disease	NOUN
cvj-35	121	4	2021	2021	NUM
cvj-35	121	5	,	,	PUNCT
cvj-35	121	6	8(2	8(2	NUM
cvj-35	121	7	)	)	PUNCT
cvj-35	121	8	,	,	PUNCT
cvj-35	121	9	117	117	NUM
cvj-35	121	10	-	-	SYM
cvj-35	121	11	123	123	NUM
cvj-35	121	12	.	.	PUNCT
cvj-35	122	1	5	5	NUM
cvj-35	122	2	.	.	X
cvj-35	122	3	hamilton	hamilton	PROPN
cvj-35	122	4	,	,	PUNCT
cvj-35	122	5	k.	k.	PROPN
cvj-35	122	6	j.	j.	PROPN
cvj-35	122	7	,	,	PUNCT
cvj-35	122	8	hewitt	hewitt	PROPN
cvj-35	122	9	,	,	PUNCT
cvj-35	122	10	s.	s.	PROPN
cvj-35	122	11	c.	c.	PROPN
cvj-35	122	12	,	,	PUNCT
cvj-35	122	13	arao	arao	PROPN
cvj-35	122	14	,	,	PUNCT
cvj-35	122	15	y.	y.	PROPN
cvj-35	122	16	,	,	PUNCT
cvj-35	122	17	korach	korach	VERB
cvj-35	122	18	,	,	PUNCT
cvj-35	122	19	k.	k.	PROPN
cvj-35	122	20	s.	s.	PROPN
cvj-35	122	21	estrogen	estrogen	PROPN
cvj-35	122	22	hormone	hormone	NOUN
cvj-35	122	23	biology	biology	NOUN
cvj-35	122	24	.	.	PUNCT
cvj-35	123	1	current	current	ADJ
cvj-35	123	2	topics	topic	NOUN
cvj-35	123	3	in	in	ADP
cvj-35	123	4	developmental	developmental	ADJ
cvj-35	123	5	biology	biology	NOUN
cvj-35	123	6	2017	2017	NUM
cvj-35	123	7	125	125	NUM
cvj-35	123	8	,	,	PUNCT
cvj-35	123	9	109–146	109–146	NUM
cvj-35	123	10	.	.	PUNCT
cvj-35	124	1	https://doi.org/10.1016/bs.ctdb.2016.12.005	https://doi.org/10.1016/bs.ctdb.2016.12.005	NOUN
cvj-35	124	2	6	6	NUM
cvj-35	124	3	.	.	PUNCT
cvj-35	125	1	brisken	brisken	PROPN
cvj-35	125	2	,	,	PUNCT
cvj-35	125	3	c.	c.	PROPN
cvj-35	125	4	,	,	PUNCT
cvj-35	125	5	o'malley	o'malley	PROPN
cvj-35	125	6	,	,	PUNCT
cvj-35	125	7	b.	b.	PROPN
cvj-35	125	8	hormone	hormone	NOUN
cvj-35	125	9	action	action	NOUN
cvj-35	125	10	in	in	ADP
cvj-35	125	11	the	the	DET
cvj-35	125	12	mammary	mammary	ADJ
cvj-35	125	13	gland	gland	NOUN
cvj-35	125	14	.	.	PUNCT
cvj-35	126	1	cold	cold	ADJ
cvj-35	126	2	spring	spring	NOUN
cvj-35	126	3	harbor	harbor	NOUN
cvj-35	126	4	perspectives	perspective	NOUN
cvj-35	126	5	in	in	ADP
cvj-35	126	6	biology	biology	NOUN
cvj-35	126	7	2010	2010	NUM
cvj-35	126	8	,	,	PUNCT
cvj-35	126	9	2(12	2(12	NUM
cvj-35	126	10	)	)	PUNCT
cvj-35	126	11	,	,	PUNCT
cvj-35	127	1	a003178	a003178	ADV
cvj-35	127	2	.	.	PUNCT
cvj-35	128	1	https://doi.org/10.1101/cshperspect.a003178	https://doi.org/10.1101/cshperspect.a003178	NOUN
cvj-35	128	2	7	7	NUM
cvj-35	128	3	.	.	PUNCT
cvj-35	128	4	liedtke	liedtke	PROPN
cvj-35	128	5	,	,	PUNCT
cvj-35	128	6	s.	s.	PROPN
cvj-35	128	7	,	,	PUNCT
cvj-35	128	8	schmidt	schmidt	PROPN
cvj-35	128	9	,	,	PUNCT
cvj-35	128	10	m.	m.	PROPN
cvj-35	128	11	e.	e.	PROPN
cvj-35	128	12	,	,	PUNCT
cvj-35	128	13	vrieling	vrieling	NOUN
cvj-35	128	14	,	,	PUNCT
cvj-35	128	15	a.	a.	PROPN
cvj-35	128	16	,	,	PUNCT
cvj-35	128	17	lukanova	lukanova	PROPN
cvj-35	128	18	,	,	PUNCT
cvj-35	128	19	a.	a.	PROPN
cvj-35	128	20	,	,	PUNCT
cvj-35	128	21	becker	becker	PROPN
cvj-35	128	22	,	,	PUNCT
cvj-35	128	23	s.	s.	PROPN
cvj-35	128	24	,	,	PUNCT
cvj-35	128	25	kaaks	kaaks	PROPN
cvj-35	128	26	,	,	PUNCT
cvj-35	128	27	r.	r.	PROPN
cvj-35	128	28	,	,	PUNCT
cvj-35	128	29	zainedin	zainedin	PROPN
cvj-35	128	30	,	,	PUNCT
cvj-35	128	31	a.k	a.k	PROPN
cvj-35	128	32	.	.	PROPN
cvj-35	128	33	,	,	PUNCT
cvj-35	128	34	buck	buck	PROPN
cvj-35	128	35	,	,	PUNCT
cvj-35	128	36	k.	k.	PROPN
cvj-35	128	37	,	,	PUNCT
cvj-35	128	38	benner	benner	PROPN
cvj-35	128	39	,	,	PUNCT
cvj-35	128	40	a.	a.	PROPN
cvj-35	128	41	,	,	PUNCT
cvj-35	128	42	chang	chang	PROPN
cvj-35	128	43	-	-	PUNCT
cvj-35	128	44	claude	claude	PROPN
cvj-35	128	45	,	,	PUNCT
cvj-35	128	46	j.	j.	PROPN
cvj-35	128	47	,	,	PUNCT
cvj-35	128	48	steindorf	steindorf	PROPN
cvj-35	128	49	,	,	PUNCT
cvj-35	128	50	k.	k.	PROPN
cvj-35	128	51	postmenopausal	postmenopausal	PROPN
cvj-35	128	52	sex	sex	NOUN
cvj-35	128	53	hormones	hormone	NOUN
cvj-35	128	54	in	in	ADP
cvj-35	128	55	relation	relation	NOUN
cvj-35	128	56	to	to	PART
cvj-35	128	57	body	body	NOUN
cvj-35	128	58	fat	fat	ADJ
cvj-35	128	59	distribution	distribution	NOUN
cvj-35	128	60	.	.	PUNCT
cvj-35	129	1	obesity	obesity	NOUN
cvj-35	129	2	2012	2012	NUM
cvj-35	129	3	,	,	PUNCT
cvj-35	129	4	20(5	20(5	NUM
cvj-35	129	5	)	)	PUNCT
cvj-35	129	6	,	,	PUNCT
cvj-35	129	7	1088	1088	NUM
cvj-35	129	8	-	-	SYM
cvj-35	129	9	1095	1095	NUM
cvj-35	129	10	.	.	PUNCT
cvj-35	130	1	8	8	X
cvj-35	130	2	.	.	X
cvj-35	130	3	purohit	purohit	PROPN
cvj-35	130	4	,	,	PUNCT
cvj-35	130	5	a.	a.	PROPN
cvj-35	130	6	,	,	PUNCT
cvj-35	130	7	reed	reed	NOUN
cvj-35	130	8	,	,	PUNCT
cvj-35	130	9	m.	m.	NOUN
cvj-35	130	10	j.	j.	PROPN
cvj-35	130	11	regulation	regulation	PROPN
cvj-35	130	12	of	of	ADP
cvj-35	130	13	estrogen	estrogen	NOUN
cvj-35	130	14	synthesis	synthesis	NOUN
cvj-35	130	15	in	in	ADP
cvj-35	130	16	postmenopausal	postmenopausal	ADJ
cvj-35	130	17	women	woman	NOUN
cvj-35	130	18	.	.	PUNCT
cvj-35	131	1	steroids	steroid	NOUN
cvj-35	131	2	2002	2002	NUM
cvj-35	131	3	,	,	PUNCT
cvj-35	131	4	67(12	67(12	NUM
cvj-35	131	5	)	)	PUNCT
cvj-35	131	6	,	,	PUNCT
cvj-35	131	7	979983	979983	NUM
cvj-35	131	8	.	.	PUNCT
cvj-35	132	1	9	9	X
cvj-35	132	2	.	.	X
cvj-35	132	3	mullooly	mullooly	ADJ
cvj-35	132	4	,	,	PUNCT
cvj-35	132	5	m.	m.	NOUN
cvj-35	132	6	,	,	PUNCT
cvj-35	132	7	yang	yang	PROPN
cvj-35	132	8	,	,	PUNCT
cvj-35	132	9	h.	h.	PROPN
cvj-35	132	10	p.	p.	PROPN
cvj-35	132	11	,	,	PUNCT
cvj-35	132	12	falk	falk	NOUN
cvj-35	132	13	,	,	PUNCT
cvj-35	132	14	r.	r.	PROPN
cvj-35	132	15	t.	t.	PROPN
cvj-35	132	16	,	,	PUNCT
cvj-35	132	17	nyante	nyante	PROPN
cvj-35	132	18	,	,	PUNCT
cvj-35	132	19	s.	s.	PROPN
cvj-35	132	20	j.	j.	PROPN
cvj-35	132	21	,	,	PUNCT
cvj-35	132	22	cora	cora	PROPN
cvj-35	132	23	,	,	PUNCT
cvj-35	132	24	r.	r.	PROPN
cvj-35	132	25	,	,	PUNCT
cvj-35	132	26	pfeiffer	pfeiffer	PROPN
cvj-35	132	27	,	,	PUNCT
cvj-35	132	28	r.	r.	PROPN
cvj-35	132	29	m.	m.	PROPN
cvj-35	132	30	,	,	PUNCT
cvj-35	132	31	radisky	radisky	PROPN
cvj-35	132	32	,	,	PUNCT
cvj-35	132	33	d.c	d.c	PROPN
cvj-35	132	34	.	.	PROPN
cvj-35	132	35	,	,	PUNCT
cvj-35	132	36	visscher	visscher	PROPN
cvj-35	132	37	,	,	PUNCT
cvj-35	132	38	d.w	d.w	PROPN
cvj-35	132	39	.	.	PROPN
cvj-35	132	40	,	,	PUNCT
cvj-35	132	41	hartmann	hartmann	PROPN
cvj-35	132	42	,	,	PUNCT
cvj-35	132	43	l.c	l.c	PROPN
cvj-35	132	44	.	.	PROPN
cvj-35	132	45	,	,	PUNCT
cvj-35	132	46	carter	carter	PROPN
cvj-35	132	47	,	,	PUNCT
cvj-35	132	48	j.m	j.m	PROPN
cvj-35	132	49	.	.	PROPN
cvj-35	132	50	,	,	PUNCT
cvj-35	132	51	degnim	degnim	NOUN
cvj-35	132	52	,	,	PUNCT
cvj-35	132	53	a.c	a.c	PROPN
cvj-35	132	54	.	.	PROPN
cvj-35	132	55	,	,	PUNCT
cvj-35	132	56	stanczyk	stanczyk	NOUN
cvj-35	132	57	,	,	PUNCT
cvj-35	132	58	f.z	f.z	PROPN
cvj-35	132	59	.	.	PROPN
cvj-35	132	60	,	,	PUNCT
cvj-35	132	61	figueroa	figueroa	PROPN
cvj-35	132	62	,	,	PUNCT
cvj-35	132	63	j.d	j.d	PROPN
cvj-35	132	64	.	.	PROPN
cvj-35	132	65	,	,	PUNCT
cvj-35	132	66	garcia	garcia	PROPN
cvj-35	132	67	-	-	PUNCT
cvj-35	132	68	closas	closas	PROPN
cvj-35	132	69	,	,	PUNCT
cvj-35	132	70	m.	m.	NOUN
cvj-35	132	71	,	,	PUNCT
cvj-35	132	72	lissowska	lissowska	PROPN
cvj-35	132	73	,	,	PUNCT
cvj-35	132	74	j.	j.	PROPN
cvj-35	132	75	,	,	PUNCT
cvj-35	132	76	troester	troester	PROPN
cvj-35	132	77	,	,	PUNCT
cvj-35	132	78	m.a	m.a	PROPN
cvj-35	132	79	.	.	PROPN
cvj-35	132	80	,	,	PUNCT
cvj-35	132	81	hewitt	hewitt	PROPN
cvj-35	132	82	,	,	PUNCT
cvj-35	132	83	s.m	s.m	PROPN
cvj-35	132	84	.	.	PROPN
cvj-35	132	85	,	,	PUNCT
cvj-35	132	86	brinton	brinton	PROPN
cvj-35	132	87	l.a	l.a	PROPN
cvj-35	132	88	.	.	PROPN
cvj-35	132	89	,	,	PUNCT
cvj-35	132	90	sherman	sherman	PROPN
cvj-35	132	91	m.e	m.e	PROPN
cvj-35	132	92	.	.	PROPN
cvj-35	132	93	,	,	PUNCT
cvj-35	132	94	gierach	gierach	PROPN
cvj-35	132	95	,	,	PUNCT
cvj-35	132	96	g.	g.	PROPN
cvj-35	132	97	l.	l.	PROPN
cvj-35	132	98	relationship	relationship	PROPN
cvj-35	132	99	between	between	ADP
cvj-35	132	100	crown	crown	NOUN
cvj-35	132	101	-	-	PUNCT
cvj-35	132	102	like	like	ADJ
cvj-35	132	103	structures	structure	NOUN
cvj-35	132	104	and	and	CCONJ
cvj-35	132	105	sex	sex	NOUN
cvj-35	132	106	-	-	PUNCT
cvj-35	132	107	steroid	steroid	NOUN
cvj-35	132	108	hormones	hormone	NOUN
cvj-35	132	109	in	in	ADP
cvj-35	132	110	breast	breast	NOUN
cvj-35	132	111	adipose	adipose	NOUN
cvj-35	132	112	tissue	tissue	NOUN
cvj-35	132	113	and	and	CCONJ
cvj-35	132	114	serum	serum	NOUN
cvj-35	132	115	among	among	ADP
cvj-35	132	116	postmenopausal	postmenopausal	ADJ
cvj-35	132	117	breast	breast	NOUN
cvj-35	132	118	cancer	cancer	NOUN
cvj-35	132	119	patients	patient	NOUN
cvj-35	132	120	.	.	PUNCT
cvj-35	133	1	breast	breast	NOUN
cvj-35	133	2	cancer	cancer	NOUN
cvj-35	133	3	research	research	PROPN
cvj-35	133	4	2017	2017	NUM
cvj-35	133	5	,	,	PUNCT
cvj-35	133	6	19(1	19(1	NUM
cvj-35	133	7	)	)	PUNCT
cvj-35	133	8	,	,	PUNCT
cvj-35	133	9	1	1	NUM
cvj-35	133	10	-	-	SYM
cvj-35	133	11	10	10	NUM
cvj-35	133	12	.	.	PUNCT
cvj-35	133	13	10	10	NUM
cvj-35	133	14	.	.	PUNCT
cvj-35	134	1	key	key	ADJ
cvj-35	134	2	,	,	PUNCT
cvj-35	134	3	t.	t.	PROPN
cvj-35	134	4	j.	j.	PROPN
cvj-35	134	5	,	,	PUNCT
cvj-35	134	6	appleby	appleby	PROPN
cvj-35	134	7	,	,	PUNCT
cvj-35	134	8	p.	p.	PROPN
cvj-35	134	9	n.	n.	PROPN
cvj-35	134	10	,	,	PUNCT
cvj-35	134	11	reeves	reeves	PROPN
cvj-35	134	12	,	,	PUNCT
cvj-35	134	13	g.	g.	PROPN
cvj-35	134	14	k.	k.	PROPN
cvj-35	134	15	,	,	PUNCT
cvj-35	134	16	travis	travis	PROPN
cvj-35	134	17	,	,	PUNCT
cvj-35	134	18	r.	r.	PROPN
cvj-35	134	19	c.	c.	PROPN
cvj-35	134	20	,	,	PUNCT
cvj-35	134	21	brinton	brinton	PROPN
cvj-35	134	22	,	,	PUNCT
cvj-35	134	23	l.	l.	PROPN
cvj-35	134	24	a.	a.	PROPN
cvj-35	134	25	,	,	PUNCT
cvj-35	134	26	helzlsouer	helzlsouer	PROPN
cvj-35	134	27	,	,	PUNCT
cvj-35	134	28	k.	k.	PROPN
cvj-35	134	29	j.	j.	PROPN
cvj-35	134	30	,	,	PUNCT
cvj-35	134	31	dorgan	dorgan	PROPN
cvj-35	134	32	,	,	PUNCT
cvj-35	134	33	j.f	j.f	PROPN
cvj-35	134	34	.	.	PROPN
cvj-35	134	35	,	,	PUNCT
cvj-35	134	36	gapstur	gapstur	PROPN
cvj-35	134	37	,	,	PUNCT
cvj-35	134	38	s.m	s.m	PROPN
cvj-35	134	39	.	.	PROPN
cvj-35	134	40	,	,	PUNCT
cvj-35	134	41	gaudet	gaudet	PROPN
cvj-35	134	42	,	,	PUNCT
cvj-35	134	43	m.m	m.m	PROPN
cvj-35	134	44	.	.	PROPN
cvj-35	134	45	,	,	PUNCT
cvj-35	134	46	kaaks	kaaks	PROPN
cvj-35	134	47	,	,	PUNCT
cvj-35	134	48	r.	r.	PROPN
cvj-35	134	49	,	,	PUNCT
cvj-35	134	50	riboli	riboli	ADV
cvj-35	134	51	,	,	PUNCT
cvj-35	134	52	e.	e.	PROPN
cvj-35	134	53	,	,	PUNCT
cvj-35	134	54	rinaldi	rinaldi	PROPN
cvj-35	134	55	,	,	PUNCT
cvj-35	134	56	s.	s.	PROPN
cvj-35	134	57	,	,	PUNCT
cvj-35	134	58	manjer	manjer	PROPN
cvj-35	134	59	,	,	PUNCT
cvj-35	134	60	j.	j.	PROPN
cvj-35	134	61	,	,	PUNCT
cvj-35	134	62	hallmans	hallman	NOUN
cvj-35	134	63	,	,	PUNCT
cvj-35	134	64	g.	g.	PROPN
cvj-35	134	65	,	,	PUNCT
cvj-35	134	66	giles	giles	PROPN
cvj-35	134	67	,	,	PUNCT
cvj-35	134	68	g.g	g.g	PROPN
cvj-35	134	69	.	.	PROPN
cvj-35	134	70	,	,	PUNCT
cvj-35	134	71	marchand	marchand	PROPN
cvj-35	134	72	,	,	PUNCT
cvj-35	134	73	l.le	l.le	PROPN
cvj-35	134	74	,	,	PUNCT
cvj-35	134	75	kolonel	kolonel	PROPN
cvj-35	134	76	,	,	PUNCT
cvj-35	134	77	l.n	l.n	PROPN
cvj-35	134	78	.	.	PROPN
cvj-35	134	79	,	,	PUNCT
cvj-35	134	80	henderson	henderson	PROPN
cvj-35	134	81	,	,	PUNCT
cvj-35	134	82	b.e	b.e	PROPN
cvj-35	134	83	.	.	PROPN
cvj-35	134	84	,	,	PUNCT
cvj-35	134	85	tworoger	tworoger	NUM
cvj-35	134	86	,	,	PUNCT
cvj-35	134	87	s.s	s.s	PROPN
cvj-35	134	88	.	.	PROPN
cvj-35	134	89	,	,	PUNCT
cvj-35	134	90	hankinson	hankinson	PROPN
cvj-35	134	91	,	,	PUNCT
cvj-35	134	92	s.e	s.e	PROPN
cvj-35	134	93	.	.	PROPN
cvj-35	134	94	,	,	PUNCT
cvj-35	134	95	zeleniuch	zeleniuch	NOUN
cvj-35	134	96	-	-	PUNCT
cvj-35	134	97	jacquotte	jacquotte	PROPN
cvj-35	134	98	a.	a.	PROPN
cvj-35	134	99	,	,	PUNCT
cvj-35	134	100	koenig	koenig	PROPN
cvj-35	134	101	,	,	PUNCT
cvj-35	134	102	k.	k.	PROPN
cvj-35	134	103	,	,	PUNCT
cvj-35	134	104	krogh	krogh	PROPN
cvj-35	134	105	,	,	PUNCT
cvj-35	134	106	v.	v.	PROPN
cvj-35	134	107	,	,	PUNCT
cvj-35	134	108	sieri	sieri	PROPN
cvj-35	134	109	,	,	PUNCT
cvj-35	134	110	s.	s.	PROPN
cvj-35	134	111	,	,	PUNCT
cvj-35	134	112	muti	muti	PROPN
cvj-35	134	113	,	,	PUNCT
cvj-35	134	114	p.	p.	PROPN
cvj-35	134	115	,	,	PUNCT
cvj-35	134	116	ziegler	ziegler	PROPN
cvj-35	134	117	,	,	PUNCT
cvj-35	134	118	r.g	r.g	PROPN
cvj-35	134	119	.	.	PROPN
cvj-35	134	120	,	,	PUNCT
cvj-35	134	121	schairer	schairer	NOUN
cvj-35	134	122	,	,	PUNCT
cvj-35	134	123	c.	c.	PROPN
cvj-35	134	124	,	,	PUNCT
cvj-35	134	125	furhman	furhman	NOUN
cvj-35	134	126	,	,	PUNCT
cvj-35	134	127	b.j	b.j	PROPN
cvj-35	134	128	.	.	PROPN
cvj-35	134	129	,	,	PUNCT
cvj-35	134	130	barrett	barrett	PROPN
cvj-35	134	131	-	-	PUNCT
cvj-35	134	132	conner	conner	PROPN
cvj-35	134	133	,	,	PUNCT
cvj-35	134	134	e.	e.	PROPN
cvj-35	134	135	,	,	PUNCT
cvj-35	134	136	laughlin	laughlin	PROPN
cvj-35	134	137	,	,	PUNCT
cvj-35	134	138	g.a	g.a	PROPN
cvj-35	134	139	.	.	PROPN
cvj-35	134	140	,	,	PUNCT
cvj-35	134	141	grant	grant	PROPN
cvj-35	134	142	,	,	PUNCT
cvj-35	134	143	e.j	e.j	PROPN
cvj-35	134	144	.	.	PROPN
cvj-35	134	145	,	,	PUNCT
cvj-35	134	146	cologne	cologne	NOUN
cvj-35	134	147	,	,	PUNCT
cvj-35	134	148	j.	j.	PROPN
cvj-35	134	149	,	,	PUNCT
cvj-35	134	150	ohishi	ohishi	PROPN
cvj-35	134	151	,	,	PUNCT
cvj-35	134	152	w.	w.	PROPN
cvj-35	134	153	,	,	PUNCT
cvj-35	134	154	hida	hida	PROPN
cvj-35	134	155	,	,	PUNCT
cvj-35	134	156	a.	a.	NOUN
cvj-35	134	157	,	,	PUNCT
cvj-35	134	158	cauley	cauley	NOUN
cvj-35	134	159	,	,	PUNCT
cvj-35	134	160	j.a	j.a	PROPN
cvj-35	134	161	.	.	PROPN
cvj-35	134	162	,	,	PUNCT
cvj-35	134	163	fourkala	fourkala	PROPN
cvj-35	134	164	,	,	PUNCT
cvj-35	134	165	e.o	e.o	PROPN
cvj-35	134	166	.	.	PROPN
cvj-35	134	167	,	,	PUNCT
cvj-35	134	168	menon	menon	PROPN
cvj-35	134	169	,	,	PUNCT
cvj-35	134	170	u.	u.	PROPN
cvj-35	134	171	,	,	PUNCT
cvj-35	134	172	rohan	rohan	PROPN
cvj-35	134	173	,	,	PUNCT
cvj-35	134	174	t.e	t.e	PROPN
cvj-35	134	175	.	.	PROPN
cvj-35	134	176	,	,	PUNCT
cvj-35	134	177	strickler	strickler	PROPN
cvj-35	134	178	,	,	PUNCT
cvj-35	134	179	h.d	h.d	PROPN
cvj-35	134	180	.	.	PROPN
cvj-35	134	181	,	,	PUNCT
cvj-35	134	182	gunter	gunter	PROPN
cvj-35	134	183	,	,	PUNCT
cvj-35	134	184	m.	m.	NOUN
cvj-35	134	185	j.	j.	PROPN
cvj-35	134	186	endogenous	endogenous	ADJ
cvj-35	134	187	hormones	hormone	NOUN
cvj-35	134	188	and	and	CCONJ
cvj-35	134	189	breast	breast	NOUN
cvj-35	134	190	cancer	cancer	NOUN
cvj-35	134	191	collaborative	collaborative	ADJ
cvj-35	134	192	group	group	NOUN
cvj-35	134	193	.	.	PUNCT
cvj-35	135	1	steroid	steroid	NOUN
cvj-35	135	2	hormone	hormone	NOUN
cvj-35	135	3	measurements	measurement	NOUN
cvj-35	135	4	from	from	ADP
cvj-35	135	5	different	different	ADJ
cvj-35	135	6	types	type	NOUN
cvj-35	135	7	of	of	ADP
cvj-35	135	8	assays	assay	NOUN
cvj-35	135	9	in	in	ADP
cvj-35	135	10	relation	relation	NOUN
cvj-35	135	11	to	to	ADP
cvj-35	135	12	body	body	NOUN
cvj-35	135	13	mass	mass	NOUN
cvj-35	135	14	index	index	NOUN
cvj-35	135	15	and	and	CCONJ
cvj-35	135	16	breast	breast	NOUN
cvj-35	135	17	cancer	cancer	NOUN
cvj-35	135	18	risk	risk	NOUN
cvj-35	135	19	in	in	ADP
cvj-35	135	20	postmenopausal	postmenopausal	ADJ
cvj-35	135	21	women	woman	NOUN
cvj-35	135	22	:	:	PUNCT
cvj-35	135	23	reanalysis	reanalysi	NOUN
cvj-35	135	24	of	of	ADP
cvj-35	135	25	eighteen	eighteen	NUM
cvj-35	135	26	prospective	prospective	ADJ
cvj-35	135	27	studies	study	NOUN
cvj-35	135	28	.	.	PUNCT
cvj-35	136	1	steroids	steroid	NOUN
cvj-35	136	2	2015	2015	NUM
cvj-35	136	3	,	,	PUNCT
cvj-35	136	4	99(pt	99(pt	NUM
cvj-35	136	5	a	a	NOUN
cvj-35	136	6	)	)	PUNCT
cvj-35	136	7	,	,	PUNCT
cvj-35	136	8	49	49	NUM
cvj-35	136	9	-	-	SYM
cvj-35	136	10	55	55	NUM
cvj-35	136	11	.	.	PUNCT
cvj-35	137	1	11	11	NUM
cvj-35	137	2	.	.	PUNCT
cvj-35	138	1	dirat	dirat	NOUN
cvj-35	138	2	,	,	PUNCT
cvj-35	138	3	b.	b.	PROPN
cvj-35	138	4	,	,	PUNCT
cvj-35	138	5	bochet	bochet	PROPN
cvj-35	138	6	,	,	PUNCT
cvj-35	138	7	l.	l.	PROPN
cvj-35	138	8	,	,	PUNCT
cvj-35	138	9	dabek	dabek	PROPN
cvj-35	138	10	,	,	PUNCT
cvj-35	138	11	m.	m.	NOUN
cvj-35	138	12	,	,	PUNCT
cvj-35	138	13	daviaud	daviaud	PROPN
cvj-35	138	14	,	,	PUNCT
cvj-35	138	15	d.	d.	PROPN
cvj-35	138	16	,	,	PUNCT
cvj-35	138	17	dauvillier	dauvillier	PROPN
cvj-35	138	18	,	,	PUNCT
cvj-35	138	19	s.	s.	PROPN
cvj-35	138	20	,	,	PUNCT
cvj-35	138	21	majed	majed	PROPN
cvj-35	138	22	,	,	PUNCT
cvj-35	138	23	b.	b.	PROPN
cvj-35	138	24	,	,	PUNCT
cvj-35	138	25	wang	wang	PROPN
cvj-35	138	26	,	,	PUNCT
cvj-35	138	27	y.y	y.y	PROPN
cvj-35	138	28	.	.	PROPN
cvj-35	138	29	,	,	PUNCT
cvj-35	138	30	meulle	meulle	PROPN
cvj-35	138	31	,	,	PUNCT
cvj-35	138	32	a.	a.	PROPN
cvj-35	138	33	,	,	PUNCT
cvj-35	138	34	salles	salles	PROPN
cvj-35	138	35	,	,	PUNCT
cvj-35	138	36	b.	b.	PROPN
cvj-35	138	37	,	,	PUNCT
cvj-35	138	38	gonidec	gonidec	PROPN
cvj-35	138	39	,	,	PUNCT
cvj-35	138	40	l.s	l.s	PROPN
cvj-35	138	41	.	.	PROPN
cvj-35	138	42	,	,	PUNCT
cvj-35	138	43	garrido	garrido	PROPN
cvj-35	138	44	,	,	PUNCT
cvj-35	138	45	i.	i.	PROPN
cvj-35	138	46	,	,	PUNCT
cvj-35	138	47	escourrou	escourrou	PROPN
cvj-35	138	48	,	,	PUNCT
cvj-35	138	49	g.	g.	PROPN
cvj-35	138	50	,	,	PUNCT
cvj-35	138	51	valet	valet	NOUN
cvj-35	138	52	,	,	PUNCT
cvj-35	138	53	p.	p.	NOUN
cvj-35	138	54	,	,	PUNCT
cvj-35	138	55	muller	muller	NOUN
cvj-35	138	56	,	,	PUNCT
cvj-35	138	57	c.	c.	PROPN
cvj-35	138	58	cancer	cancer	NOUN
cvj-35	138	59	-	-	PUNCT
cvj-35	138	60	associated	associate	VERB
cvj-35	138	61	adipocytes	adipocyte	NOUN
cvj-35	138	62	exhibit	exhibit	VERB
cvj-35	138	63	an	an	DET
cvj-35	138	64	activated	activated	ADJ
cvj-35	138	65	phenotype	phenotype	NOUN
cvj-35	138	66	and	and	CCONJ
cvj-35	138	67	contribute	contribute	VERB
cvj-35	138	68	to	to	ADP
cvj-35	138	69	breast	breast	NOUN
cvj-35	138	70	cancer	cancer	NOUN
cvj-35	138	71	invasion	invasion	NOUN
cvj-35	138	72	.	.	PUNCT
cvj-35	139	1	cancer	cancer	NOUN
cvj-35	139	2	research	research	PROPN
cvj-35	139	3	2011	2011	NUM
cvj-35	139	4	,	,	PUNCT
cvj-35	139	5	71(7	71(7	NUM
cvj-35	139	6	)	)	PUNCT
cvj-35	139	7	,	,	PUNCT
cvj-35	139	8	2455	2455	NUM
cvj-35	139	9	-	-	SYM
cvj-35	139	10	2465	2465	NUM
cvj-35	139	11	.	.	PUNCT
cvj-35	140	1	12	12	NUM
cvj-35	140	2	.	.	PUNCT
cvj-35	141	1	mueller	mueller	PROPN
cvj-35	141	2	mm	mm	PROPN
cvj-35	141	3	,	,	PUNCT
cvj-35	141	4	fusenig	fusenig	PROPN
cvj-35	141	5	ne	ne	PROPN
cvj-35	141	6	.	.	PUNCT
cvj-35	142	1	friends	friend	NOUN
cvj-35	142	2	or	or	CCONJ
cvj-35	142	3	foes	foe	NOUN
cvj-35	142	4	—	—	PUNCT
cvj-35	142	5	bipolar	bipolar	ADJ
cvj-35	142	6	effects	effect	NOUN
cvj-35	142	7	of	of	ADP
cvj-35	142	8	the	the	DET
cvj-35	142	9	tumour	tumour	NOUN
cvj-35	142	10	stroma	stroma	NOUN
cvj-35	142	11	in	in	ADP
cvj-35	142	12	cancer	cancer	NOUN
cvj-35	142	13	.	.	PUNCT
cvj-35	143	1	nat	nat	PROPN
cvj-35	143	2	rev	rev	VERB
cvj-35	143	3	cancer	cancer	NOUN
cvj-35	143	4	2004	2004	NUM
cvj-35	143	5	;	;	PUNCT
cvj-35	144	1	4:839–49	4:839–49	NUM
cvj-35	144	2	.	.	PUNCT
cvj-35	144	3	cluj	cluj	PROPN
cvj-35	144	4	vet	vet	PROPN
cvj-35	144	5	j	j	PROPN
cvj-35	144	6	2021	2021	NUM
cvj-35	144	7	,	,	PUNCT
cvj-35	144	8	26	26	NUM
cvj-35	144	9	,	,	PUNCT
cvj-35	144	10	3	3	NUM
cvj-35	144	11	26	26	NUM
cvj-35	144	12	13	13	NUM
cvj-35	144	13	.	.	PUNCT
cvj-35	145	1	kim	kim	PROPN
cvj-35	145	2	,	,	PUNCT
cvj-35	145	3	j.	j.	PROPN
cvj-35	145	4	h.	h.	PROPN
cvj-35	145	5	,	,	PUNCT
cvj-35	145	6	bachmann	bachmann	PROPN
cvj-35	145	7	,	,	PUNCT
cvj-35	145	8	r.	r.	PROPN
cvj-35	145	9	a.	a.	PROPN
cvj-35	145	10	,	,	PUNCT
cvj-35	145	11	chen	chen	PROPN
cvj-35	145	12	,	,	PUNCT
cvj-35	145	13	j.	j.	PROPN
cvj-35	145	14	interleukin-6	interleukin-6	PROPN
cvj-35	145	15	and	and	CCONJ
cvj-35	145	16	insulin	insulin	NOUN
cvj-35	145	17	resistance	resistance	NOUN
cvj-35	145	18	.	.	PUNCT
cvj-35	146	1	vitamins	vitamin	NOUN
cvj-35	146	2	&	&	CCONJ
cvj-35	146	3	hormones	hormone	NOUN
cvj-35	146	4	2009	2009	NUM
cvj-35	146	5	,	,	PUNCT
cvj-35	146	6	80	80	NUM
cvj-35	146	7	,	,	PUNCT
cvj-35	146	8	613633	613633	NUM
cvj-35	146	9	.	.	PUNCT
cvj-35	147	1	14	14	NUM
cvj-35	147	2	.	.	PUNCT
cvj-35	148	1	makki	makki	PROPN
cvj-35	148	2	,	,	PUNCT
cvj-35	148	3	k.	k.	PROPN
cvj-35	148	4	,	,	PUNCT
cvj-35	148	5	froguel	froguel	NOUN
cvj-35	148	6	,	,	PUNCT
cvj-35	148	7	p.	p.	NOUN
cvj-35	148	8	,	,	PUNCT
cvj-35	148	9	wolowczuk	wolowczuk	PROPN
cvj-35	148	10	,	,	PUNCT
cvj-35	148	11	i.	i.	NOUN
cvj-35	148	12	adipose	adipose	NOUN
cvj-35	148	13	tissue	tissue	NOUN
cvj-35	148	14	in	in	ADP
cvj-35	148	15	obesity	obesity	NOUN
cvj-35	148	16	-	-	PUNCT
cvj-35	148	17	related	relate	VERB
cvj-35	148	18	inflammation	inflammation	NOUN
cvj-35	148	19	and	and	CCONJ
cvj-35	148	20	insulin	insulin	NOUN
cvj-35	148	21	resistance	resistance	NOUN
cvj-35	148	22	:	:	PUNCT
cvj-35	148	23	cells	cell	NOUN
cvj-35	148	24	,	,	PUNCT
cvj-35	148	25	cytokines	cytokine	NOUN
cvj-35	148	26	,	,	PUNCT
cvj-35	148	27	and	and	CCONJ
cvj-35	148	28	chemokines	chemokine	NOUN
cvj-35	148	29	.	.	PUNCT
cvj-35	149	1	isrn	isrn	PROPN
cvj-35	149	2	inflammation	inflammation	NOUN
cvj-35	149	3	2013	2013	NUM
cvj-35	149	4	,	,	PUNCT
cvj-35	149	5	139239	139239	NUM
cvj-35	149	6	.	.	PUNCT
cvj-35	150	1	https://doi.org/10.1155/2013/139239	https://doi.org/10.1155/2013/139239	PROPN
cvj-35	150	2	15	15	PROPN
cvj-35	150	3	.	.	PUNCT
cvj-35	151	1	chaudhary	chaudhary	PROPN
cvj-35	151	2	,	,	PUNCT
cvj-35	151	3	r.	r.	PROPN
cvj-35	151	4	,	,	PUNCT
cvj-35	151	5	garg	garg	PROPN
cvj-35	151	6	,	,	PUNCT
cvj-35	151	7	j.	j.	PROPN
cvj-35	151	8	,	,	PUNCT
cvj-35	151	9	shah	shah	PROPN
cvj-35	151	10	,	,	PUNCT
cvj-35	151	11	n.	n.	NOUN
cvj-35	151	12	,	,	PUNCT
cvj-35	151	13	sumner	sumner	PROPN
cvj-35	151	14	,	,	PUNCT
cvj-35	151	15	a.	a.	NOUN
cvj-35	151	16	pcsk9	pcsk9	NOUN
cvj-35	151	17	inhibitors	inhibitor	NOUN
cvj-35	151	18	:	:	PUNCT
cvj-35	151	19	a	a	DET
cvj-35	151	20	new	new	ADJ
cvj-35	151	21	era	era	NOUN
cvj-35	151	22	of	of	ADP
cvj-35	151	23	lipid	lipid	NOUN
cvj-35	151	24	lowering	lower	VERB
cvj-35	151	25	therapy	therapy	NOUN
cvj-35	151	26	.	.	PUNCT
cvj-35	152	1	world	world	PROPN
cvj-35	152	2	journal	journal	PROPN
cvj-35	152	3	of	of	ADP
cvj-35	152	4	cardiology	cardiology	NOUN
cvj-35	152	5	2017	2017	NUM
cvj-35	152	6	,	,	PUNCT
cvj-35	152	7	9(2	9(2	NUM
cvj-35	152	8	)	)	PUNCT
cvj-35	152	9	,	,	PUNCT
cvj-35	152	10	76–91	76–91	NUM
cvj-35	152	11	.	.	PUNCT
cvj-35	153	1	https://doi.org/10.4330/wjc.v9.i2.76	https://doi.org/10.4330/wjc.v9.i2.76	PROPN
cvj-35	154	1	16	16	NUM
cvj-35	154	2	.	.	PUNCT
cvj-35	155	1	fattori	fattori	PROPN
cvj-35	155	2	,	,	PUNCT
cvj-35	155	3	e.	e.	PROPN
cvj-35	155	4	,	,	PUNCT
cvj-35	155	5	cappelletti	cappelletti	PROPN
cvj-35	155	6	,	,	PUNCT
cvj-35	155	7	m.	m.	NOUN
cvj-35	155	8	,	,	PUNCT
cvj-35	155	9	lo	lo	PROPN
cvj-35	155	10	surdo	surdo	NOUN
cvj-35	155	11	,	,	PUNCT
cvj-35	155	12	p.	p.	NOUN
cvj-35	155	13	,	,	PUNCT
cvj-35	155	14	calzetta	calzetta	PROPN
cvj-35	155	15	,	,	PUNCT
cvj-35	155	16	a.	a.	NOUN
cvj-35	155	17	,	,	PUNCT
cvj-35	155	18	bendtsen	bendtsen	PROPN
cvj-35	155	19	,	,	PUNCT
cvj-35	155	20	c.	c.	PROPN
cvj-35	155	21	,	,	PUNCT
cvj-35	155	22	ni	ni	PROPN
cvj-35	155	23	,	,	PUNCT
cvj-35	155	24	y.	y.	PROPN
cvj-35	155	25	g.	g.	PROPN
cvj-35	155	26	,	,	PUNCT
cvj-35	155	27	pandit	pandit	PROPN
cvj-35	155	28	,	,	PUNCT
cvj-35	155	29	s.	s.	PROPN
cvj-35	155	30	,	,	PUNCT
cvj-35	155	31	sitlani	sitlani	PROPN
cvj-35	155	32	,	,	PUNCT
cvj-35	155	33	a.	a.	NOUN
cvj-35	155	34	,	,	PUNCT
cvj-35	155	35	mesiti	mesiti	PROPN
cvj-35	155	36	,	,	PUNCT
cvj-35	155	37	g.	g.	PROPN
cvj-35	155	38	,	,	PUNCT
cvj-35	155	39	carfí	carfí	NOUN
cvj-35	155	40	,	,	PUNCT
cvj-35	155	41	a.	a.	NOUN
cvj-35	155	42	,	,	PUNCT
cvj-35	155	43	monaci	monaci	NOUN
cvj-35	155	44	,	,	PUNCT
cvj-35	155	45	p.	p.	NOUN
cvj-35	155	46	immunization	immunization	NOUN
cvj-35	155	47	against	against	ADP
cvj-35	155	48	proprotein	proprotein	PROPN
cvj-35	155	49	convertase	convertase	PROPN
cvj-35	155	50	subtilisin	subtilisin	NOUN
cvj-35	155	51	-	-	PUNCT
cvj-35	155	52	like	like	ADJ
cvj-35	155	53	/	/	SYM
cvj-35	155	54	kexin	kexin	NOUN
cvj-35	155	55	type	type	NOUN
cvj-35	155	56	9	9	NUM
cvj-35	155	57	lowers	lower	VERB
cvj-35	155	58	plasma	plasma	NOUN
cvj-35	155	59	ldl	ldl	NOUN
cvj-35	155	60	-	-	PUNCT
cvj-35	155	61	cholesterol	cholesterol	NOUN
cvj-35	155	62	levels	level	NOUN
cvj-35	155	63	in	in	ADP
cvj-35	155	64	mice	mouse	NOUN
cvj-35	155	65	.	.	PUNCT
cvj-35	156	1	journal	journal	PROPN
cvj-35	156	2	of	of	ADP
cvj-35	156	3	lipid	lipid	PROPN
cvj-35	156	4	research	research	PROPN
cvj-35	156	5	2012	2012	NUM
cvj-35	156	6	,	,	PUNCT
cvj-35	156	7	53(8	53(8	NUM
cvj-35	156	8	)	)	PUNCT
cvj-35	156	9	,	,	PUNCT
cvj-35	156	10	1654–1661	1654–1661	NUM
cvj-35	156	11	.	.	PUNCT
cvj-35	157	1	https://doi.org/10.1194/jlr.m028340	https://doi.org/10.1194/jlr.m028340	PROPN
cvj-35	157	2	17	17	NUM
cvj-35	157	3	.	.	PUNCT
cvj-35	158	1	klop	klop	PROPN
cvj-35	158	2	,	,	PUNCT
cvj-35	158	3	b.	b.	PROPN
cvj-35	158	4	,	,	PUNCT
cvj-35	158	5	elte	elte	PROPN
cvj-35	158	6	,	,	PUNCT
cvj-35	158	7	j.	j.	PROPN
cvj-35	158	8	w.	w.	PROPN
cvj-35	158	9	,	,	PUNCT
cvj-35	158	10	cabezas	cabezas	PROPN
cvj-35	158	11	,	,	PUNCT
cvj-35	158	12	m.	m.	NOUN
cvj-35	158	13	c.	c.	PROPN
cvj-35	158	14	dyslipidemia	dyslipidemia	NOUN
cvj-35	158	15	in	in	ADP
cvj-35	158	16	obesity	obesity	NOUN
cvj-35	158	17	:	:	PUNCT
cvj-35	158	18	mechanisms	mechanism	NOUN
cvj-35	158	19	and	and	CCONJ
cvj-35	158	20	potential	potential	ADJ
cvj-35	158	21	targets	target	NOUN
cvj-35	158	22	.	.	PUNCT
cvj-35	159	1	nutrients	nutrient	NOUN
cvj-35	159	2	2013	2013	NUM
cvj-35	159	3	,	,	PUNCT
cvj-35	159	4	5(4	5(4	NUM
cvj-35	159	5	)	)	PUNCT
cvj-35	159	6	,	,	PUNCT
cvj-35	159	7	1218–1240	1218–1240	NUM
cvj-35	159	8	.	.	PUNCT
cvj-35	160	1	https://doi.org/10.3390/nu5041218	https://doi.org/10.3390/nu5041218	X
cvj-35	160	2	18	18	NUM
cvj-35	160	3	.	.	PUNCT
cvj-35	160	4	onat	onat	PROPN
cvj-35	160	5	,	,	PUNCT
cvj-35	160	6	s.	s.	PROPN
cvj-35	160	7	,	,	PUNCT
cvj-35	160	8	ates	ates	PROPN
cvj-35	160	9	,	,	PUNCT
cvj-35	160	10	g.	g.	PROPN
cvj-35	160	11	,	,	PUNCT
cvj-35	160	12	avcı	avcı	PROPN
cvj-35	160	13	,	,	PUNCT
cvj-35	160	14	a.	a.	PROPN
cvj-35	160	15	,	,	PUNCT
cvj-35	160	16	yıldız	yıldız	PROPN
cvj-35	160	17	,	,	PUNCT
cvj-35	160	18	t.	t.	PROPN
cvj-35	160	19	,	,	PUNCT
cvj-35	160	20	birak	birak	PROPN
cvj-35	160	21	,	,	PUNCT
cvj-35	160	22	a.	a.	NOUN
cvj-35	160	23	,	,	PUNCT
cvj-35	160	24	ozmen	ozmen	PROPN
cvj-35	160	25	,	,	PUNCT
cvj-35	160	26	c.	c.	PROPN
cvj-35	160	27	a.	a.	PROPN
cvj-35	160	28	,	,	PUNCT
cvj-35	160	29	ulku	ulku	VERB
cvj-35	160	30	,	,	PUNCT
cvj-35	160	31	r.	r.	VERB
cvj-35	160	32	the	the	DET
cvj-35	160	33	role	role	NOUN
cvj-35	160	34	of	of	ADP
cvj-35	160	35	mediastinoscopy	mediastinoscopy	NOUN
cvj-35	160	36	in	in	ADP
cvj-35	160	37	the	the	DET
cvj-35	160	38	diagnosis	diagnosis	NOUN
cvj-35	160	39	of	of	ADP
cvj-35	160	40	non	non	ADJ
cvj-35	160	41	-	-	ADJ
cvj-35	160	42	lung	lung	ADJ
cvj-35	160	43	cancer	cancer	NOUN
cvj-35	160	44	diseases	disease	NOUN
cvj-35	160	45	.	.	PUNCT
cvj-35	161	1	therapeutics	therapeutic	NOUN
cvj-35	161	2	and	and	CCONJ
cvj-35	161	3	clinical	clinical	ADJ
cvj-35	161	4	risk	risk	NOUN
cvj-35	161	5	management	management	NOUN
cvj-35	161	6	2017	2017	NUM
cvj-35	161	7	,	,	PUNCT
cvj-35	161	8	13	13	NUM
cvj-35	161	9	,	,	PUNCT
cvj-35	161	10	939	939	NUM
cvj-35	161	11	.	.	PUNCT
cvj-35	161	12	19	19	NUM
cvj-35	161	13	.	.	X
cvj-35	161	14	la	la	PROPN
cvj-35	161	15	vecchia	vecchia	PROPN
cvj-35	161	16	c	c	PROPN
cvj-35	161	17	,	,	PUNCT
cvj-35	161	18	giordano	giordano	PROPN
cvj-35	161	19	sh	sh	PROPN
cvj-35	161	20	,	,	PUNCT
cvj-35	161	21	hortobagyi	hortobagyi	PROPN
cvj-35	161	22	gn	gn	PROPN
cvj-35	161	23	,	,	PUNCT
cvj-35	161	24	chabner	chabner	PROPN
cvj-35	161	25	b.	b.	PROPN
cvj-35	161	26	overweight	overweight	PROPN
cvj-35	161	27	,	,	PUNCT
cvj-35	161	28	obesity	obesity	NOUN
cvj-35	161	29	,	,	PUNCT
cvj-35	161	30	diabetes	diabetes	NOUN
cvj-35	161	31	,	,	PUNCT
cvj-35	161	32	and	and	CCONJ
cvj-35	161	33	risk	risk	NOUN
cvj-35	161	34	of	of	ADP
cvj-35	161	35	breast	breast	NOUN
cvj-35	161	36	cancer	cancer	NOUN
cvj-35	161	37	:	:	PUNCT
cvj-35	161	38	interlocking	interlock	VERB
cvj-35	161	39	pieces	piece	NOUN
cvj-35	161	40	of	of	ADP
cvj-35	161	41	the	the	DET
cvj-35	161	42	puzzle	puzzle	NOUN
cvj-35	161	43	.	.	PUNCT
cvj-35	162	1	oncologist	oncologist	NOUN
cvj-35	162	2	.	.	PUNCT
cvj-35	163	1	2011;16(6):726	2011;16(6):726	NUM
cvj-35	163	2	-	-	PUNCT
cvj-35	163	3	729	729	NUM
cvj-35	163	4	.	.	PUNCT
cvj-35	163	5	doi:10.1634	doi:10.1634	NOUN
cvj-35	163	6	/	/	SYM
cvj-35	163	7	theoncologist.2011	theoncologist.2011	PROPN
cvj-35	163	8	-	-	PUNCT
cvj-35	163	9	0050	0050	NUM
cvj-35	163	10	20	20	NUM
cvj-35	163	11	.	.	PUNCT
cvj-35	164	1	must	must	AUX
cvj-35	164	2	,	,	PUNCT
cvj-35	164	3	a.	a.	NOUN
cvj-35	164	4	,	,	PUNCT
cvj-35	164	5	spadano	spadano	NOUN
cvj-35	164	6	,	,	PUNCT
cvj-35	164	7	j.	j.	PROPN
cvj-35	164	8	,	,	PUNCT
cvj-35	164	9	coakley	coakley	PROPN
cvj-35	164	10	,	,	PUNCT
cvj-35	164	11	e.	e.	PROPN
cvj-35	164	12	h.	h.	PROPN
cvj-35	164	13	,	,	PUNCT
cvj-35	164	14	field	field	NOUN
cvj-35	164	15	,	,	PUNCT
cvj-35	164	16	a.	a.	PROPN
cvj-35	164	17	e.	e.	PROPN
cvj-35	164	18	,	,	PUNCT
cvj-35	164	19	colditz	colditz	PROPN
cvj-35	164	20	,	,	PUNCT
cvj-35	164	21	g.	g.	PROPN
cvj-35	164	22	,	,	PUNCT
cvj-35	164	23	dietz	dietz	PROPN
cvj-35	164	24	,	,	PUNCT
cvj-35	164	25	w.	w.	PROPN
cvj-35	164	26	h.	h.	PROPN
cvj-35	165	1	the	the	DET
cvj-35	165	2	disease	disease	NOUN
cvj-35	165	3	burden	burden	NOUN
cvj-35	165	4	associated	associate	VERB
cvj-35	165	5	with	with	ADP
cvj-35	165	6	overweight	overweight	NOUN
cvj-35	165	7	and	and	CCONJ
cvj-35	165	8	obesity	obesity	NOUN
cvj-35	165	9	.	.	PUNCT
cvj-35	166	1	jama	jama	PROPN
cvj-35	166	2	1999	1999	NUM
cvj-35	166	3	,	,	PUNCT
cvj-35	166	4	282(16	282(16	NUM
cvj-35	166	5	)	)	PUNCT
cvj-35	166	6	,	,	PUNCT
cvj-35	166	7	1523	1523	NUM
cvj-35	166	8	-	-	SYM
cvj-35	166	9	1529	1529	NUM
cvj-35	166	10	.	.	PUNCT
cvj-35	167	1	21	21	NUM
cvj-35	167	2	.	.	PUNCT
cvj-35	167	3	nelson	nelson	PROPN
cvj-35	167	4	,	,	PUNCT
cvj-35	167	5	e.	e.	PROPN
cvj-35	167	6	r.	r.	PROPN
cvj-35	167	7	,	,	PUNCT
cvj-35	167	8	chang	chang	PROPN
cvj-35	167	9	,	,	PUNCT
cvj-35	167	10	c.	c.	PROPN
cvj-35	167	11	y.	y.	PROPN
cvj-35	167	12	,	,	PUNCT
cvj-35	167	13	mcdonnell	mcdonnell	PROPN
cvj-35	167	14	,	,	PUNCT
cvj-35	167	15	d.	d.	PROPN
cvj-35	167	16	p.	p.	PROPN
cvj-35	167	17	cholesterol	cholesterol	PROPN
cvj-35	167	18	and	and	CCONJ
cvj-35	167	19	breast	breast	NOUN
cvj-35	167	20	cancer	cancer	NOUN
cvj-35	167	21	pathophysiology	pathophysiology	NOUN
cvj-35	167	22	.	.	PUNCT
cvj-35	168	1	trends	trend	NOUN
cvj-35	168	2	in	in	ADP
cvj-35	168	3	endocrinology	endocrinology	NOUN
cvj-35	168	4	&	&	CCONJ
cvj-35	168	5	metabolism	metabolism	NOUN
cvj-35	168	6	2014	2014	NUM
cvj-35	168	7	,	,	PUNCT
cvj-35	168	8	25(12	25(12	NUM
cvj-35	168	9	)	)	PUNCT
cvj-35	168	10	,	,	PUNCT
cvj-35	168	11	649	649	NUM
cvj-35	168	12	-	-	SYM
cvj-35	168	13	655	655	NUM
cvj-35	168	14	.	.	PUNCT
cvj-35	169	1	22	22	NUM
cvj-35	169	2	.	.	PUNCT
cvj-35	170	1	touvier	touvier	PROPN
cvj-35	170	2	m	m	PROPN
cvj-35	170	3	,	,	PUNCT
cvj-35	170	4	fassier	fassi	ADJ
cvj-35	170	5	p	p	NOUN
cvj-35	170	6	,	,	PUNCT
cvj-35	170	7	his	his	PRON
cvj-35	170	8	m	m	NOUN
cvj-35	170	9	,	,	PUNCT
cvj-35	170	10	norat	norat	NOUN
cvj-35	170	11	t	t	PROPN
cvj-35	170	12	,	,	PUNCT
cvj-35	170	13	chan	chan	PROPN
cvj-35	170	14	ds	ds	PROPN
cvj-35	170	15	,	,	PUNCT
cvj-35	170	16	blacher	blacher	PROPN
cvj-35	170	17	j	j	PROPN
cvj-35	170	18	,	,	PUNCT
cvj-35	170	19	hercberg	hercberg	PROPN
cvj-35	170	20	s	s	PROPN
cvj-35	170	21	,	,	PUNCT
cvj-35	170	22	galan	galan	PROPN
cvj-35	170	23	p	p	PROPN
cvj-35	170	24	,	,	PUNCT
cvj-35	170	25	druesne	druesne	ADJ
cvj-35	170	26	-	-	PUNCT
cvj-35	170	27	pecollo	pecollo	NOUN
cvj-35	170	28	n	n	CCONJ
cvj-35	170	29	,	,	PUNCT
cvj-35	170	30	latinomartel	latinomartel	ADJ
cvj-35	170	31	p.	p.	NOUN
cvj-35	170	32	cholesterol	cholesterol	NOUN
cvj-35	170	33	and	and	CCONJ
cvj-35	170	34	breast	breast	NOUN
cvj-35	170	35	cancer	cancer	NOUN
cvj-35	170	36	risk	risk	NOUN
cvj-35	170	37	:	:	PUNCT
cvj-35	170	38	a	a	DET
cvj-35	170	39	systematic	systematic	ADJ
cvj-35	170	40	review	review	NOUN
cvj-35	170	41	and	and	CCONJ
cvj-35	170	42	meta	meta	ADJ
cvj-35	170	43	-	-	PUNCT
cvj-35	170	44	analysis	analysis	NOUN
cvj-35	170	45	of	of	ADP
cvj-35	170	46	prospective	prospective	ADJ
cvj-35	170	47	studies	study	NOUN
cvj-35	170	48	.	.	PUNCT
cvj-35	171	1	br	br	PROPN
cvj-35	171	2	j	j	PROPN
cvj-35	171	3	nutr	nutr	PROPN
cvj-35	171	4	.	.	PROPN
cvj-35	171	5	2015	2015	NUM
cvj-35	171	6	,	,	PUNCT
cvj-35	171	7	14;114(3):347	14;114(3):347	NUM
cvj-35	171	8	-	-	SYM
cvj-35	171	9	57	57	NUM
cvj-35	171	10	.	.	PUNCT
cvj-35	172	1	doi	doi	NOUN
cvj-35	172	2	:	:	PUNCT
cvj-35	172	3	10.1017	10.1017	NUM
cvj-35	172	4	/	/	SYM
cvj-35	172	5	s000711451500183x	s000711451500183x	PROPN
cvj-35	172	6	.	.	PROPN
cvj-35	172	7	epub	epub	PROPN
cvj-35	172	8	2015	2015	NUM
cvj-35	172	9	jul	jul	PROPN
cvj-35	172	10	15	15	NUM
cvj-35	172	11	.	.	PUNCT
cvj-35	173	1	pmid	pmid	NOUN
cvj-35	173	2	:	:	PUNCT
cvj-35	173	3	26173770	26173770	NUM
cvj-35	173	4	.	.	PUNCT
cvj-35	174	1	23	23	NUM
cvj-35	174	2	.	.	X
cvj-35	175	1	salonen	salonen	PROPN
cvj-35	175	2	,	,	PUNCT
cvj-35	175	3	j.	j.	PROPN
cvj-35	175	4	t.	t.	PROPN
cvj-35	175	5	risk	risk	NOUN
cvj-35	175	6	of	of	ADP
cvj-35	175	7	cancer	cancer	NOUN
cvj-35	175	8	and	and	CCONJ
cvj-35	175	9	death	death	NOUN
cvj-35	175	10	in	in	ADP
cvj-35	175	11	relation	relation	NOUN
cvj-35	175	12	to	to	PART
cvj-35	175	13	serum	serum	VERB
cvj-35	175	14	cholesterol	cholesterol	NOUN
cvj-35	175	15	:	:	PUNCT
cvj-35	175	16	a	a	DET
cvj-35	175	17	longitudinal	longitudinal	ADJ
cvj-35	175	18	study	study	NOUN
cvj-35	175	19	in	in	ADP
cvj-35	175	20	an	an	DET
cvj-35	175	21	eastern	eastern	ADJ
cvj-35	175	22	finnish	finnish	ADJ
cvj-35	175	23	population	population	NOUN
cvj-35	175	24	with	with	ADP
cvj-35	175	25	high	high	ADJ
cvj-35	175	26	overall	overall	ADJ
cvj-35	175	27	cholesterol	cholesterol	NOUN
cvj-35	175	28	level	level	NOUN
cvj-35	175	29	.	.	PUNCT
cvj-35	176	1	american	american	ADJ
cvj-35	176	2	journal	journal	PROPN
cvj-35	176	3	of	of	ADP
cvj-35	176	4	epidemiology	epidemiology	NOUN
cvj-35	176	5	1982	1982	NUM
cvj-35	176	6	,	,	PUNCT
cvj-35	176	7	116(4	116(4	NUM
cvj-35	176	8	)	)	PUNCT
cvj-35	176	9	,	,	PUNCT
cvj-35	176	10	622	622	NUM
cvj-35	176	11	-	-	SYM
cvj-35	176	12	630	630	NUM
cvj-35	176	13	.	.	PUNCT
cvj-35	176	14	24	24	NUM
cvj-35	176	15	.	.	PUNCT
cvj-35	177	1	guo	guo	PROPN
cvj-35	177	2	,	,	PUNCT
cvj-35	177	3	h.	h.	PROPN
cvj-35	177	4	,	,	PUNCT
cvj-35	177	5	callaway	callaway	PROPN
cvj-35	177	6	,	,	PUNCT
cvj-35	177	7	j.	j.	PROPN
cvj-35	177	8	b.	b.	PROPN
cvj-35	177	9	,	,	PUNCT
cvj-35	177	10	ting	ting	PROPN
cvj-35	177	11	,	,	PUNCT
cvj-35	177	12	j.	j.	PROPN
cvj-35	177	13	p.	p.	PROPN
cvj-35	177	14	inflammasomes	inflammasome	NOUN
cvj-35	177	15	:	:	PUNCT
cvj-35	177	16	mechanism	mechanism	NOUN
cvj-35	177	17	of	of	ADP
cvj-35	177	18	action	action	NOUN
cvj-35	177	19	,	,	PUNCT
cvj-35	177	20	role	role	NOUN
cvj-35	177	21	in	in	ADP
cvj-35	177	22	disease	disease	NOUN
cvj-35	177	23	,	,	PUNCT
cvj-35	177	24	and	and	CCONJ
cvj-35	177	25	therapeutics	therapeutic	NOUN
cvj-35	177	26	.	.	PUNCT
cvj-35	178	1	nature	nature	NOUN
cvj-35	178	2	medicine	medicine	PROPN
cvj-35	178	3	2015	2015	NUM
cvj-35	178	4	,	,	PUNCT
cvj-35	178	5	21(7	21(7	NOUN
cvj-35	178	6	)	)	PUNCT
cvj-35	178	7	,	,	PUNCT
cvj-35	178	8	677	677	NUM
cvj-35	178	9	-	-	SYM
cvj-35	178	10	687	687	NUM
cvj-35	178	11	.	.	PUNCT
cvj-35	179	1	25	25	NUM
cvj-35	179	2	.	.	PUNCT
cvj-35	179	3	nelson	nelson	PROPN
cvj-35	179	4	,	,	PUNCT
cvj-35	179	5	e.	e.	PROPN
cvj-35	179	6	r.	r.	PROPN
cvj-35	179	7	,	,	PUNCT
cvj-35	179	8	wardell	wardell	PROPN
cvj-35	179	9	,	,	PUNCT
cvj-35	179	10	s.	s.	PROPN
cvj-35	179	11	e.	e.	PROPN
cvj-35	179	12	,	,	PUNCT
cvj-35	179	13	jasper	jasper	PROPN
cvj-35	179	14	,	,	PUNCT
cvj-35	179	15	j.	j.	PROPN
cvj-35	179	16	s.	s.	PROPN
cvj-35	179	17	,	,	PUNCT
cvj-35	179	18	park	park	PROPN
cvj-35	179	19	,	,	PUNCT
cvj-35	179	20	s.	s.	PROPN
cvj-35	179	21	,	,	PUNCT
cvj-35	179	22	suchindran	suchindran	NOUN
cvj-35	179	23	,	,	PUNCT
cvj-35	179	24	s.	s.	PROPN
cvj-35	179	25	,	,	PUNCT
cvj-35	179	26	howe	howe	PROPN
cvj-35	179	27	,	,	PUNCT
cvj-35	179	28	m.	m.	PROPN
cvj-35	179	29	k.	k.	PROPN
cvj-35	179	30	,	,	PUNCT
cvj-35	179	31	carver	carver	PROPN
cvj-35	179	32	,	,	PUNCT
cvj-35	179	33	n.j	n.j	PROPN
cvj-35	179	34	.	.	PROPN
cvj-35	179	35	,	,	PUNCT
cvj-35	179	36	pillai	pillai	PROPN
cvj-35	179	37	,	,	PUNCT
cvj-35	179	38	r.v	r.v	PROPN
cvj-35	179	39	.	.	PROPN
cvj-35	179	40	,	,	PUNCT
cvj-35	179	41	sullivan	sullivan	PROPN
cvj-35	179	42	,	,	PUNCT
cvj-35	179	43	p.m.	p.m.	ADV
cvj-35	179	44	,	,	PUNCT
cvj-35	179	45	sondhi	sondhi	PROPN
cvj-35	179	46	,	,	PUNCT
cvj-35	179	47	v.	v.	ADV
cvj-35	179	48	,	,	PUNCT
cvj-35	179	49	umetani	umetani	PROPN
cvj-35	179	50	,	,	PUNCT
cvj-35	179	51	m.	m.	NOUN
cvj-35	179	52	,	,	PUNCT
cvj-35	179	53	geradts	geradts	ADJ
cvj-35	179	54	,	,	PUNCT
cvj-35	179	55	j.	j.	PROPN
cvj-35	179	56	,	,	PUNCT
cvj-35	179	57	mcdonnell	mcdonnell	PROPN
cvj-35	179	58	,	,	PUNCT
cvj-35	179	59	d.	d.	PROPN
cvj-35	179	60	p.	p.	PROPN
cvj-35	179	61	27	27	NUM
cvj-35	179	62	-	-	PUNCT
cvj-35	179	63	hydroxycholesterol	hydroxycholesterol	NOUN
cvj-35	179	64	links	link	NOUN
cvj-35	179	65	hypercholesterolemia	hypercholesterolemia	NOUN
cvj-35	179	66	and	and	CCONJ
cvj-35	179	67	breast	breast	NOUN
cvj-35	179	68	cancer	cancer	NOUN
cvj-35	179	69	pathophysiology	pathophysiology	NOUN
cvj-35	179	70	.	.	PUNCT
cvj-35	180	1	science	science	NOUN
cvj-35	180	2	2013	2013	NUM
cvj-35	180	3	,	,	PUNCT
cvj-35	180	4	342(6162	342(6162	NUM
cvj-35	180	5	)	)	PUNCT
cvj-35	180	6	,	,	PUNCT
cvj-35	180	7	1094	1094	NUM
cvj-35	180	8	-	-	SYM
cvj-35	180	9	1098	1098	NUM
cvj-35	180	10	.	.	PUNCT
cvj-35	181	1	26	26	NUM
cvj-35	181	2	.	.	X
cvj-35	182	1	oliver	oliver	PROPN
cvj-35	182	2	,	,	PUNCT
cvj-35	182	3	m.	m.	PROPN
cvj-35	182	4	f.	f.	PROPN
cvj-35	182	5	(	(	PUNCT
cvj-35	182	6	1981	1981	NUM
cvj-35	182	7	)	)	PUNCT
cvj-35	182	8	.	.	PUNCT
cvj-35	183	1	serum	serum	PROPN
cvj-35	183	2	cholesterol	cholesterol	PROPN
cvj-35	183	3	-	-	PUNCT
cvj-35	183	4	the	the	DET
cvj-35	183	5	knave	knave	NOUN
cvj-35	183	6	of	of	ADP
cvj-35	183	7	hearts	heart	NOUN
cvj-35	183	8	and	and	CCONJ
cvj-35	183	9	the	the	DET
cvj-35	183	10	joker	joker	NOUN
cvj-35	183	11	.	.	PUNCT
cvj-35	184	1	the	the	DET
cvj-35	184	2	lancet	lancet	PROPN
cvj-35	184	3	,	,	PUNCT
cvj-35	184	4	318(8255	318(8255	NUM
cvj-35	184	5	)	)	PUNCT
cvj-35	184	6	,	,	PUNCT
cvj-35	184	7	1090	1090	NUM
cvj-35	184	8	-	-	SYM
cvj-35	184	9	1095	1095	NUM
cvj-35	184	10	.	.	PUNCT
cvj-35	185	1	27	27	NUM
cvj-35	185	2	.	.	PUNCT
cvj-35	186	1	shinitzky	shinitzky	PROPN
cvj-35	186	2	,	,	PUNCT
cvj-35	186	3	m.	m.	NOUN
cvj-35	186	4	membrane	membrane	NOUN
cvj-35	186	5	fluidity	fluidity	NOUN
cvj-35	186	6	and	and	CCONJ
cvj-35	186	7	receptor	receptor	NOUN
cvj-35	186	8	function	function	NOUN
cvj-35	186	9	.	.	PUNCT
cvj-35	187	1	in	in	ADP
cvj-35	187	2	membrane	membrane	NOUN
cvj-35	187	3	fluidity	fluidity	NOUN
cvj-35	187	4	.	.	PUNCT
cvj-35	188	1	springer	springer	NOUN
cvj-35	188	2	1984	1984	NUM
cvj-35	188	3	,	,	PUNCT
cvj-35	188	4	pp	pp	ADP
cvj-35	188	5	.	.	PUNCT
cvj-35	189	1	585	585	NUM
cvj-35	189	2	-	-	SYM
cvj-35	189	3	601	601	NUM
cvj-35	189	4	.	.	PUNCT
cvj-35	190	1	boston	boston	PROPN
cvj-35	190	2	,	,	PUNCT
cvj-35	190	3	ma	ma	PROPN
cvj-35	190	4	.	.	PROPN
cvj-35	190	5	28	28	NUM
cvj-35	190	6	.	.	PUNCT
cvj-35	191	1	nelson	nelson	PROPN
cvj-35	191	2	,	,	PUNCT
cvj-35	191	3	e.	e.	PROPN
cvj-35	191	4	r.	r.	PROPN
cvj-35	191	5	the	the	DET
cvj-35	191	6	significance	significance	NOUN
cvj-35	191	7	of	of	ADP
cvj-35	191	8	cholesterol	cholesterol	NOUN
cvj-35	191	9	and	and	CCONJ
cvj-35	191	10	its	its	PRON
cvj-35	191	11	metabolite	metabolite	NOUN
cvj-35	191	12	,	,	PUNCT
cvj-35	191	13	27	27	NUM
cvj-35	191	14	-	-	PUNCT
cvj-35	191	15	hydroxycholesterol	hydroxycholesterol	NOUN
cvj-35	191	16	in	in	ADP
cvj-35	191	17	breast	breast	NOUN
cvj-35	191	18	cancer	cancer	NOUN
cvj-35	191	19	.	.	PUNCT
cvj-35	192	1	molecular	molecular	ADJ
cvj-35	192	2	and	and	CCONJ
cvj-35	192	3	cellular	cellular	ADJ
cvj-35	192	4	endocrinology	endocrinology	NOUN
cvj-35	192	5	2018	2018	NUM
cvj-35	192	6	,	,	PUNCT
cvj-35	192	7	466	466	NUM
cvj-35	192	8	,	,	PUNCT
cvj-35	192	9	73	73	NUM
cvj-35	192	10	-	-	SYM
cvj-35	192	11	80	80	NUM
cvj-35	192	12	.	.	PUNCT
cvj-35	193	1	29	29	NUM
cvj-35	193	2	.	.	PUNCT
cvj-35	194	1	wu	wu	PROPN
cvj-35	194	2	,	,	PUNCT
cvj-35	194	3	q.	q.	PROPN
cvj-35	194	4	,	,	PUNCT
cvj-35	194	5	ishikawa	ishikawa	PROPN
cvj-35	194	6	,	,	PUNCT
cvj-35	194	7	t.	t.	PROPN
cvj-35	194	8	,	,	PUNCT
cvj-35	194	9	sirianni	sirianni	PROPN
cvj-35	194	10	,	,	PUNCT
cvj-35	194	11	r.	r.	PROPN
cvj-35	194	12	,	,	PUNCT
cvj-35	194	13	tang	tang	PROPN
cvj-35	194	14	,	,	PUNCT
cvj-35	194	15	h.	h.	PROPN
cvj-35	194	16	,	,	PUNCT
cvj-35	194	17	mcdonald	mcdonald	PROPN
cvj-35	194	18	,	,	PUNCT
cvj-35	194	19	j.	j.	PROPN
cvj-35	194	20	g.	g.	PROPN
cvj-35	194	21	,	,	PUNCT
cvj-35	194	22	yuhanna	yuhanna	NOUN
cvj-35	194	23	,	,	PUNCT
cvj-35	194	24	i.	i.	PROPN
cvj-35	194	25	s.	s.	PROPN
cvj-35	194	26	,	,	PUNCT
cvj-35	194	27	thompson	thompson	PROPN
cvj-35	194	28	,	,	PUNCT
cvj-35	194	29	b.	b.	PROPN
cvj-35	194	30	,	,	PUNCT
cvj-35	194	31	girard	girard	PROPN
cvj-35	194	32	,	,	PUNCT
cvj-35	194	33	l.	l.	PROPN
cvj-35	194	34	,	,	PUNCT
cvj-35	194	35	mineo	mineo	PROPN
cvj-35	194	36	,	,	PUNCT
cvj-35	194	37	c.	c.	PROPN
cvj-35	194	38	,	,	PUNCT
cvj-35	194	39	brekken	brekken	VERB
cvj-35	194	40	,	,	PUNCT
cvj-35	194	41	r.a	r.a	PROPN
cvj-35	194	42	.	.	PROPN
cvj-35	194	43	,	,	PUNCT
cvj-35	194	44	umetani	umetani	PROPN
cvj-35	194	45	,	,	PUNCT
cvj-35	194	46	m.	m.	NOUN
cvj-35	194	47	,	,	PUNCT
cvj-35	194	48	euhus	euhus	PROPN
cvj-35	194	49	,	,	PUNCT
cvj-35	194	50	d.m	d.m	PROPN
cvj-35	194	51	.	.	PROPN
cvj-35	194	52	,	,	PUNCT
cvj-35	194	53	xie	xie	PROPN
cvj-35	194	54	,	,	PUNCT
cvj-35	194	55	y.	y.	PROPN
cvj-35	194	56	,	,	PUNCT
cvj-35	194	57	shaul	shaul	PROPN
cvj-35	194	58	,	,	PUNCT
cvj-35	194	59	p.	p.	NOUN
cvj-35	194	60	w.	w.	NOUN
cvj-35	195	1	27	27	NUM
cvj-35	195	2	-	-	PUNCT
cvj-35	195	3	hydroxycholesterol	hydroxycholesterol	NOUN
cvj-35	195	4	promotes	promote	VERB
cvj-35	195	5	cell	cell	NOUN
cvj-35	195	6	-	-	PUNCT
cvj-35	195	7	autonomous	autonomous	ADJ
cvj-35	195	8	,	,	PUNCT
cvj-35	195	9	er	er	INTJ
cvj-35	195	10	-	-	PUNCT
cvj-35	195	11	positive	positive	ADJ
cvj-35	195	12	breast	breast	NOUN
cvj-35	195	13	cancer	cancer	NOUN
cvj-35	195	14	growth	growth	NOUN
cvj-35	195	15	.	.	PUNCT
cvj-35	196	1	cell	cell	NOUN
cvj-35	196	2	reports	report	NOUN
cvj-35	196	3	2013	2013	NUM
cvj-35	196	4	,	,	PUNCT
cvj-35	196	5	5(3	5(3	NUM
cvj-35	196	6	)	)	PUNCT
cvj-35	196	7	,	,	PUNCT
cvj-35	196	8	637	637	NUM
cvj-35	196	9	-	-	SYM
cvj-35	196	10	645	645	NUM
cvj-35	196	11	.	.	NOUN
cvj-35	196	12	30	30	NUM
cvj-35	196	13	.	.	PUNCT
cvj-35	197	1	picon	picon	NOUN
cvj-35	197	2	-	-	PUNCT
cvj-35	197	3	ruiz	ruiz	NOUN
cvj-35	197	4	,	,	PUNCT
cvj-35	197	5	m.	m.	NOUN
cvj-35	197	6	,	,	PUNCT
cvj-35	197	7	morata	morata	NOUN
cvj-35	197	8	-	-	PUNCT
cvj-35	197	9	tarifa	tarifa	PROPN
cvj-35	197	10	,	,	PUNCT
cvj-35	197	11	c.	c.	NOUN
cvj-35	197	12	,	,	PUNCT
cvj-35	197	13	valle	valle	NOUN
cvj-35	197	14	-	-	PUNCT
cvj-35	197	15	goffin	goffin	PROPN
cvj-35	197	16	,	,	PUNCT
cvj-35	197	17	j.	j.	PROPN
cvj-35	197	18	j.	j.	PROPN
cvj-35	197	19	,	,	PUNCT
cvj-35	197	20	friedman	friedman	PROPN
cvj-35	197	21	,	,	PUNCT
cvj-35	197	22	e.	e.	PROPN
cvj-35	197	23	r.	r.	PROPN
cvj-35	197	24	,	,	PUNCT
cvj-35	197	25	slingerland	slingerland	PROPN
cvj-35	197	26	,	,	PUNCT
cvj-35	197	27	j.	j.	PROPN
cvj-35	197	28	m.	m.	PROPN
cvj-35	197	29	obesity	obesity	PROPN
cvj-35	197	30	and	and	CCONJ
cvj-35	197	31	adverse	adverse	ADJ
cvj-35	197	32	breast	breast	NOUN
cvj-35	197	33	cancer	cancer	NOUN
cvj-35	197	34	risk	risk	NOUN
cvj-35	197	35	and	and	CCONJ
cvj-35	197	36	outcome	outcome	NOUN
cvj-35	197	37	:	:	PUNCT
cvj-35	197	38	mechanistic	mechanistic	ADJ
cvj-35	197	39	insights	insight	NOUN
cvj-35	197	40	and	and	CCONJ
cvj-35	197	41	strategies	strategy	NOUN
cvj-35	197	42	for	for	ADP
cvj-35	197	43	intervention	intervention	NOUN
cvj-35	197	44	.	.	PUNCT
cvj-35	198	1	ca	can	AUX
cvj-35	198	2	:	:	PUNCT
cvj-35	198	3	a	a	DET
cvj-35	198	4	cancer	cancer	NOUN
cvj-35	198	5	journal	journal	NOUN
cvj-35	198	6	for	for	ADP
cvj-35	198	7	clinicians	clinician	NOUN
cvj-35	198	8	2017	2017	NUM
cvj-35	198	9	67(5	67(5	NOUN
cvj-35	198	10	)	)	PUNCT
cvj-35	198	11	,	,	PUNCT
cvj-35	198	12	378–397	378–397	NUM
cvj-35	198	13	.	.	PUNCT
cvj-35	199	1	https://doi.org/10.3322/caac.21405	https://doi.org/10.3322/caac.21405	NOUN
cvj-35	199	2	cluj	cluj	PROPN
cvj-35	199	3	vet	vet	PROPN
cvj-35	199	4	j	j	PROPN
cvj-35	199	5	2021	2021	NUM
cvj-35	199	6	,	,	PUNCT
cvj-35	199	7	26	26	NUM
cvj-35	199	8	,	,	PUNCT
cvj-35	199	9	3	3	NUM
cvj-35	199	10	27	27	NUM
cvj-35	199	11	31	31	NUM
cvj-35	199	12	.	.	PUNCT
cvj-35	200	1	zatterale	zatterale	PROPN
cvj-35	200	2	,	,	PUNCT
cvj-35	200	3	f.	f.	PROPN
cvj-35	200	4	,	,	PUNCT
cvj-35	200	5	longo	longo	PROPN
cvj-35	200	6	,	,	PUNCT
cvj-35	200	7	m.	m.	NOUN
cvj-35	200	8	,	,	PUNCT
cvj-35	200	9	naderi	naderi	PROPN
cvj-35	200	10	,	,	PUNCT
cvj-35	200	11	j.	j.	PROPN
cvj-35	200	12	,	,	PUNCT
cvj-35	200	13	raciti	raciti	PROPN
cvj-35	200	14	,	,	PUNCT
cvj-35	200	15	g.	g.	PROPN
cvj-35	200	16	a.	a.	PROPN
cvj-35	200	17	,	,	PUNCT
cvj-35	200	18	desiderio	desiderio	PROPN
cvj-35	200	19	,	,	PUNCT
cvj-35	200	20	a.	a.	PROPN
cvj-35	200	21	,	,	PUNCT
cvj-35	200	22	miele	miele	PROPN
cvj-35	200	23	,	,	PUNCT
cvj-35	200	24	c.	c.	PROPN
cvj-35	200	25	,	,	PUNCT
cvj-35	200	26	beguinot	beguinot	VERB
cvj-35	200	27	,	,	PUNCT
cvj-35	200	28	f.	f.	PROPN
cvj-35	200	29	chronic	chronic	PROPN
cvj-35	201	1	adipose	adipose	ADP
cvj-35	201	2	tissue	tissue	NOUN
cvj-35	201	3	inflammation	inflammation	NOUN
cvj-35	201	4	linking	link	VERB
cvj-35	201	5	obesity	obesity	NOUN
cvj-35	201	6	to	to	ADP
cvj-35	201	7	insulin	insulin	NOUN
cvj-35	201	8	resistance	resistance	NOUN
cvj-35	201	9	and	and	CCONJ
cvj-35	201	10	type	type	NOUN
cvj-35	201	11	2	2	NUM
cvj-35	201	12	diabetes	diabetes	NOUN
cvj-35	201	13	.	.	PUNCT
cvj-35	202	1	frontiers	frontier	NOUN
cvj-35	202	2	in	in	ADP
cvj-35	202	3	physiology	physiology	NOUN
cvj-35	202	4	2020	2020	NUM
cvj-35	202	5	,	,	PUNCT
cvj-35	202	6	10	10	NUM
cvj-35	202	7	,	,	PUNCT
cvj-35	202	8	1607	1607	NUM
cvj-35	202	9	.	.	PUNCT
cvj-35	203	1	https://doi.org/10.3389/fphys.2019.01607	https://doi.org/10.3389/fphys.2019.01607	PROPN
cvj-35	203	2	32	32	NUM
cvj-35	203	3	.	.	PUNCT
cvj-35	204	1	simons	simon	NOUN
cvj-35	204	2	,	,	PUNCT
cvj-35	204	3	p.	p.	PROPN
cvj-35	204	4	j.	j.	PROPN
cvj-35	204	5	,	,	PUNCT
cvj-35	204	6	van	van	PROPN
cvj-35	204	7	den	den	PROPN
cvj-35	204	8	pangaart	pangaart	PROPN
cvj-35	204	9	,	,	PUNCT
cvj-35	204	10	p.	p.	PROPN
cvj-35	204	11	s.	s.	PROPN
cvj-35	204	12	,	,	PUNCT
cvj-35	204	13	van	van	PROPN
cvj-35	204	14	roomen	rooman	NOUN
cvj-35	204	15	,	,	PUNCT
cvj-35	204	16	c.	c.	PROPN
cvj-35	204	17	p.	p.	PROPN
cvj-35	204	18	,	,	PUNCT
cvj-35	204	19	aerts	aert	NOUN
cvj-35	204	20	,	,	PUNCT
cvj-35	204	21	j.	j.	PROPN
cvj-35	204	22	m.	m.	PROPN
cvj-35	204	23	,	,	PUNCT
cvj-35	204	24	boon	boon	NOUN
cvj-35	204	25	,	,	PUNCT
cvj-35	204	26	l.	l.	PROPN
cvj-35	204	27	cytokine	cytokine	PROPN
cvj-35	204	28	-	-	PUNCT
cvj-35	204	29	mediated	mediate	VERB
cvj-35	204	30	modulation	modulation	NOUN
cvj-35	204	31	of	of	ADP
cvj-35	204	32	leptin	leptin	NOUN
cvj-35	204	33	and	and	CCONJ
cvj-35	204	34	adiponectin	adiponectin	NOUN
cvj-35	204	35	secretion	secretion	NOUN
cvj-35	204	36	during	during	ADP
cvj-35	204	37	in	in	ADP
cvj-35	204	38	vitro	vitro	X
cvj-35	204	39	adipogenesis	adipogenesis	NOUN
cvj-35	204	40	:	:	PUNCT
cvj-35	204	41	evidence	evidence	NOUN
cvj-35	204	42	that	that	SCONJ
cvj-35	204	43	tumor	tumor	NOUN
cvj-35	204	44	necrosis	necrosis	NOUN
cvj-35	204	45	factor	factor	NOUN
cvj-35	204	46	-	-	PUNCT
cvj-35	204	47	αand	αand	NOUN
cvj-35	204	48	interleukin-1β	interleukin-1β	NOUN
cvj-35	204	49	-	-	PUNCT
cvj-35	204	50	treated	treat	VERB
cvj-35	204	51	human	human	ADJ
cvj-35	204	52	preadipocytes	preadipocyte	NOUN
cvj-35	204	53	are	be	AUX
cvj-35	204	54	potent	potent	ADJ
cvj-35	204	55	leptin	leptin	NOUN
cvj-35	204	56	producers	producer	NOUN
cvj-35	204	57	.	.	PUNCT
cvj-35	205	1	cytokine	cytokine	VERB
cvj-35	205	2	2005	2005	NUM
cvj-35	205	3	,	,	PUNCT
cvj-35	205	4	32(2	32(2	NUM
cvj-35	205	5	)	)	PUNCT
cvj-35	205	6	,	,	PUNCT
cvj-35	205	7	94	94	NUM
cvj-35	205	8	-	-	SYM
cvj-35	205	9	103	103	NUM
cvj-35	205	10	.	.	PUNCT
cvj-35	206	1	33	33	NUM
cvj-35	206	2	.	.	PUNCT
cvj-35	206	3	kern	kern	PROPN
cvj-35	206	4	,	,	PUNCT
cvj-35	206	5	p.	p.	NOUN
cvj-35	206	6	a.	a.	PROPN
cvj-35	206	7	,	,	PUNCT
cvj-35	206	8	ranganathan	ranganathan	PROPN
cvj-35	206	9	,	,	PUNCT
cvj-35	206	10	s.	s.	PROPN
cvj-35	206	11	,	,	PUNCT
cvj-35	206	12	li	li	PROPN
cvj-35	206	13	,	,	PUNCT
cvj-35	206	14	c.	c.	PROPN
cvj-35	206	15	,	,	PUNCT
cvj-35	206	16	wood	wood	PROPN
cvj-35	206	17	,	,	PUNCT
cvj-35	206	18	l.	l.	PROPN
cvj-35	206	19	,	,	PUNCT
cvj-35	206	20	ranganathan	ranganathan	PROPN
cvj-35	206	21	,	,	PUNCT
cvj-35	206	22	g.	g.	PROPN
cvj-35	206	23	adipose	adipose	PRON
cvj-35	206	24	tissue	tissue	NOUN
cvj-35	206	25	tumor	tumor	NOUN
cvj-35	206	26	necrosis	necrosis	NOUN
cvj-35	206	27	factor	factor	NOUN
cvj-35	206	28	and	and	CCONJ
cvj-35	206	29	interleukin-6	interleukin-6	NUM
cvj-35	206	30	expression	expression	NOUN
cvj-35	206	31	in	in	ADP
cvj-35	206	32	human	human	ADJ
cvj-35	206	33	obesity	obesity	NOUN
cvj-35	206	34	and	and	CCONJ
cvj-35	206	35	insulin	insulin	NOUN
cvj-35	206	36	resistance	resistance	NOUN
cvj-35	206	37	.	.	PUNCT
cvj-35	207	1	american	american	PROPN
cvj-35	207	2	journal	journal	PROPN
cvj-35	207	3	of	of	ADP
cvj-35	207	4	physiology	physiology	NOUN
cvj-35	207	5	-	-	PUNCT
cvj-35	207	6	endocrinology	endocrinology	NOUN
cvj-35	207	7	and	and	CCONJ
cvj-35	207	8	metabolism	metabolism	NOUN
cvj-35	207	9	2001	2001	NUM
cvj-35	207	10	,	,	PUNCT
cvj-35	207	11	280(5	280(5	NUM
cvj-35	207	12	)	)	PUNCT
cvj-35	207	13	,	,	PUNCT
cvj-35	207	14	e745	e745	PROPN
cvj-35	207	15	-	-	PUNCT
cvj-35	207	16	e751	e751	PROPN
cvj-35	207	17	.	.	PROPN
cvj-35	208	1	34	34	NUM
cvj-35	208	2	.	.	PUNCT
cvj-35	209	1	thelen	thelen	PROPN
cvj-35	209	2	,	,	PUNCT
cvj-35	209	3	k.	k.	PROPN
cvj-35	209	4	m.	m.	PROPN
cvj-35	209	5	,	,	PUNCT
cvj-35	209	6	lütjohann	lütjohann	PROPN
cvj-35	209	7	,	,	PUNCT
cvj-35	209	8	d.	d.	PROPN
cvj-35	209	9	,	,	PUNCT
cvj-35	209	10	vesalainen	vesalainen	PROPN
cvj-35	209	11	,	,	PUNCT
cvj-35	209	12	r.	r.	PROPN
cvj-35	209	13	,	,	PUNCT
cvj-35	209	14	janatuinen	janatuinen	PROPN
cvj-35	209	15	,	,	PUNCT
cvj-35	209	16	t.	t.	PROPN
cvj-35	209	17	,	,	PUNCT
cvj-35	209	18	knuuti	knuuti	PROPN
cvj-35	209	19	,	,	PUNCT
cvj-35	209	20	j.	j.	PROPN
cvj-35	209	21	,	,	PUNCT
cvj-35	209	22	von	von	PROPN
cvj-35	209	23	bergmann	bergmann	PROPN
cvj-35	209	24	,	,	PUNCT
cvj-35	209	25	k.	k.	PROPN
cvj-35	209	26	,	,	PUNCT
cvj-35	209	27	lehtimäki	lehtimäki	PROPN
cvj-35	209	28	,	,	PUNCT
cvj-35	209	29	t.	t.	PROPN
cvj-35	209	30	,	,	PUNCT
cvj-35	209	31	laaksonen	laaksonen	PROPN
cvj-35	209	32	,	,	PUNCT
cvj-35	209	33	r.	r.	X
cvj-35	209	34	effect	effect	NOUN
cvj-35	209	35	of	of	ADP
cvj-35	209	36	pravastatin	pravastatin	NOUN
cvj-35	209	37	on	on	ADP
cvj-35	209	38	plasma	plasma	NOUN
cvj-35	209	39	sterols	sterol	NOUN
cvj-35	209	40	and	and	CCONJ
cvj-35	209	41	oxysterols	oxysterol	NOUN
cvj-35	209	42	in	in	ADP
cvj-35	209	43	men	man	NOUN
cvj-35	209	44	.	.	PUNCT
cvj-35	210	1	european	european	ADJ
cvj-35	210	2	journal	journal	PROPN
cvj-35	210	3	of	of	ADP
cvj-35	210	4	clinical	clinical	ADJ
cvj-35	210	5	pharmacology	pharmacology	NOUN
cvj-35	210	6	2006	2006	NUM
cvj-35	210	7	,	,	PUNCT
cvj-35	210	8	62(1	62(1	NOUN
cvj-35	210	9	)	)	PUNCT
cvj-35	210	10	,	,	PUNCT
cvj-35	210	11	9	9	NUM
cvj-35	210	12	-	-	SYM
cvj-35	210	13	14	14	NUM
cvj-35	210	14	.	.	PUNCT